
<html lang="en"     class="pb-page"  data-request-id="aaec3819-8b21-4dca-872a-50f314ea8cfc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm500537u;issue:issue:10.1021/jmcmar.2015.58.issue-1;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents" /></meta><meta name="dc.Creator" content="Peter B.  Sampson" /></meta><meta name="dc.Creator" content="Yong  Liu" /></meta><meta name="dc.Creator" content="Narendra Kumar  Patel" /></meta><meta name="dc.Creator" content="Miklos  Feher" /></meta><meta name="dc.Creator" content="Bryan  Forrest" /></meta><meta name="dc.Creator" content="Sze-Wan  Li" /></meta><meta name="dc.Creator" content="Louise  Edwards" /></meta><meta name="dc.Creator" content="Radoslaw  Laufer" /></meta><meta name="dc.Creator" content="Yunhui  Lang" /></meta><meta name="dc.Creator" content="Fuqiang  Ban" /></meta><meta name="dc.Creator" content="Donald E.  Awrey" /></meta><meta name="dc.Creator" content="Guodong  Mao" /></meta><meta name="dc.Creator" content="Olga  Plotnikova" /></meta><meta name="dc.Creator" content="Genie  Leung" /></meta><meta name="dc.Creator" content="Richard  Hodgson" /></meta><meta name="dc.Creator" content="Jacqueline  Mason" /></meta><meta name="dc.Creator" content="Xin  Wei" /></meta><meta name="dc.Creator" content="Reza  Kiarash" /></meta><meta name="dc.Creator" content="Erin  Green" /></meta><meta name="dc.Creator" content="Wei  Qiu" /></meta><meta name="dc.Creator" content="Nickolay Y.  Chirgadze" /></meta><meta name="dc.Creator" content="Tak W.  Mak" /></meta><meta name="dc.Creator" content="Guohua  Pan" /></meta><meta name="dc.Creator" content="Henry W.  Pauls" /></meta><meta name="dc.Description" content="Polo-like kinase 4 (PLK4), a unique member of the polo-like kinase family of serine-threonine kinases, is a master regulator of centriole duplication that is important for maintaining genome integr..." /></meta><meta name="Description" content="Polo-like kinase 4 (PLK4), a unique member of the polo-like kinase family of serine-threonine kinases, is a master regulator of centriole duplication that is important for maintaining genome integr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 24, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500537u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500537u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500537u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500537u" /></link>
        
    
    

<title>The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500537u" /></meta><meta property="og:title" content="The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0009.jpeg" /></meta><meta property="og:description" content="Polo-like kinase 4 (PLK4), a unique member of the polo-like kinase family of serine-threonine kinases, is a master regulator of centriole duplication that is important for maintaining genome integrity. Overexpression of PLK4 is found in several human cancers and is linked with a predisposition to tumorigenesis. Previous efforts to identify potent and efficacious PLK4 inhibitors resulted in the discovery of (E)-3-((1H-indazol-6-yl)methylene)indolin-2-ones, which are superseded by the bioisosteric 2-(1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones reported herein. Optimization of this new cyclopropane-linked series was based on a computational model of a PLK4 X-ray structure and SAR attained from the analogous alkene-linked series. The racemic cyclopropane-linked compounds showed PLK4 affinity and antiproliferative activity comparable to their alkene-linked congeners with improved physicochemical, ADME, and pharmacokinetic properties. Positive xenograft results from the MDA-MB-468 human breast cancer xenograft model for compound 18 support the investigation of PLK4 inhibitors as anticancer therapeutics. A PLK4 X-ray co-structure with racemate 18 revealed preferential binding of the 1R,2S enantiomer to the PLK4 kinase domain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500537u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500537u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500537u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500537u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500537u&amp;href=/doi/10.1021/jm500537u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 130-146</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501613q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5005336" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3<i>H</i>]indol]-2′(1′<i>H</i>)-ones as Orally Bioavailable Antitumor Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+B.++Sampson">Peter B. Sampson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Liu">Yong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Narendra+Kumar++Patel">Narendra Kumar Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miklos++Feher">Miklos Feher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan++Forrest">Bryan Forrest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sze-Wan++Li">Sze-Wan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Edwards">Louise Edwards</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Radoslaw++Laufer">Radoslaw Laufer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunhui++Lang">Yunhui Lang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fuqiang++Ban">Fuqiang Ban</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+E.++Awrey">Donald E. Awrey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guodong++Mao">Guodong Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Plotnikova">Olga Plotnikova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Genie++Leung">Genie Leung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Hodgson">Richard Hodgson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline++Mason">Jacqueline Mason</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Wei">Xin Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reza++Kiarash">Reza Kiarash</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin++Green">Erin Green</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Qiu">Wei Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nickolay+Y.++Chirgadze">Nickolay Y. Chirgadze</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tak+W.++Mak">Tak W. Mak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guohua++Pan">Guohua Pan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry+W.++Pauls">Henry W. Pauls</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Campbell Family Institute for Breast Cancer Research, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Princess Margaret Cancer Center, University Health Network, Toronto, Ontario M5G 2C4, Canada</span></div><div class="corresp-info"><strong>*</strong>Phone: 416-581-7724. Fax: 416-581-7573. E-mail: <a href="/cdn-cgi/l/email-protection#067675676b7675696846736e68746375636774656e286567"><span class="__cf_email__" data-cfemail="82f2f1e3eff2f1edecc2f7eaecf0e7f1e7e3f0e1eaace1e3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500537u&amp;href=/doi/10.1021%2Fjm500537u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 130–146</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 27, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 April 2014</li><li><span class="item_label"><b>Published</b> online</span>24 June 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 January 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500537u" title="DOI URL">https://doi.org/10.1021/jm500537u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D130%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPeter%2BB.%2BSampson%252C%2BYong%2BLiu%252C%2BNarendra%2BKumar%2BPatel%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D1%26contentID%3Djm500537u%26title%3DThe%2BDiscovery%2Bof%2BPolo-Like%2BKinase%2B4%2BInhibitors%253A%2BDesign%2Band%2BOptimization%2Bof%2BSpiro%255Bcyclopropane-1%252C3%25E2%2580%25B2%255B3H%255Dindol%255D-2%25E2%2580%25B2%25281%25E2%2580%25B2H%2529-ones%2Bas%2BOrally%2BBioavailable%2BAntitumor%2BAgents%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D146%26publicationDate%3DJanuary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500537u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3463</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">62</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500537u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;B. Sampson&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Narendra&quot;,&quot;last_name&quot;:&quot;Kumar Patel&quot;},{&quot;first_name&quot;:&quot;Miklos&quot;,&quot;last_name&quot;:&quot;Feher&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;Forrest&quot;},{&quot;first_name&quot;:&quot;Sze-Wan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Edwards&quot;},{&quot;first_name&quot;:&quot;Radoslaw&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Yunhui&quot;,&quot;last_name&quot;:&quot;Lang&quot;},{&quot;first_name&quot;:&quot;Fuqiang&quot;,&quot;last_name&quot;:&quot;Ban&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;E. Awrey&quot;},{&quot;first_name&quot;:&quot;Guodong&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Plotnikova&quot;},{&quot;first_name&quot;:&quot;Genie&quot;,&quot;last_name&quot;:&quot;Leung&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Hodgson&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;Mason&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Reza&quot;,&quot;last_name&quot;:&quot;Kiarash&quot;},{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;Green&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Nickolay&quot;,&quot;last_name&quot;:&quot;Y. Chirgadze&quot;},{&quot;first_name&quot;:&quot;Tak&quot;,&quot;last_name&quot;:&quot;W. Mak&quot;},{&quot;first_name&quot;:&quot;Guohua&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;W. Pauls&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;130-146&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500537u&quot;},&quot;abstract&quot;:&quot;Polo-like kinase 4 (PLK4), a unique member of the polo-like kinase family of serine-threonine kinases, is a master regulator of centriole duplication that is important for maintaining genome integrity. Overexpression of PLK4 is found in several human cancers and is linked with a predisposition to tumorigenesis. Previous efforts to identify potent and efficacious PLK4 inhibitors resulted in the discovery of (E)-3-((1H-indazol-6-yl)methylene)indolin-2-ones, which are superseded by the bioisosteric 2-(1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones reported herein. Optimization of this new cyclopropane-linked series was based on a computational model of a PLK4 X-ray structure and SAR attained from the analogous alkene-linked series. The racemic cyclopropane-linked compounds showed PLK4 affinity and antiproliferative activity comparable to their alkene-linked congeners with improved physicochemical, ADME, and pharmacokinetic properties. Positive xenograft results from the MDA-MB-468 human breast cancer x&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500537u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500537u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500537u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500537u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500537u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500537u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500537u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500537u&amp;href=/doi/10.1021/jm500537u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500537u" /></input><a href="/doi/pdf/10.1021/jm500537u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500537u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500537u%26sid%3Dliteratum%253Aachs%26pmid%3D24867164%26genre%3Darticle%26aulast%3DSampson%26date%3D2015%26atitle%3DThe%2BDiscovery%2Bof%2BPolo-Like%2BKinase%2B4%2BInhibitors%253A%2BDesign%2Band%2BOptimization%2Bof%2BSpiro%255Bcyclopropane-1%252C3%25E2%2580%25B2%255B3H%255Dindol%255D-2%25E2%2580%25B2%25281%25E2%2580%25B2H%2529-ones%2Bas%2BOrally%2BBioavailable%2BAntitumor%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D1%26spage%3D130%26epage%3D146%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jmcmar.2015.58.issue-1/20150108/jmcmar.2015.58.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Polo-like kinase 4 (PLK4), a unique member of the polo-like kinase family of serine-threonine kinases, is a master regulator of centriole duplication that is important for maintaining genome integrity. Overexpression of PLK4 is found in several human cancers and is linked with a predisposition to tumorigenesis. Previous efforts to identify potent and efficacious PLK4 inhibitors resulted in the discovery of (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones, which are superseded by the bioisosteric 2-(1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones reported herein. Optimization of this new cyclopropane-linked series was based on a computational model of a PLK4 X-ray structure and SAR attained from the analogous alkene-linked series. The racemic cyclopropane-linked compounds showed PLK4 affinity and antiproliferative activity comparable to their alkene-linked congeners with improved physicochemical, ADME, and pharmacokinetic properties. Positive xenograft results from the MDA-MB-468 human breast cancer xenograft model for compound <b>18</b> support the investigation of PLK4 inhibitors as anticancer therapeutics. A PLK4 X-ray co-structure with racemate <b>18</b> revealed preferential binding of the 1<i>R</i>,2<i>S</i> enantiomer to the PLK4 kinase domain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/58/1"><issue-title>New Frontiers in Kinases</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Blocking cell division through the inhibition of mitosis is one of the most successful clinical strategies for the treatment of cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Antimitotic drugs, such as the vinca alkaloids and taxanes, have demonstrated therapeutic efficacy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The ubiquitous role of tubulin during mitosis in both cancer and normal cells, however, limits the clinical use of these antimitotics as a result of significant toxicities in normal cells.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> A number of mitotic kinases have been identified as having unique and essential roles in cell division, and some of these are the focus of chemotherapeutic drug discovery.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The selectivity and distinct ways in which these new targeted kinase inhibitors interfere with mitosis provide the potential to not only overcome certain limitations of current antimitotic therapeutics but to expand the area of clinical efficacy established by those drugs. The Aurora kinases, AURKA and AURKB, are established druggable targets,<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1, 3)</a> with several inhibitors,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> such as Alisertib<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (<b>1</b>), currently undergoing clinical evaluation as anticancer agents. Another class of mitotic kinases that have gained attention as therapeutic targets are the Polo-like kinases.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The human Polo-like kinase (PLK) family consists of five serine-threonine kinases, PLK1, PLK2 (Snk), PLK3 (Fnk, Prk), PLK4 (Sak), and PLK5, and are characterized by the presence of a highly conserved N-terminal catalytic domain and one or two C-terminal polo-box domains.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Of the five, PLK1 has been the most extensively studied and there are several PLK1 inhibitors currently in phase 1 and phase 2 clinical trials.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">PLK4 is the most structurally diverse of the PLKs, sharing little homology with the rest of the family, possessing only one polo-box domain instead of two.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> PLK4 is a low abundance kinase present only in proliferating tissues and is a conserved upstream regulator of centriole duplication. PLK4 is aberrantly expressed in breast cancer and, in particular, the triple-negative/basal-like (TNBC) subclass, as well as other tumor types. Upregulation of PLK4 causes centriole overduplication, and this can result in centrosome amplification.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Human cancers frequently contain extra centrosomes, and they are proposed to play a causative role in genome instability and tumor development. Conversely, depletion of PLK4 by RNA interference (RNAi) prevents centriole duplication,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> resulting in mitotic defects<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and cell death. These observations were corroborated by our internal RNAi results;<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> PLK4 knockdown caused breast cancer cell death while normal cells were unaffected. In addition, PLK4 depletion was shown to cause the suppression of breast cancer tumor growth in mice xenograft experiments. We rationalized that small-molecule inhibition of PLK4 would potentially be beneficial therapeutically, and recently we have reported our PLK4-directed drug discovery efforts.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><div class="NLM_p">A number of known kinase inhibitors, such as the Aurora kinase inhibitor VX-680<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<b>2</b>), and the antiangiogenic Axitinib<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (<b>3</b>) are also low nM inhibitors of PLK4 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We developed our first-generation PLK4 inhibitors from a screening exercise that yielded simple compounds with micromolar PLK4 activity. Subsequent iterations of structure based design, synthesis, and in vitro screening yielded substituted indazolyl-indolinone compounds such as <b>4</b>, <b>5</b>, and <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As a class, these inhibitors displayed excellent PLK4 potency, antiproliferative activity, and robust tumor growth inhibition upon IP dosing. Unfortunately, this series displayed poor pharmacokinetic properties, in particular, low oral exposure. An additional drawback was the configurational lability inherent in these alkene-linked inhibitors. The indazolylmethyleneindolinone compounds, while preferentially isolated as the <i>E</i>-isomer, have the potential to isomerize in vivo, yielding indeterminate mixtures of <i>E</i>/<i>Z</i> isomers. We envisioned that configurational stability and physicochemical properties would be improved through bioisosteric replacement of the double bond with a cyclopropane ring. Cyclopropanes are present in many natural products and pharmaceuticals<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> and have been used in drug discovery programs to prepare conformationally restricted analogues of peptidomimetics<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and SSRIs.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Moreover, spirocyclopropyl-oxindoles have been investigated as reverse transcriptase inhibitors<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and reported as kinase inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PLK4 activity of known kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)indolin-2-one PLK4 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein we describe the synthesis of 2-(1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones and optimization of this series as novel PLK-4 inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemical Synthesis</h3><div class="NLM_p">Treatment of indazol-6-ylmethyleneindolin-2-one (<b>7</b>) with trimethylsulfoxonium iodide under modified Corey–Chaykovsky<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> conditions gave the racemic cyclopropyl analogues in a 14:1 mixture of trans (<b>8</b>) and cis (<b>9</b>) diastereomers, as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, which were separated by silica gel chromatography. The trans relative stereochemistry was defined based on the work by Moldvai and co-workers as described for a series of pyridyl spirocyclopropylindolones.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Irradiation of the 2-H cyclopropane proton resonance only showed a NOE enhancement to one of the 3-H cyclopropane protons of <b>8</b>. However, 2-H cyclopropane proton resonance irradiation of compound <b>9</b> gives an NOE enhancement of the signal assigned to the 4′-H of the indolone ring. Moreover, the 4′-H proton is shifted upfield in the trans conformation compared to the cis by 1.2 ppm as a result of anisotropic shielding by the indazole ring. Thus, trans diastereomers can readily be distinguished from the cis diastereomers by <sup>1</sup>H NMR.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Racemic 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) Me<sub>3</sub>SOI, NaH, DMF, rt.</p></p></figure><div class="NLM_p">Compounds carrying the vinyl-aryl substituent were prepared by various methods, as outlined in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Cyclopropanation of SEM-protected indolinone <b>10</b> under Corey–Chaykovsky conditions gave <b>11</b>. Cyclopropane analogues of indolinones <b>4</b> and <b>5</b> were prepared via installation of the vinyl-aryl substituent under conventional Heck reaction conditions, followed by removal of the SEM group by stepwise treatment with boron trifluoride etherate and 2 M HCl to give <b>12</b> and <b>13</b>. Alternatively, indolinones such as <b>6</b>, <b>14</b>, and <b>15</b> could be treated under Corey–Chaykovsky conditions to give the cyclopropyl analogues <b>16</b>, <b>17</b>, and <b>18</b> directly.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Racemic Vinylaryl 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones by Cyclopropanation of Methylene-indolin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Me<sub>3</sub>SOI, NaH, DMF, rt; (ii) ArCH═CH<sub>2</sub>, 5 mol % Pd(OAc)<sub>2</sub>, P(o-Tol)<sub>3</sub>, DIPEA, DMF, 130 °C, 2 h; (iii) BF<sub>3</sub>OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 2 h; (iv) 2:1 EtOH/2 M aq HCl, 50 °C, 2 h.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Racemic Vinylaryl 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Me<sub>3</sub>SOI, NaH, DMF, rt; (ii) 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, 2 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, 2:1 PhCH<sub>3</sub>/EtOH, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, 125 °C, 3 h; (iii) ArBr, 5 mol % Pd(OAc)<sub>2</sub>, P(<i>o</i>-tol)<sub>3</sub>, DIPEA, DMF, 125 °C, 2 h; (iv) 3:1 EtOH/PhCH<sub>3</sub>, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 120 °C, 2 h; (v) diethyl 4-cyanobenzylphosphonate, <i>t</i>-BuOK, DMF, 0 °C; (vi) Raney Nickel, NaH<sub>2</sub>PO<sub>2</sub>, DMF, pyridine, AcOH, H<sub>2</sub>O, 60 °C; (vii) R′<sub>2</sub>NH, Ti(Oi-Pr)<sub>4</sub>, NaBH<sub>4</sub>, THF, 40 °C.</p></p></figure><div class="NLM_p">To prepare analogues via a more convergent route and avoid the use of protecting groups, three additional synthetic paths were developed in which the cyclopropyl modification was introduced at an earlier stage, and the vinyl-aryl group was installed at either the penultimate or final stage. Cyclopropyl iodides (<b>20a</b>–<b>g</b>) were prepared under standard conditions from indolinones (<b>19a</b>–<b>g</b>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In general, Heck coupling to introduce the vinyl-aryl group to cyclopropyl iodides <b>20a</b>–<b>g</b> either failed or generated the desired compound in low yield. However, switching to Suzuki–Miyaura conditions with vinylboronate esters (prepared either via ruthenium catalyzed hydroboration of the corresponding terminal alkyne<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> or vinyl boronate Heck coupling with the appropriate aryl bromide<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a>) gave the desired inhibitors <b>26</b>–<b>37</b> and <b>39</b> directly from iodides <b>20a</b>–<b>g</b> in better yields.</div><div class="NLM_p">Second, the desired analogues were generated by treatment of <b>20a</b> under Suzuki–Miyaura conditions with commercially available vinyl boronate ester to give the vinylindazole <b>21</b>. The vinyl analogue, <b>21</b>, was then arylated under Heck conditions with the appropriate aryl bromide to give compounds <b>24</b>, <b>25</b>, and <b>38</b> directly in good yield. The main drawback of this route was the formation of up to 6% of a branched byproduct, in which the aryl group couples to the C-1 position of the olefin.</div><div class="NLM_p last">Concurrently to the above two synthetic pathways, a reductive amination approach was developed. Compound <b>23</b> was prepared in two steps from aldehyde <b>22</b> with high selectivity as the <i>E</i>-isomer. Inhibitors <b>40</b> and <b>41</b> were then prepared via reductive amination of <b>23</b> with pyrrolidine and piperidine, respectively.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Lead Optimization</h3><div class="NLM_p">The rationale for morphing the (indazol-6-yl)methylene-indolin-2-ones to the structurally analogous (indazol-6-yl)-3-spirocyclopropyl-oxindole series was to lock the molecule into a stable configuration. Our stability studies, empirical evidence, and computational models were consistent with the <i>E</i> isomer of the (indazol-6-yl)methylene-indolin-2-ones being responsible for the observed in vitro activity.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, it was not possible to unequivocally assign the biological responses observed to this species alone. Prior to synthesis, the modification was checked computationally to predict whether compound activity would be retained upon replacing the <i>E</i>-alkene <b>7</b> with the trans-cyclopropane <b>8</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). PLK4 docking, performed using a computational model based on the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> X-ray structure,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> predicted retention of activity for this bioisosteric replacement. This was true for molecules with or without the vinyl-aryl substitution on the indazole. It can be seen that the <i>E</i>-form of <b>7</b> and the 1<i>R</i>,2<i>S</i> stereoisomer of <b>8</b> have nearly identical topology and similar binding poses. Moreover their interactions with the active site and their docking scores are also similar. However, the 1<i>S</i>,2<i>R</i> enantiomer of <b>8</b> exhibits a poorer fit into the site and its docking score is about 1/2 log unit lower. In absence of a facile method for enantiomeric resolution, we continued with racemic compounds for the purposes of compound optimization.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of <i>E</i>-alkene <b>7</b> (green) and the (1<i>R</i>,2<i>S</i>)-cyclopropane <b>8</b> (gray) bioisosteres in the PLK4 binding site. This view was generated by GlideXP docking into the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a>-based model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although there is a possibility of <i>E</i>/<i>Z</i> equilibration of the (indazol-6-yl)methylene-indolin-2-ones in solution, we were pleased to observe that the major product from the Corey–Chaykovsky cyclopropanation was the trans diastereomer (<b>8</b>). The minor cis diastereomer (<b>9</b>) was easily separated by column chromatography. We were equally pleased to see that the <i>trans</i>-cyclopropane analogue <b>8</b> was active against PLK4 and performed favorably with respect to the <i>E</i>-alkene congener <b>7</b> in terms of selectivity toward Flt3 and KDR. In contrast, the <i>cis</i>-cyclopropane diastereomer <b>9</b>, topologically similar to the <i>Z</i>-alkene, did not inhibit PLK4 in this assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Alkene to Cyclopropane Bioisosteric Replacement on Kinase and CYP450 Inhibition</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">kinase IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="5" align="center">CYP450 enzyme IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">PLK4</th><th class="colsep0 rowsep0" align="center">Flt3</th><th class="colsep0 rowsep0" align="center">KDR</th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center">(<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)indolin-2-one</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.050</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">>1.0</td><td class="colsep0 rowsep0" align="left">∼10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">0.0024</td><td class="colsep0 rowsep0" align="left">0.035</td><td class="colsep0 rowsep0" align="left">0.034</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.004</td><td class="colsep0 rowsep0" align="left">0.035</td><td class="colsep0 rowsep0" align="left">0.022</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">0.0004</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center">(2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">∼10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.0036</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.0018</td><td class="colsep0 rowsep0" align="left">0.011</td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.0018</td><td class="colsep0 rowsep0" align="left">0.024</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Racemic mixture.</p></div></div></div><div class="NLM_p">Furthermore, we found the cyclopropyl modification imparts improved aqueous solubility for <b>8</b> vs <b>7</b> (8.0 μg/mL vs 0.7 μg/mL at pH 7.4). This improvement is attributed to the nature of the cyclopropane ring, being orthogonal to the plane of the indolinone; it serves to counter crystal packing forces. The cyclopropane disrupts the through-conjugation of the alkene linked system and results in a difference in color between the alkene linked <b>7</b> (yellow–orange) to the cyclopropane <b>8</b> (off white). Compound <b>8</b> also demonstrated desirable ADME properties, which included an improved profile for five CYP450 isoforms (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), lower plasma protein binding (83% vs >99.9%), and better microsomal stability (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Most significantly, compound <b>8</b> achieves up to 100-fold higher level of exposure in mouse plasma upon IP dosing at 50 mg/kg.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Alkene to Cyclopropane Bioisosteric Replacement on Cell Activity, Solubility, and ADME Properties</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">cancer cell line GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">microsomal <i>t</i><sub>1/2</sub> (min)</th><th class="rowsep1 colsep0" colspan="2" align="center">IP mouse plasma levels (50 mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">MCF-7</th><th class="colsep0 rowsep0" align="center">MDA-MB-468</th><th class="colsep0 rowsep0" align="center">sol @ pH 7.4 (μg/mL)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">PPB %</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center">AUC (μg·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center">(<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)indolin-2-one</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">>99.9</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">0.011</td><td class="colsep0 rowsep0" align="left">0.061</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">98.9</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left"><0.1</td><td class="colsep0 rowsep0" align="left">98.4</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.1</td><td class="colsep0 rowsep0" align="left">99.1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.09</td><td class="colsep0 rowsep0" align="left">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="9" align="center">2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">1.20</td><td class="colsep0 rowsep0" align="left">1.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.51</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">95.5</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">94.7</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">0.45</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Racemic mixture.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Aqueous solubilities provided by pION Inc, Billerica, MA.</p></div></div></div><div class="NLM_p">From the preliminary PLK4 IC<sub>50</sub> values and our binding hypothesis, we reasoned that the SAR observed for the (indazol-6-yl)methylene-indolin-2-ones series<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> was likely transferable to the new (indazol-6-yl)-3-spirocyclopropyl-oxindole scaffold. Accordingly, syntheses of cyclopropane inhibitors which carry the 3-aryl-vinyl substitution on the indazole moiety, analogous to some promising leads from the alkene series (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), were initiated. With the substituted analogues, there was no discernible difference in the PLK4 IC<sub>50</sub> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) or potency in the cell-proliferation assays (MCF-7 and MDA-MB-468 cell lines) for cyclopropyl compounds <b>12</b>, <b>13</b>, and <b>16</b> compared to alkene compounds <b>4</b>, <b>5</b>, and <b>6</b>, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In addition, the trend toward better aqueous solubility, microsomal stability, lower plasma protein binding, and KDR selectivity held. Moreover, the selectivity toward other members of the PLK family, observed in the alkene linked compounds, was recapitulated in the spirocyclopropane modification (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Unfortunately, the improvement in Flt3 selectivity observed for <b>8</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) was not imparted to analogues carrying the vinyl-aryl side chain. We also observed that the 4-pyridinylvinyl analogues <b>4</b> and <b>12</b> both exhibit very strong inhibition of CYP 2C9 and 2C19. It appears that the 4-pyridyl function is driving this interaction, independent of the core structure. Nonetheless, compounds <b>13</b> and <b>16</b> showed weak CYP450 inhibition for all five isoforms tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Polo-Like Kinase Activity of Alkene and Racemic Cyclopropane Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="&gt;" /></col><col align="char" char="&gt;" /></col><col align="char" char="&gt;" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char=".">PLK4</th><th class="colsep0 rowsep0" align="center" char="&gt;">PLK1</th><th class="colsep0 rowsep0" align="center" char="&gt;">PLK2</th><th class="colsep0 rowsep0" align="center" char="&gt;">PLK3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td><td class="colsep0 rowsep0" align="char" char="&gt;">>10<sup>5</sup></td></tr></tbody></table></div></div><div class="NLM_p">We were particularly gratified to see that the higher mouse plasma levels seen for the core molecule carried over for elaborated analogues <b>12</b>, <b>13</b>, and <b>16</b>. For example, although alkene <b>4</b> had undetectable plasma levels at 50 mg/kg IP, a dramatic improvement in exposure was seen for the analogous cyclopropane analogue <b>12</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Going forward, efforts were focused on improving kinase selectivity (e.g., Flt3), maintaining the desirable profiles seen in the first iteration of cyclopropane inhibitors and to test whether this profile translated into good oral exposure.</div><div class="NLM_p">Analogues of <b>12</b>, in which the position of the pyridine nitrogen was changed or the nitrogen was framed with methyl groups, such as in <b>17</b>, <b>24</b>, and <b>25</b>, maintained PLK4 activity. A moderate reduction in CYP 2C9 inhibition for <b>24</b> (IC<sub>50</sub> = 400 nM), along with a moderate improvement in cell-based activity relative to the marketed anticancer agent <b>3</b>, was observed. Modeling of <b>12</b> in the modified PLK4 X-ray crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a>, vide infra) revealed that the vinyl group resided in a hydrophobic groove encompassed by Leu18 and the nitrogen on the pyridine ring was pointing toward the solvent interface in the same fashion observed for the alkene series.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It was envisioned that following the SAR gleaned from the alkene-linked series, the addition of solubilizing functionalities on pyridyl ring would not be detrimental to PLK4 activity. Indeed, as can be seen from examples <b>26</b> and <b>27</b>, potent PLK4 activity was retained (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Unfortunately, <b>26</b> still exhibited strong CYP 2C9 inhibition (IC<sub>50</sub> = 90 nM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Activity of Racemic 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one PLK4 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0005.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0006.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Substituted styryls that carried a solvent exposed solubilizing group were modeled and predicted to retain PLK4 activity compared to the 4-pyridinylvinyl analogues. As can be seen in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the nature of the solubilizing group (dimethylamine, piperidine, piperazine, or morpholine) was indiscriminant for PLK4 inhibition in general, although compounds <b>30</b> and <b>31</b> have measured PLK4 inhibition in the subnanomolar range. However, these subnanomolar values should be viewed as apparent values as they approach the nominal concentration of enzyme in the assay (PLK4 concentration = 0.4 nM).</div><div class="NLM_p">The analogues were tested against a panel of four human breast cancer-derived cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and compared to the structurally related compound <b>3</b>. The pyridyl compounds <b>12</b>, <b>16</b>, and <b>24</b> show good potency in the cell-based assay against MCF-7, MDA-MB-468, and MDA-MB-231 cells, although the values for SKBr-3 remain comparable to <b>3</b>. However, potency toward the MCF-7 and MDA-MB-468 cell lines was dramatically enhanced when the tertiary amino group is added, as shown with compounds <b>26</b> and <b>27</b>. The enhanced sensitivity, relative to <b>3</b>, of these two cell lines was also observed for styryl analogues <b>13</b>, <b>18</b>, and <b>28</b>–<b>41</b>. Overall, the responsiveness for the SKBr-3 cell line remained comparable to <b>3</b> for all the cyclopropane compounds tested.</div><div class="NLM_p">A subset of compounds was examined for selectivity against KDR, AURKB and Flt3, compared to indolinone <b>4</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The pyridyl analogues <b>12</b> and <b>25</b> showed high selectivity against KDR, but no selectivity against AURKB and Flt3, compared to <b>4</b>. Strongly basic amines, such as dimethylamino <b>13</b> and piperidine <b>41</b>, that are unsubstituted on the oxindole ring are again unselective with respect to AURKB and Flt3. However, substitution of the oxindole ring in the 5′-position, as shown with dimethylamino analogues <b>18</b> and <b>28</b>, gives high selectivity for KDR and a moderate 10-fold selectivity toward AURKB and Flt3. When a less basic solubilizing group such as morpholine is used as in <b>33</b>, <b>34</b>, and <b>37</b>, a 30–50 fold PLK4/Flt3 selectivity and excellent KDR selectivity was observed. Interestingly, when a dibasic piperazine group is introduced as in <b>38</b>, 75-fold PLK4/AURKB selectivity and 50-fold PLK4/Flt3 selectivity was attained.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Kinase Selectivity of Racemic 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one PLK4 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0008.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">The pharmacokinetic profile for select PLK4 inhibitors is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Analogues such as <b>12</b>, <b>17</b>, and <b>27</b> show low oral exposure and strong CYP inhibition for the 2C9 and 2C19 isoforms. CYP inhibition was improved slightly for styryl analogues <b>13</b>, <b>18</b>, and <b>38</b>, however, this was not accompanied by an increase in oral exposure, likely due to the strongly basic pendent solubilizing groups. A significant improvement in <i>C</i><sub>max</sub> and AUC was observed for compounds <b>33</b>, <b>34</b>, and <b>35</b>, which carry the less basic morpholino substituent. Compound <b>34</b> exhibited a high <i>C</i><sub>max</sub> of 1700 ng/mL and AUC of 4900 ng·h/mL, as well as a respectable CYP inhibition profile, with IC<sub>50</sub> values greater than one micromolar for CYP 1A2, 2C9, 2C19, 2D6, and 3A4.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mouse Plasma Exposure and Cytochrome P450 Profile of PLK4 Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">mouse plasma (oral, 25 mg/kg)</th><th class="rowsep1 colsep0" colspan="5" align="center">P450 enzyme IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">2D6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>12</b></td><td class="colsep0 rowsep0" align="center">470</td><td class="colsep0 rowsep0" align="center">650</td><td class="colsep0 rowsep0" align="center">0.03</td><td class="colsep0 rowsep0" align="center">0.26</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17</b></td><td class="colsep0 rowsep0" align="center">37</td><td class="colsep0 rowsep0" align="center">93</td><td class="colsep0 rowsep0" align="center">0.32</td><td class="colsep0 rowsep0" align="center">0.11</td><td class="colsep0 rowsep0" align="center">0.14</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>27</b></td><td class="colsep0 rowsep0" align="center">290</td><td class="colsep0 rowsep0" align="center">740</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">0.6</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>13</b></td><td class="colsep0 rowsep0" align="center">290</td><td class="colsep0 rowsep0" align="center">310</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>18</b></td><td class="colsep0 rowsep0" align="center">350</td><td class="colsep0 rowsep0" align="center">730</td><td class="colsep0 rowsep0" align="center">0.85</td><td class="colsep0 rowsep0" align="center">0.75</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>33</b></td><td class="colsep0 rowsep0" align="center">1800</td><td class="colsep0 rowsep0" align="center">4300</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>34</b></td><td class="colsep0 rowsep0" align="center">1700</td><td class="colsep0 rowsep0" align="center">4900</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>35</b></td><td class="colsep0 rowsep0" align="center">3700</td><td class="colsep0 rowsep0" align="center">7940</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>38</b></td><td class="colsep0 rowsep0" align="center">190</td><td class="colsep0 rowsep0" align="center">580</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Efficacy</h3><div class="NLM_p">To investigate the efficacy of (indazol-6-yl)-3-spirocyclopropyl-oxindoles in vivo, compounds <b>13</b> and <b>18</b> were administered to mice bearing MDA-MB-468 breast cancer tumors in a xenograft study. Animals were dosed orally (PEG400/H<sub>2</sub>O) at 25 mg/kg QD for 21 days. Antitumor activity was observed in vivo for each case, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Tumor inhibition of 76% for <b>18</b> and 84% for <b>13</b> was achieved, with no significant decrease in body weight by the end of the study (day 21). These results compare favorably with <b>2</b>, a known antiproliferative agent, which showed 73% inhibition (day 21) upon IP dosing at 50 mg/kg QD.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of in vivo efficacy of PLK4 inhibitors in a mouse MDA-MB-468 breast cancer xenograft model after 21-day treatment (<i>n</i> = 5). <b>2</b>, TGI = 73%, <i>p</i> = 0.036; compound <b>13</b>, TGI = 84%, <i>p</i> = 0.03; compound <b>18</b>, TGI = 76%, <i>p</i> = 0.03. No animals were lost during the course of the study and weight loss was <20% for all treatment arms; TGI, tumor growth inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> PLK4 X-ray Structure</h3><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> displays the binding site, seen in the PLK4 X-ray structure cocrystallized with <b>18</b>. A hydrogen bonding network in the hinge region is shown between the indazole and the backbone carbonyl and NH of Glu90 and Cys92, respectively. Two other hydrogen bonds are observed between the oxindole and the side chains of Lys41 and Gln160. As well, there is hydrophobic contact between the enzyme and the ligand, especially surrounding the indazole (Leu18, Ala39, Val26, Leu73, and Leu143) and encompassing the vinyl-phenyl group side chain (e.g., Leu18). The oxindole group, including the methoxy substituent, is fully embedded in a pocket surrounded by protein backbone from the top and the sides. One of the main focuses of the lead optimization effort was the placement of solubilizing functionalities in the inhibitor which could occupy a hydrophilic region when bound to PLK4. Our modified <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> PLK4 model predicted that a viable site for inclusion of a solubilizing group was the aryl ring of the pendent vinyl-aryl group. As observed in the X-ray co-structure, the solubilizing dimethylamino functionality of <b>18</b> resides at the solvent interface.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of the active site of the PLK4 enzyme at 2.4 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF">4JXF</a>), co-crystallized with racemic compound <b>18</b>. The co-structure clearly shows binding of the 1<i>R</i>,2<i>S</i> enantiomer of compound <b>18</b>. Hydrogen bonds are depicted by dashed lines. (A) Hydrogen bonding of the indazole to Glu90 and Cys 92 of the hinge region; H-bonds from the indolinone moiety to the side chain of Lys41 and the backbone carbonyl of Gln160. (B) 180° flipped view of PLK4 active site surface: the dimethylamino group extends into solvent; hydrophobic surfaces engage the indazole and vinyl groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the PLK4 enzyme was soaked with the racemate of <b>18</b>, only density for the 1<i>R</i>,2<i>S</i> enantiomer is observed in the co-structure. The 1<i>S</i>,2<i>R</i> enantiomer does not fit with the experimental electron density. This result is supported by modeling, which predicted a two log unit binding preference for the 1<i>R</i>,2<i>S</i> enantiomer compared to the 1<i>S</i>,2<i>R</i> enantiomer.</div><div class="NLM_p last">It is important to note that this X-ray structure and the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> structure enable significantly different ligand interactions. The <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> structure is in a DFG-in conformation: the backbone of the activation loop (T-loop) runs relatively close to the plane of the fused ring system and then branches off, away from the ligand. In contrast, the co-structure of <b>18</b> is in a DFG-out conformation and the activation loop runs close to the indolinone nitrogen. In turn, the G-loop moves away in the co-structure to enable the activation loop to close down on the ligand. As a result, the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> site is substantially open to the solvent from the distal side of the indolinone, while in our co-structure this area is essentially shielded from the solvent, enabling further interactions with the ligand.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this investigation, (indazol-6-yl)-3-spirocyclopropyl-indolin-2-ones were prepared as configurationally stable congeners of the previously described (indazol-6-yl)methylene-indolin-2-ones. The bioisosteric replacement of the alkene linker with a cyclopropane ring serves to disrupt planarity and results in potent PLK4 inhibitors with improved physicochemical properties. The (indazol-6-yl)-3-spirocyclopropyl-indolin-2-one core also displays superior ADME properties such as reduced CYP inhibition and plasma protein binding and an enhanced pharmacokinetic profile in mice.</div><div class="NLM_p">The first set of molecules, elaborated at the 3 position of the indazole moiety with a pyridinyl vinylic attachment, showed high affinity for PLK4. However, these compounds exhibited significant CYP450 inhibition, in particular for the 2C9 isoform. Further SAR exploration revealed that there was no significant difference in PLK4 inhibitory activity between pyridinylvinyl and styryl analogues. Nonetheless, this change did serve to decrease CYP inhibition for the more sensitive isoforms into the single-digit micromolar range. As a group, the dialkylaminomethyl styryl analogues were potent PLK4 inhibitors, more soluble (especially at low pH), and effective inhibitors of breast cancer cell growth. In addition, compounds <b>13</b> and <b>18</b> potently inhibited tumor growth in an MDA-MB-468 xenograft model. Compound <b>18</b> exhibited 84% tumor growth inhibition after 21 days, which compared favorably with <b>2</b>, a well-known antimitotic agent. Pharmacokinetic properties of the inhibitors were generally improved when morpholine was employed as the solubilizing group, with compounds <b>33</b>, <b>34</b>, and <b>35</b> showing high exposure in plasma upon oral administration in mice.</div><div class="NLM_p last">Although all compounds tested in this study were cyclopropyl racemates, we now have strong evidence for the preferential affinity of the 1<i>R</i>,2<i>S</i> enantiomer over the 1<i>S</i>,2<i>R</i> enantiomer. Refinement of the PLK4/compound <b>18</b> complex indicated density consistent with the presence of the 1<i>R</i>,2<i>S</i> enantiomer in the active site. The subsequent article<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> describes the development of a stereoselective synthesis of the (indazol-6-yl)-3-spirocyclopropyl-indolin-2-ones and further optimization of the orally bioavailable morpholine analogues toward the identification of a development candidate for anticancer therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Biochemical Assays</h3><div class="NLM_p">Active PLK4, as an amino terminal GST fusion of residues 1–391 of human PLK4, was purified from an <i>Escherichia coli</i> expression system. The protein was purified from clarified cell extracts after induction at 15°C overnight using glutathione sepharose, gel permeation chromatography, and ion exchange chromatography (Resource Q). The resulting protein was dephosphorylated with λ phosphatase (NEB cat. no. P0753) and resolved using glutathione sepharose. The dephosphorylated GST-PLK4 was stored in aliquots at −80 °C until use.</div><div class="NLM_p">PLK4 activity was measured using an indirect ELISA detection system. Dephosphorylated GST-PLK4 (4 nM) was incubated in the presence of 15 μM ATP (Sigma cat. no. A7699), 50 mM HEPES-Na<sup>2+</sup> pH 7.4, 10 mM MgCl<sub>2</sub>, and 0.01% Brij 35 (Sigma cat. no. 03–3170) in a 96-well microtiter plate precoated with MBP (Millipore cat. no. 30–011). After 30 min, the plate was washed five times with wash buffer (50 mM TRIS-Cl pH 7.4 and 0.2% Tween 20) and incubated for 30 min with a 1:3000 dilution of primary antibody (Cell Signaling cat. no. 9381). The plate was then washed 5 times with wash buffer, incubated for 30 min in the presence of secondary antibody coupled to horse radish peroxidase (BioRad cat. no. 1721019, 1:3000 concentration), washed an additional 5 times with wash buffer, and incubated in the presence of TMB substrate (Sigma cat. no. T0440). The colorimetric reaction was quenched after 5 min by the addition of stop solution (0.5 N H<sub>2</sub>SO<sub>4</sub>) and quantified by detection at 450 nm with either a monochromatic or filter-based plate reader (Molecular Devices M5 or Beckman DTX880, respectively).</div><div class="NLM_p">Inhibition of AurB, FLT-3, KDR PLK1, PLK2, and PLK3 were determined using FRET-based homogeneous assays from Invitrogen. The assays were performed according to the manufacturer’s specifications with ATP concentrations of 25, 60, 80, 128, 940, and 156 μM, for PLK1, PLK2, PLK3, AurB, FLT3, and KDR, respectively.</div><div class="NLM_p">Compound inhibition was determined at either a fixed concentration (10 μM) or at a variable inhibitor concentration (typically 50–0.1 μM and 0.1–0.0002 μM in a 10-point dose response titration). Compounds were preincubated in the presence of enzyme for 15 min prior to addition of ATP. The remaining activity was quantified using the above-described activity assay. The percent inhibition of a compound was determined using the following formula: % inhibition = 100(1 – (experimental value – background value)/(high activity control – background value)). The IC<sub>50</sub> value was determined using a nonlinear four-point logistic curve fit (XLfit4, IDBS) with the formula: (<i>A</i> + (<i>B</i>/(1 + ((<i>x</i>/<i>C</i>)<sup><i>D</i></sup>)))), where <i>A</i> = background value, <i>B</i> = range, <i>C</i> = inflection point, <i>D</i> = curve fit parameter.</div><div class="NLM_p">Fluorogenic CYP inhibition studies were conducted at 37 °C in 96-well, round-bottom, white polystyrene plates. Supersome mixtures containing CYP protein, insect control supersomes, substrate, and potassium phosphate buffer (pH 7.4) were prepared with the following final concentrations: CYP 3A4, 4 nM 3A4 + OR + <i>b</i>5 supersomes + 40 μM BFC in 160 mM buffer; CYP 3A4, 0.8 nM 3A4 + OR + <i>b</i>5 supersomes + 0.8 μM DBF in 160 mM buffer; CYP 2D6, 6 nM 2D6 + OR supersomes + 1.2 μM AMMC in 40 mM buffer; CYP 2C9, 4 nM CYP 2C9 + OR + <i>b</i>5 + 8 μM MFC in 40 mM buffer; CYP 2C19, 4 nM CYP 2C19 + OR + <i>b</i>5 + 20 μM CEC in 40 mM buffer; and CYP 1A2, 2 nM CYP 1A2 + OR + 4 μM CEC in 40 mM buffer. Reaction times were verified to be within the limits of kinetics linearity (not shown). All probe substrate concentrations selected for these determinations were approximately equal to the <i>K</i><sub>m</sub>. The final cofactor concentrations were 1.3 mM NADP, 3.3 mM glucose-6-phosphate, and 0.4 U/mL G6PDH for all enzymes. The final incubation volume was 0.2 mL. The plates were prewarmed at 37 °C for 10 min. The solvent concentration was constant (≤0.2% DMSO for test articles, ≤ 2% CH<sub>3</sub>CN for positive control inhibitors) for all conditions within an experiment. Incubations were initiated by the addition of prewarmed enzyme/substrate mix. After the specified incubation times (10 min for CYP 3A4/DBF; 15 min for CYP 1A2/CEC; 30 min for CYP 2D6/AMMC, CYP 2C19/MFC, and CYP 3A4/BFC; 45 min for CYP 2C9/MFC) reactions were quenched by the addition of 75 μL of 80% CH<sub>3</sub>CN/20% 0.5 M Tris, with the exception of 3A4/DBF, which was stopped by addition of 75 μL of 2 N NaOH. Fluorescence was then measured at the following excitation/emission wavelengths: 3A4 (485/535 nm), 2D6 (390/465 nm), and 2C9 (409/535 nm).</div><div class="NLM_p last">For data analysis, the fluorescence signals within a dilution series were normalized based on the range defined by the positive and negative control inhibitors for each isoform/substrate to 0% and 100% inhibition. The percent inhibition of a compound was determined using the same formula described above for AurB, FLT-3, KDR, PLK1, PLK2, and PLK3.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Microsomal Stability Assay (Microsomal <i>T</i><sub>1/2</sub>)</h3><div class="NLM_p last">Test compounds were incubated at 1 μM concentration with human, dog, rat, and mouse liver microsomes at 37 °C. The 200 μL of reaction mixture in 100 mM Tris/HCl, pH 7.5, contained 35 μg of microsomal protein, 9.5 μL of NADPH Regenerating System Solution A (BD Biosciences cat. no. 451220), and 2 μL of NADPH Regenerating System Solution B (BD Biosciences cat. no. 451200). After 0, 5, 10, 20, 40, and 60 min incubation, 20 μL aliquots were removed from each reaction and mixed with 80 μL of ice-cold CH<sub>3</sub>CN. Stopped reactions were applied to a filter plate and centrifuged at 500<i>g</i> for 5 min. The filtrate (60 μL) was transferred to a fresh 96-well plate containing 100 μL water, mixed, and the plate was sealed with a preslit silicone sealing mat. LC-MS (Bruker HCT ion trap coupled to an Agilent 1100 HPLC was used to quantify the remaining parent. Microsoft Excel was used for the calculations. Curve fitting was used to determine <i>k</i> (first-order rate constant) using an exponential fit. The half-life was calculated as: microsomal <i>T</i><sub>1/2</sub> = <i>In</i>(2)/<i>k</i>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cell Viability Assay (GI<sub>50</sub>)</h3><div class="NLM_p last">MDA-MB-231, MDA-MB-468, MCF-7, and SKBr-3 breast cancer cells were seeded into 96-well plates at 2500, 3000, 4000, 4000, and 4000 cells per 80 μL, respectively, 24 h before compound overlay, and cultured at 37 °C and 5% CO<sub>2</sub>. Compounds were prepared as 10 mM DMSO stocks. Each 10 mM stock was diluted with DMEM (Dulbecco’s Modified Eagle’s Medium) cell growth medium (Invitrogen, Burlington, ON, Canada), containing 10% FBS (fetal bovine serum) such that the final concentrations ranged from 50 nM to 250 μM. Aliquots (20 μL) from each concentration were overlaid to 80 μL of preseeded cells to achieve final concentrations of 10–50 μM. After 5 d, the cells were fixed in situ by gently removing the culture media and adding 50 μL of ice-cold 10% TCA per well and incubated at 4 °C for 30 min. The plates were washed with water five times and allowed to air-dry for 5 min. SRB (Sigma, Oakville, ON, Canada) [50 μL of 0.4% (w/v)] solution in 1% (v/v) acetic acid was added to each well, followed by incubation for 30 min at rt. The plates were washed four times with 1% acetic acid to remove unbound SRB and then air-dried for 5 min. The SRB was solubilized with 100 μL of 10 mM Tris pH 10.5 per well, and absorbance was read at 570 nm using a SpectraPlus microplate reader (Molecular Devices Corporation). The percentage of relative inhibition of cell viability was calculated by comparison to cells treated with DMSO only. GI<sub>50</sub>s were calculated using GraphPad PRISM software (GraphPad Software, Inc., San Diego, CA, USA). Three cell lines (MDA-MB-468, MCF-7, and MDA-MB-231) generally exhibit comparable sensitivity, with the inflection point for the dose response beginning at about 10 nM. Cell line SKBr-3 is less sensitive, resulting in typical dose response curves where the inflection point is gradual and indistinct. For this cell line, the GI<sub>50</sub> is calculated as the concentration required to inhibit cell growth at 50% of the maximal response.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Mouse Plasma Levels</h3><div class="NLM_p last">Adult female SCID mice (Princess Margaret Hospital Animal Facility, Toronto, ON) were used in the experiments. All animal experiments were approved by UHN IACUC. Nine mice were dosed at either 25 mg/kg (free base equivalents) via oral gavage (examples <b>13</b> and <b>18</b>) or intraperitoneal injection (water with final pH adjusted to pH 4 with 1 M NaOH) using a volume of 200 μL (example <b>2</b>). Saphenous vein blood was collected from three mice per time point over an 8 h period. The plasma samples were analyzed by LCMS/MS for the presence of drug and internal standard. The pharmacokinetic parameters were calculated using Microsoft Excel with pharmacokinetic add-in functions.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Parameters were calculated using plasma concentration time data for composite averages.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Structural Biology</h3><div class="NLM_p">The kinase domain fragment of human PLK4 (amino acids 6–269) was subcloned into the pET_SUMO vector (Invitrogen) for bacterial expression. The protein was expressed in <i>E. coli</i> BL21 (DE3) codon plus RIL (Stratagene) cells in TB broth media in the presence of 10% glucose overnight at 15 °C with 0.5 mM IPTG.</div><div class="NLM_p">For the purification, the bacterial pellet was lysed in the lysis buffer (LB) supplemented with 1 mM imidazole and 1 mM PMSF (25 mM HEPES pH 7.5, 500 mM NaCl, 10% glycerol, and 1 mM TECEP). After lysis using an EmulsiFlex C5 homogenizer (Avestin), the lysate was clarified by centrifugation (50000<i>g</i> for 1h at 4 °C) and loaded onto a 5 mL HiTrap Chelating column (GE Health Care) charged with Ni<sup>2+</sup>. The column was washed with 10 column volumes of LB supplemented with 1 mM imidazole, followed by 10 column volumes of LB supplemented with 50 mM imidazole, and the protein was eluted with LB supplemented with 300 mM imidazole. SUMO protease (LifeSensors) was added to fractions containing the PLK4 KD to remove the His6-tag, and the cleavage reaction was allowed to proceed overnight at 4 °C. The cleaved PLK4 KD protein was separated from uncleaved protein, His6_SUMO protein, and His6_SUMO protease by loading onto a 5 mL HiTrap Chelating column (GE Health Care), charged with Ni<sup>2+</sup>. The cleaved PLK4 KD was eluted from the column with LB supplemented with 50 mM imidazole, while uncleaved protein, His6_SUMO protein, and His6_SUMO protease were retained on the column. The protein was loaded onto a Superdex 200 column (GE Health Care) equilibrated with LB. The protein was further purified to homogeneity by ion-exchange chromatography.</div><div class="NLM_p last">Purified PLK4 KD was crystallized in the presence of <b>18</b> using the hanging drop vapor diffusion method at 22 °C by mixing equal volume of the protein solution and the reservoir solution. The PLK4–<b>18</b> binary complex (protein:compound at a molar ratio of 1:5) was crystallized in 20% PEG 4000, 0.2 M magnesium chloride hexahydrate, and 0.1 M Tris pH 8.5. All the crystals were soaked in the mother liquor supplemented with 15% glycerol as cryoprotectant before freezing in liquid nitrogen.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> X-ray Data Collection and Processing</h3><div class="NLM_p last">The X-ray data set of PLK4/compound <b>18</b> complex was collected at an in-house facility using HF-007 Rigaku rotating anode (Cu Kα) equipped with Osmic VariMax focusing system and MAR-345 image detector at temperature of 100 K. The diffraction data were reduced and scaled with the program XDS.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The summary of crystallographic data and refinement statistics are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Structure Determination and Crystallographic Refinement</h3><div class="NLM_p last">The crystals of PLK4 complex belonged to <i>I</i>23 space group. The initial phase of PLK4 complex was determined by molecular replacement using Phaser from Phenix package.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Following the initial rigid body refinement, interactive cycles of model building and refinement were carried out using COOT<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and phenix.refine<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> or buster-TNT.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The coordinates and topologies of the ligands from this study were generated using phenix.elbow.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Ligands were introduced at the later stages of refinement after most of the protein models were built. Water molecules, as well as other solvent ligands, were added based on 2m<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> map in COOT and refined with phenix.refine or buster-TNT.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Computational Methods</h3><div class="NLM_p last">In much of this work, the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a> X-ray structure was used for modeling purposes. As described previously,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> this structure was modified to enable hydrogen bonding between the side chain of Lys41 and the indolinone carbonyl. The protein structure was prepared using standard settings with the help of the Protein Preparation Wizard in the Schrodinger suite.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> All water molecules were deleted because none of them were judged as structural water (i.e., part of the binding pattern). Ligands were prepared, and docking results were analyzed in the MOE software,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> appropriate protonation states were generated using the Wash process, all reasonable stereoisomers were obtained using Corina,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and low energy conformations were generated using Conformer Import (max 30 conformers within a 1 kcal/mol window) and minimized using the MMFF94x force field within MOE. These conformers were all docked using GlideXP, and the highest scoring solution was selected, as had been recommended in order to minimize sensitivity to initial conditions.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> For cyclopropane compounds, note that docking conditions typically favored the 1<i>R</i>,2<i>S</i> form, which had 1/2 to 2 orders of magnitude better docking scores than the 1<i>S</i>,2<i>R</i> enantiomer, hence only these forms appeared for comparison in the docking scores. Mostly default conditions were applied in GlideXP docking,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> but with the ring conformational search switched off. Docking scores were calculated without the Epik state penalties and using protein hydrogen bond constraints to the hinge (at least 1 of the hydrogen bonds to Glu90 or Cys92 had to be satisfied). This model was sufficiently predictive on PLK4 ligands to enable ranking (the correlation coefficient (<i>R</i><sup>2</sup>) between docking score and PLK4 pIC<sub>50</sub> was 0.53 with an RMSE of 0.91 and <i>n</i> = 553). During the course of the study, an X-ray co-structure with <b>18</b> was obtained and a docking model was generated based on this new structure. This co-structure already indicated a hydrogen bond between Lys41 and the ligand, so it was applied for generating a docking model without further modifications. This model provided superior performance on the same ligand set (<i>R</i><sup>2</sup> of 0.60 with RMSE of 0.84 with <i>n</i> = 563) and was used in the latter stages of this work.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis</h3><div class="NLM_p last">General Experimental Methods: Commercially available starting materials, reagents, and solvents were used as received. In general, anhydrous reactions were performed under an inert atmosphere such as nitrogen or argon. Microwave reactions were performed using a Biotage Initiator microwave reactor. Reaction progress was generally monitored by TLC using Merck silica gel plates with visualization by UV at 254 nm by analytical HPLC or by LCMS (Bruker Esquire 4000). Flash column chromatographic purification of intermediates or final products was performed using 230–400 mesh silica gel 60 from EMD chemicals or on a Biotage Isolera One purification system using SNAP KP-sil cartridges. Crude reactions were partially purified using Waters PoraPak Rxn CX cartridges. Preparative reverse-phase HPLC purification was performed on a Varian PrepStar model SD-1 HPLC system with a Varian Monochrom 10 μ C-18 reverse-phase column. Elution was performed using a gradient of 10% MeOH/water to 90% MeOH/water (0.05% TFA) over a 40 min period at a flow rate of 40 mL/min. Fractions containing the desired material were concentrated and lyophilized to obtain the final products. Compound purity by analytical HPLC (UV detection at λ = 214 and 254 nm) was performed on a Varian Prostar HPLC, using a 100 mm × 4.6 mm Phenomenex Luna 3 μ C-18 column. Elution was performed using a gradient 10% MeOH/water to 90% MeOH/water (0.05% TFA) between 1 and 10 min at a flow rate of 1 mL/min. Purity is reported as area percent; the purity of all final compounds was shown by HPLC to be ≥95%. Proton NMRs were recorded on a Bruker 400 MHz spectrometer, and mass spectra were obtained using a Bruker Esquire 4000 spectrometer. All reported yields are not optimized.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Preparation of 3-Spirocyclopropyl-oxindoles: General Procedure A</h3><div class="NLM_p">To a solution of trimethylsulfoxonium iodide (2 equiv) in anhydrous DMF (40 mL) was added NaH (60% dispersion in oil) (6 equiv) at 0 °C. The mixture was stirred for 15 min, after which time the appropriate methylene-indolin-2-one (1 equiv) was added. The solution was stirred overnight at rt. The reaction was quenched with satd aq NH<sub>4</sub>Cl solution, extracted with 4 volumes EtOAc, dried over MgSO<sub>4</sub>, and concentrated to dryness. The major trans diastereomer was isolated by either by silica gel chromatography or preparative HPLC.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (1<i>R</i>*,2<i>S</i>*)-2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>8</b>)</h4><div class="NLM_p last">The title compound was prepared in a manner similar to general procedure A by utilizing <b>7</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (151 mg, 0.58 mmol). The major diastereomer <b>8</b> was isolated by silica gel chromatography (50% EtOAc in hexanes) as a beige solid (44 mg, 28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.01 (s, 1H), 10.61 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (s, 1H), 7.63 (d, <i>J</i> = 8.3 Hz, 1H), 7.44 (s, 1H), 6.99 (t, <i>J</i> = 7.5 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 1H), 6.84 (d, <i>J</i> = 8.0 Hz, 1H), 6.51 (t, <i>J</i> = 7.0 Hz, 1H), 5.98 (d, <i>J</i> = 8.0 Hz, 1H), 3.20–3.17 (m, 1H), 2.30–2.26 (m, 1H), 2.00–1.95 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>13</sub>N<sub>3</sub>O + H]<sup>+</sup>, 276.1; found, 276.1.</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (1<i>R</i>*,2<i>R</i>*)-2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>9</b>)</h4><div class="NLM_p last">The minor diastereomer from the reaction of example <b>8</b> was isolated as beige solid (3.5 mg, 2%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.97 (s, 1H), 10.33 (d, <i>J</i> = 8.3 Hz, 1H), 7.99 (s, 1H), 7.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.41 (s, 1H), 7.18–7.12 (m, 2H), 6.99–6.94 (m, 2H), 6.86 (d, <i>J</i> = 7.8 Hz, 1H), 3.32 (t, <i>J</i> = 8.3 Hz, 1H), 2.27–2.23 (m, 1H), 2.18–2.15 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>13</sub>N<sub>3</sub>O + H]<sup>+</sup>, 276.1; found, 276.1.</div></div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (1<i>R</i>*,2<i>S</i>*)-2-(3-Iodo-1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>11</b>)</h4><div class="NLM_p last">To a solution of trimethylsulfoxonium iodide (1.89 g, 8.6 mmol) in anhydrous DMF (40 mL) was added NaH (60% dispersion in oil) (1.03 g, 25.8 mmol) at 0 °C. The mixture was stirred for 15 min, after which time <b>10</b> (2.2 g, 4.3 mmol) was added. The solution was stirred overnight at rt. The reaction was quenched with satd aq NH<sub>4</sub>Cl solution (50 mL), extracted with EtOAc (4 × 100 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The title compound was isolated by silica gel chromatography (2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) as a yellow solid (1.5 g, 66%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.46 (s, 1H), 7.39 (d, <i>J</i> = 8.3 Hz, 1H), 7.09 (t, <i>J</i> = 7.5 Hz, 1H), 7.04 (d, <i>J</i> = 8.0 Hz, 1H), 6.92 (d, <i>J</i> = 7.8 Hz, 1H), 6.61 (t, <i>J</i> = 8.0 Hz, 1H), 5.90 (d, <i>J</i> = 8.0 Hz, 1H), 5.70 (s, 2H), 3.57–3.53 (m, 2H), 3.49–3.44 (m, 1H), 2.31–2.28 (m, 1H), 2.12–2.09 (m, 1H), 0.89–0.84 (m, 2H), −0.05 (s, 9H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>23</sub>H<sub>26</sub>IN<sub>3</sub>O<sub>2</sub>Si+ H]<sup>+</sup>, 532.1; found, 532.1.</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(2-(Pyridin-4-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro-[cyclopropane-1,3′-indolin]-2′-one (<b>12</b>)</h4><div class="NLM_p last">To a solution of <b>11</b> (375 mg, 0.7 mmol), 4-vinylpyridine (110 mg, 1.05 mmol), DIPEA (0.25 mL, 1.4 mmol), and DMF (2.5 mL) was added Pd(OAc)<sub>2</sub> (8 mg, 0.035 mmol) and P(<i>o</i>-tol)<sub>3</sub> (22 mg, 0.07 mmol). The mixture was heated under microwave irradiation (130 °C) for 2 h. Ethyl acetate (150 mL) was added, and the solution was washed with water (2 × 20 mL) and brine (20 mL), dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by silica gel chromatography (1:1 hexanes/EtOAc to 100% EtOAc) to give SEM-protected intermediate as a beige solid (320 mg). The material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) under an atmosphere of N<sub>2</sub>. Boron trifluoride etherate (1 mL) was added dropwise, and the reaction was stirred for 2 h. Methylene chloride was removed in vacuo, and a 2:1 mixture of EtOH/2 M aq HCl (5 mL) was added and the reaction heated to 50 °C for 2 h. The reaction was cooled with an ice-bath and neutralized with 1 M NH<sub>4</sub>OH to pH ∼ 8. Ethanol was removed in vacuo, and the resulting precipitate was collected which was further purified by silica gel chromatography (15% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give the title compound as a yellow solid (220 mg, 81%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.31 (s, 1H), 10.63 (s, 1H), 8.57–8.50 (m, 2H), 8.10 (d, <i>J</i> = 8.1 Hz, 1H), 7.80 (d, <i>J</i> = 16.6 Hz, 1H), 7.75–7.70 (m, 2H), 7.50–7.42 (m, 2H), 7.09–6.99 (m, 2H), 6.85 (d, <i>J</i> = 7.6 Hz, 1H), 6.53 (t, <i>J</i> = 7.5 Hz, 1H), 6.01 (d, <i>J</i> = 7.8 Hz, 1H) 3.23–3.19 (m, 1H), 2.35–2.31 (m, 1H), 2.02–1.98 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O + H]<sup>+</sup>, 379.1559; found, 379.1559. HPLC purity: 98.8% at 214 nM.</div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>13</b>)</h4><div class="NLM_p last">To a solution of <b>11</b> (250 mg, 0.5 mmol), <i>N</i>,<i>N</i>-dimethyl-1-(4-vinylphenyl)methanamine (125 mg, 0.78 mmol), DIPEA (0.25 mL, 1.5 mmol), and DMF (1 mL) was added Pd(OAc)<sub>2</sub> (5 mg, 0.025 mmol) and P(<i>o</i>-tol)<sub>3</sub> (15 mg, 0.05 mmol). The mixture was heated under microwave irradiation (130 °C) for 2 h. Ethyl acetate (20 mL) was added, and the solution was washed with water (2 × 5 mL) and brine (5 mL), dried over MgSO<sub>4</sub>, and concentrated. The residue was purified by silica gel chromatography (50% to 100% EtOAc in hexanes) to give SEM-protected intermediate as a beige solid (95 mg). The material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) under an atmosphere of N<sub>2</sub>. Boron trifluoride etherate (0.2 mL) was added dropwise, and the reaction was stirred for 2 h. Methylene chloride was removed in vacuo, and a 2:1 mixture of EtOH/2 M HCl (0.5 mL) was added and the reaction heated to 50 °C for 2 h. The reaction was cooled with an ice-bath and neutralized with 1 M NH<sub>4</sub>OH to pH ∼ 8. Ethanol was removed in vacuo, and the resulting precipitate was collected, which was further purified by reverse phase HPLC to give the title compound as a yellow solid (63 mg, 23%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.3 Hz, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.56–7.48 (m, 5H), 7.08–7.04 (m, 2H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 6.59 (t, <i>J</i> = 7.8 Hz, 1H), 6.00 (d, <i>J</i> = 8.0 Hz, 1H), 4.38 (s, 2H), 3.39–3.33 (m, 1H), 2.90 (s, 6H), 2.28–2.22 (m, 1H), 2.22–2.17 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O + H]<sup>+</sup>, 435.2185; found, 435.2183. HPLC purity: 98.8% at 214 nM.</div></div><div id="sec4_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (1<i>R</i>*,2<i>S*</i>)-5′-Methoxy-2-(3-((<i>E</i>)-2-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>16</b>)</h4><div class="NLM_p last">The title compound was prepared according to the general procedure A using compound <b>6</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (155 mg, 0.28 mmol) The crude product was purified by silica gel chromatography (5–7.5% 2 M NH<sub>3</sub>–MeOH in DCM) to yield an 85:15 mixture of the title compound and the cis-diastereomer. The major isomer was isolated by silica gel chromatography (3–5% MeOH and 2% Et<sub>3</sub>N in CHCl<sub>3</sub>) to yield a sticky yellow solid which was triturated with Et<sub>2</sub>O to give the <b>16</b> as a yellow powder (57 mg, 41%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.26 (s, 1 H), 8.00 (d, <i>J</i> = 8.4 Hz, 1 H), 7.92 (d, <i>J</i> = 9.2 Hz, 1 H), 7.45 (s, 1 H), 7.40 (d, <i>J</i> = 16.8 Hz, 1 H), 7.28 (d, <i>J</i> = 16.8 Hz, 1 H), 7.03 (d, <i>J</i> = 7.6 Hz, 1 H), 6.87 (d, <i>J</i> = 9.2 Hz, 1 H), 6.83 (d, <i>J</i> = 8.4 Hz, 1 H), 6.61 (dd, <i>J</i> = 8.4, 2.4 Hz, 1 H), 5.58 (d, <i>J</i> = 2.0 Hz, 1 H), 3.61 (s, 4 H), 3.39–3.37 (m, 1 H), 3.26 (s, 3 H), 2.59–2.57 (m, 4 H), 2.36 (s, 3 H), 2.25–2.17 (m, 2 H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>30</sub>N<sub>6</sub>O<sub>2</sub> + H]<sup>+</sup>, 507.2508; found, 507.2802. HPLC purity: 95.6% at 214 nM.</div></div><div id="sec4_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (1<i>R</i>*,2<i>S</i>*)-2-(3-((<i>E</i>)-2-(Pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro-[cyclopropane-1,3′-indolin]-2′-one (<b>17</b>)</h4><div class="NLM_p last">To a mixture of trimethylsulfoxonium iodide (176 mg, 0.8 mmol) and 60% NaH (96 mg, 2.4 mmol) in a RBF was added DMF (5 mL). The resulting mixture was stirred for 2 min at rt then cooled to 0 °C. A solution of (<i>E</i>)-3-((3-((<i>E</i>)-2-(pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)methylene)indolin-2-one (<b>14</b>)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (122 mg, 0.33 mmol)) in DMF (20 mL) was added via pipet. After addition, the resulting mixture was heated at 55 °C for 2 h and cooled to rt. Additional trimethylsulfoxonium iodide (176 mg, 0.8 mmol) and 60% NaH (96 mg, 2.4 mmol) were added, and the resulting mixture was stirred overnight at rt and poured onto ice (80 mL). The reaction mixture was acidified with satd aq NH<sub>4</sub>Cl and extracted with EtOAc (3 × 40 mL). The combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give a light-brown liquid. This residue was purified by flash chromatography (eluent: CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>/MeOH/TEA = 200:10:1) to give the crude title compound as a light-yellow solid, which was triturated with MeOH (5 mL) and suction filtered to give the title compound as a yellow solid (43 mg, 34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.21 (s, 1H), 10.64 (s, 1H), 8.86 (s, 1H), 8.45 (d, <i>J</i> = 3.2 Hz, 1H), 8.15 (d, <i>J</i> = 8.0 Hz, 1H), 8.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.65 (d, <i>J</i> = 16.8 Hz, 1H), 7.49 (d, <i>J</i> = 16.8 Hz, 1H), 7.47 (s, 1H), 7.40 (dd, <i>J</i> = 8.0 Hz, 4.8 Hz, 1H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 6.99 (d, <i>J</i> = 7.2 Hz, 1H), 6.86 (d, <i>J</i> = 7.6 Hz, 1H), 6.53 (t, <i>J</i> = 7.4 Hz, 1H), 6.01 (d, <i>J</i> = 7.6 Hz, 1H), 3.21 (t, <i>J</i> = 8.4 Hz, 1H), 2.32 (dd, <i>J</i> = 7.6 Hz, 4.8 Hz, 1H), 2.00 (dd, <i>J</i> = 9.0 Hz, 4.8 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O + H]<sup>+</sup>, 379.1559; found, 379.1559. HPLC purity: 99% at 254 nM.</div></div><div id="sec4_10_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (1<i>R*</i>,2<i>S*</i>)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (<b>18</b>)</h4><div class="NLM_p last">DMF (3 mL) was added to a mixture of NaH (60%, 85 mg, 2.1 mmol) and trimethylsulfoxonium iodide (132 mg, 0.6 mmol). The resulting mixture was stirred at rt for 10 min followed by the addition of (<i>E</i>)-3-((3-(4-((dimethylamino)methyl)-styryl)-1<i>H</i>-indazol-6-yl)methylene)-5-methoxyindolin-2-one (<b>15</b>)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (163 mg, 0.29 mmol) as a solution in DMF (6 mL, divided for transfer and vial rinse). The reaction was not complete after stirring at rt for 24 h. The mixture was heated at 55 °C for 1 h but was still not complete. After cooling to rt, NaH (60%, 44 mg, 1.1 mmol) and trimethylsulfoxonium iodide (69.5 mg, 0.31 mmol) was added, and the mixture was heated at 55 °C for 1 h prior to quenching by addition of water (25 mL) and brine (25 mL). The mixture was extracted with EtOAc (300 mL), and the organic layer was washed with brine (2 × 25 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was purified by silica gel chromatography (5–7.5% 2 M NH<sub>3</sub>–MeOH in DCM), followed by prep-HPLC to yield the title compound as a yellow TFA salt (43 mg, 32%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (d, <i>J</i> = 8.3 Hz, 2H), 7.57–7.46 (m, 5H), 7.05 (d, <i>J</i> = 8.0 Hz, 1H), 6.84 (d, <i>J</i> = 8.3 Hz, 1H), 6.61 (dd, <i>J</i> = 2.26, 8.5 Hz, 1H), 5.58 (d, <i>J</i> = 2.5 Hz, 1H), 4.33 (s, 2H), 3.37 (t, <i>J</i> = 8.4 Hz, 1H), 3.26 (s, 3H), 2.88 (s, 6H), 2.26–2.23 (m, 1H), 2.22–2.15 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 465.2290; found, 465.2289. HPLC purity: 95.8% at 254 nM.</div></div><div id="sec4_10_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (1<i>R</i>*,2<i>S</i>*)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>20a</b>)</h4><div class="NLM_p last">The title compound was prepared according to the general procedure A using <b>19a</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (500 mg, 1.3 mmol) to yield <b>20a</b> as a white solid (330 mg, 64%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.47 (s, 1H), 10.62 (s, 1H), 7.47 (s, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.02–6.98 (m, 2H), 6.84 (d, <i>J</i> = 7.6 Hz, 1H), 6.53 (t, <i>J</i> = 7.6 Hz, 1H), 5.97 (d, <i>J</i> = 7.6 Hz, 1H), 3.18 (t, <i>J</i> = 8.4 Hz, 1H), 2.31 (dd, <i>J</i> = 7.2 Hz, 4.8 Hz, 1H), 1.98 (dd, <i>J</i> = 8.8 Hz, 4.8 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>12</sub>IN<sub>3</sub>O + H]<sup>+</sup>, 402.0; found, 402.0.</div></div><div id="sec4_10_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (1<i>R*</i>,2<i>S*</i>)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (<b>20b</b>)</h4><div class="NLM_p last">The title compound was prepared according to the general procedure A using <b>19b</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (658 mg, 1.6 mmol) to yield <b>20b</b> as a white solid (470 mg, 69%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.48 (s, 1H), 10.43 (s, 1H), 7.49 (s, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.4 Hz, 1H), 6.74 (d, <i>J</i> = 8.4 Hz, 1H), 6.57 (dd, <i>J</i> = 8.4 Hz, 2.4 Hz, 1H), 5.62 (d, <i>J</i> = 2.4 Hz, 1H), 3.29 (s, 3H), 3.18 (t, <i>J</i> = 8.2 Hz, 1H), 2.34 (dd, <i>J</i> = 7.8 Hz, 4.6 Hz, 1H), 1.98 (dd, <i>J</i> = 9.2 Hz, 4.8 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>IN<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 432.1; found, 432.0.</div></div><div id="sec4_10_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (1<i>R</i>*,2<i>S</i>*)-5′-Fluoro-2-(3-iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>20c</b>)</h4><div class="NLM_p last">The title compound was prepared according to the general procedure A using <b>19c</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (160 mg, 0.39 mmol) to yield <b>20c</b> as a cream solid (89 mg, 54%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.50 (s, 1H), 10.65 (s, 1H), 7.50 (s, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.00 (d, <i>J</i> = 8.4 Hz, 1H), 6.85–6.81 (m, 2H), 5.81 (d, <i>J</i> = 8.4 Hz, 1H), 3.23 (t, <i>J</i> = 8.4 Hz, 1H), 2.45–2.41 (m, 1H), 2.03–2.00 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>11</sub>FIN<sub>3</sub>O + H]<sup>+</sup>, 420.0; found, 420.0.</div></div><div id="sec4_10_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (1<i>R</i>*,2<i>S</i>*)-5′-Ethyl-2-(3-iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>20d</b>)</h4><div class="NLM_p last">To a mixture of 3-iodo-1<i>H</i>-indazole-6-carbaldehyde (1.36 g, 5 mmol) and 5-ethylindolin-2-one (885 mg, 5.5 mmol) in MeOH (25 mL) was added piperidine (0.1 mL, 1 mmol). The resulting mixture was refluxed for 90 min, then cooled to rt. The resulting red precipitate was collected by suction filtration and dried to give the indolinone <b>19d</b>, which was used without further purification to prepare <b>20d</b>, according to the general procedure A, as a light-orange solid (710 mg, 33%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.44 (s, 1H), 10.51 (s, 1H), 7.44 (s, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 6.99 (d, <i>J</i> = 8.8 Hz, 1H), 6.80 (d, <i>J</i> = 7.2 Hz 1H), 6.72 (d, <i>J</i> = 7.6 Hz, 1H), 5.76 (s, 1H), 3.17 (t, <i>J</i> = 7.8 Hz, 1H), 2.29 (dd, <i>J</i> = 8.0 Hz, 4.8 Hz, 1H), 2.18–2.04 (m, 2H), 1.98 (dd, <i>J</i> = 8.6 Hz, 4.8 Hz, 1H), 0.60 (t, <i>J</i> = 7.4 Hz, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for for [C<sub>19</sub>H<sub>16</sub>IN<sub>3</sub>O + H]<sup>+</sup>, 430.0; found, 430.0.</div></div><div id="sec4_10_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (1<i>R</i>*,2<i>S</i>*)-5′-(Difluoromethoxy)-2-(3-iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>20e</b>)</h4><div class="NLM_p last">The title compound was prepared in a manner similar to general procedure A by utilizing <b>19e</b> (150 mg, 0.33 mmol) to yield <b>20e</b> as a white solid (70 mg, 45%) after purification by Biotage silica column chromatography (0–30% acetone gradient in hexanes). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.31 (s, 1 H), 7.40–7.43 (m, 2 H), 7.00 (d, <i>J</i> = 8.4 Hz, 1H), 6.92 (d, <i>J</i> = 8.4 Hz, 1H), 6.84–6.86 (m, 1 H), 5.99 (t, <i>J</i> = 74 Hz, 1H), 5.69 (s, 1H), 3.50 (t, <i>J</i> = 8.8 Hz, 1 H), 2.31–2.35 (m, 1 H), 2.10–2.15 (m, 1 H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>12</sub>F<sub>2</sub>IN<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 468.0; found, 468.0.</div></div><div id="sec4_10_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (1<i>R</i>*,2<i>S</i>*)-5′-Chloro-2-(3-iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>20f</b>)</h4><div class="NLM_p last">To a mixture of 3-iodo-1<i>H</i>-indazole-6-carbaldehyde (1.36 g, 5 mmol) and 5-chloroindolin-2-one (880 mg, 5.5 mmol) in MeOH (25 mL) was added piperidine (0.1 mL, 1 mmol). The resulting mixture was refluxed for 90 min, then cooled to rt. The resulting yellow precipitate was collected by suction filtration and dried to give the indolinone <b>19f</b>, which was used without further purification to prepare <b>20f</b>, according to the general procedure A, as a light-beige solid (2.29 g, quantitative). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.51 (s, 1H), 10.76 (s, 1H), 7.52 (s, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 7.04 (t, <i>J</i> = 8.8 Hz, 2H), 6.84 (d, <i>J</i> = 8.4 Hz, 1H), 6.03 (s, 1H), 3.23 (t, <i>J</i> = 8.0 Hz, 1H), 2.06–1.97 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>11</sub>ClIN<sub>3</sub>O + H]<sup>+</sup>, 436.0; found, 436.2.</div></div><div id="sec4_10_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (1<i>R</i>*,2<i>S</i>*)-2-(3-Iodo-1<i>H</i>-indazol-6-yl)-5′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>20g</b>)</h4><div class="NLM_p last">To a mixture of 3-iodo-1<i>H</i>-indazole-6-carbaldehyde (1.36 g, 5 mmol) and 5-methylindolin-2-one (772 mg, 5.25 mmol) in MeOH (25 mL) was added piperidine (0.1 mL, 1 mmol). The resulting mixture was refluxed for 90 min, then cooled to rt. The resulting yellow precipitate was collected by suction filtration and dried to give the indolinone <b>19g</b>, which was used without further purification to prepare <b>20g</b>, according to the general procedure A, as a yellow solid and a 6:1 mixture of diastereomers (2.06 g, 99%), which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.43 (s, 1H), 10.51 (s, 1H), 7.47 (s, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.8 Hz, 1H), 6.81 (d, <i>J</i> = 8.4 Hz, 1H), 6.73 (d, <i>J</i> = 7.6 Hz, 1H), 5.86 (s, 1H), 3.18 (t, <i>J</i> = 8.2 Hz, 1H), 2.30–2.20 (m 1H), 2.00–1.90 (m, 1H), 1.85 (s, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>14</sub>IN<sub>3</sub>O + H]<sup>+</sup>, 416.0; found, 416.1.</div></div><div id="sec4_10_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (1<i>R</i>*,2<i>S</i>*)-2-(3-Vinyl-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>21</b>)</h4><div class="NLM_p last">To a mixture of <b>20a</b> (802 mg, 2 mmol) and 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (462 mg, 3 mmol) in a 20 mL microwave vial was added PhCH<sub>3</sub>/EtOH (8 mL/4 mL), followed by 1 M aq Na<sub>2</sub>CO<sub>3</sub> (3 mL, 3 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (46 mg, 0.04 mmol, 2 mol %), and the resulting mixture was purged with argon and microwaved 3 h at 120 °C. After aqueous work-up, the solution was extracted with EtOAc and was purified by flash chromatography (50% hexanes in EtOAc) to give the crude title compound as a light-yellow foam (512 mg), which was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.74 (d, <i>J</i> = 8.4 Hz, 1H), 7.35 (s, 1H), 7.10–6.88 (m, 5H), 6.54 (t, <i>J</i> = 7.4 Hz, 1H), 6.06 (d, <i>J</i> = 18.0 Hz, 1H), 5.92 (d, <i>J</i> = 7.6 Hz, 1H), 5.49 (d, <i>J</i> = 7.6 Hz, 1H), 3.46 (d, <i>J</i> = 8.2 Hz, 1H), 2.30–2.18 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O + H]<sup>+</sup>, 302.1; found, 302.0.</div></div><div id="sec4_10_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-((<i>E</i>)-2-(6-((1<i>R</i>*,2<i>S</i>*)-2′-Oxospiro[cyclopropane-1,3′-indoline]-2-yl)-1<i>H</i>-indazol-3-yl)vinyl)benzaldehyde (<b>23</b>)</h4><div class="NLM_p last">Diethyl 4-cyanobenzylphosphonate (600 mg, 2.4 mmol) was dissolved in DMF (5 mL) at 0 °C. Potassium <i>tert</i>-butoxide (540 mg, 4.8 mmol) was added, and the mixture was stirred for 5 min. 6-((1<i>R</i>*,2<i>S</i>*)-2′-Oxospiro[cyclopropane-1,3′-indoline]-2-yl)-1<i>H</i>-indazole-3-carbaldehyde <b>22</b> (200 mg, 0.66 mmol) was dissolved into DMF (5 mL), added dropwise, and the reaction mixture was stirred for 90 min. The reaction was neutralized with aq HCl (0.1 N) and the resulting precipitate collected. The precipitate was dissolved in EtOAc (100 mL) and washed with H<sub>2</sub>O (2 × 10 mL), brine (10 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by silica gel chromatography to give 4-((<i>E</i>)-2-(6-((1<i>R</i>*,2<i>S</i>*)-2′-oxospiro[cyclopropane-1,3′-indoline]-2-yl)-1<i>H</i>-indazol-3-yl)vinyl)benzonitrile as a white solid (100 mg, 38%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04 (d, <i>J</i> = 8.5 Hz, 1H), 7.82 (d, <i>J</i> = 8.6 Hz, 2H), 7.74 (d, <i>J</i> = 8.6 Hz, 2H), 7.66–7.53 (m, 2H), 7.48 (s, 1H), 7.08–7.04 (m, 2H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 6.59 (t, <i>J</i> = 7.6 Hz, 1H), 5.99 (d, <i>J</i> = 7.5 Hz, 1H), 3.38–3.34 (m, 1H), 2.27–2.18 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>26</sub>H<sub>18</sub>N<sub>4</sub>O + H]+, 403.1; found, 403.1. The nitrile (100 mg, 0.25 mmol) was then dissolved in pyridine (3 mL), acetic acid (0.8 mL), and water (1 mL). Raney Nickel (100 mg), was added, following by dropwise addition of aqueous sodium hypophosphite (180 mg, 2.1 mmol in 1 mL of water), and the reaction was stirred overnight at 60 °C. The product was extracted into EtOAc (30 mL), washed with brine (5 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by silica gel chromatography (99:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH) to give the title compound as an orange solid (95 mg, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.03 (s, 1H), 8.20 (s, 1H), 7.86–7.97 (m, 3H), 7.74 (d, <i>J</i> = 8.3 Hz, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.41 (s, 1H), 7.07–7.13 (m, 2H), 6.88–7.03 (m, 2H), 6.63 (t, <i>J</i> = 7.5 Hz, 1H), 5.94 (d, <i>J</i> = 7.8 Hz, 1H), 3.40 (t, <i>J</i> = 7.1 Hz, 1H), 2.35–2.44 (m, 1H), 2.08–2.02 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>26</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> + H]<sup>+</sup>, 406.2; found, 406.2.</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Heck Arylation of 3-Vinylspirocyclopropaneindolinones: General Procedure B</h3><div class="NLM_p">To a mixture of 2-(3-vinyl-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (1 equiv) and aryl bromide (1 equiv) in DMF was added DIPEA (2 equiv), followed by Pd(OAc)<sub>2</sub> (5 mol %) and P(<i>o</i>-tol)<sub>3</sub> (10 mol %). The resulting mixture was purged with argon and then microwaved 2 h at 125 °C. The mixture was filtered through a Waters PoraPak CX column and then purified by preparative HPLC.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-2-(6-Methylpyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>24</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure B using <b>21</b> (60 mg, 0.2 mmol) and 5-bromo-2-methylpyridine (34.4 mg, 0.2 mmol). Purification by preparative HPLC gave <b>24</b> as a light-yellow solid (25 mg, 25%) contaminated with ∼6% of the branched isomer. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.90 (s, 1H), 7.74 (dd, <i>J</i> = 8.4 Hz, 1.6 Hz, 1H), 8.02 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (d, <i>J</i> = 16.8 Hz, 1H), 7.55 (d, <i>J</i> = 16.8 Hz, 1H), 7.49 (s, 1H), 7.07–7.00 (m, 2H), 6.94 (d, <i>J</i> = 8.0 Hz, 1H), 6.55 (t, <i>J</i> = 7.6 Hz, 1H), 5.97 (d, <i>J</i> = 7.6 Hz, 1H), 3.34 (t, <i>J</i> = 8.4 Hz, 1H), 2.78 (s, 3H), 2.23 (dd, <i>J</i> = 7.6 Hz, 4.8 Hz, 1H), 2.18 (dd, <i>J</i> = 8.8 Hz, 4.8 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>25</sub>H<sub>20</sub>N<sub>4</sub>O + H]<sup>+</sup>, 393.1715; found, 393.1711. HPLC purity: 94% at 214 nM.</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (1<i>R</i>*,2<i>S</i>*)-2-(3-((<i>E</i>)-2-(2,6-Dimethylpyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>25</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure B using <b>21</b> (60 mg, 0.2 mmol) and 3-bromo-2,6-dimethylpyridine (37 mg, 0.2 mmol). Purification by preparative HPLC gave <b>25</b> as a light-yellow solid (23 mg, 22%) contaminated with ∼3% of the branched isomer. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.73 (d, <i>J</i> = 8.0 Hz, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.72 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (d, <i>J</i> = 16.4 Hz, 1H), 7.59 (d, <i>J</i> = 16.4 Hz, 1H), 7.50 (s, 1H), 7.06 (d, <i>J</i> = 8.8 Hz, 1H), 7.05 (t, <i>J</i> = 8.6 Hz, 1H), 6.94 (d, <i>J</i> = 8.0 Hz, 1H), 6.56 (t, <i>J</i> = 7.6 Hz, 1H), 5.98 (d, <i>J</i> = 7.6 Hz, 1H), 3.35 (t, <i>J</i> = 8.4 Hz, 1H), 2.86 (s, 3H), 2.76 (s, 3H), 2.24 (dd, <i>J</i> = 7.6 Hz, 4.8 Hz, 1H), 2.18 (dd, <i>J</i> = 9.0 Hz, 5.0 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>26</sub>H<sub>22</sub>N<sub>4</sub>O + H]<sup>+</sup>, 407.1872; found, 407.1877. HPLC purity: 96.9% at 214 nM.</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Suzuki–Miyaura Cross Coupling of 3-Iodospirocyclopropaneindolinones: General Procedure C</h3><div class="NLM_p">The appropriate 2-(3-iodo-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one <b>20</b> (1 equiv) was dissolved into 2:1 PhCH<sub>3</sub>/EtOH and 1 M Na<sub>2</sub>CO<sub>3</sub> (2 equiv). The appropriate vinyl boronic ester (1.2 equiv) and catalyst, Pd(PPh<sub>3</sub>)<sub>4</sub> (5 mol %), were added, and resulting mixture was heated in a microwave for 2 h at 125 °C. After cooling to rt, the mixture was diluted with H<sub>2</sub>O, extracted with EtOAc (×2), and dried (MgSO<sub>4</sub>). After removal of solvents, the residue was redissolved in MeOH and filtered through a Waters CX column and purified by preparative HPLC to give the title compound as a TFA salt.</div><div id="sec4_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-((<i>E</i>)-2-(6-(Piperidin-1-ylmethyl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>26</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C using <b>20a</b> (50 mg, 0.12 mmol) and (<i>E</i>)-2-(piperidin-1-ylmethyl)-5-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)pyridine (65 mg, 0.2 mmol). Purification by reverse phase preparative HPLC gave <b>26</b> as a yellow TFA salt (9 mg, 15%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.91 (s, 1H), 8.20 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 1H), 7.68–7.49 (m, 4H), 7.08–7.04 (m, 2H), 6.95 (d, <i>J</i> = 7.8 Hz, 1H), 6.60–6.56 (m, 1H), 5.99 (d, <i>J</i> = 7.5 Hz, 1H), 4.45 (s, 2H) 3.39–3.10 (m, 3H), 2.27–2.18 (m, 2H), 1.95–1.60 (m, 8H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>29</sub>N<sub>5</sub>O + H]<sup>+</sup>, 476.2450; found, 476.2448. HPLC purity: 97.8% at 214 nM.</div></div><div id="sec4_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (1<i>R</i>*,2<i>S</i>*)-5′-Methoxy-2-(3-((<i>E</i>)-2-(6-(piperidin-1-ylmethyl)pyridin-3-yl)vinyl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>27</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C using <b>20b</b> (51 mg, 0.12 mmol) and (<i>E</i>)-2-(piperidin-1-ylmethyl)-5-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)pyridine (65 mg, 0.2 mmol). Purification by reverse phase preparative HPLC gave <b>27</b> as a yellow TFA salt (15 mg, 21%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.90 (d, <i>J</i> = 1.2 Hz, 1H), 8.19 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 1H), 7.67–7.51 (m, 4H), 7.07 (d, <i>J</i> = 8.3 Hz, 1H), 6.84 (d, <i>J</i> = 8.3 Hz, 1H), 6.62 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 5.58 (d, <i>J</i> = 2.3 Hz, 1H), 4.45 (s, 2H), 3.39–3.10 (m, 3H), 3.27 (s, 3H), 2.27–2.17 (m, 2H), 1.95–1.80 (m, 5H), 1.80–1.60 (m, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 506.2556; found, 506.2562. HPLC purity: 97.9% at 214 nM.</div></div><div id="sec4_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (1<i>R*</i>,2<i>S*</i>)-(<i>E</i>)-5′-Difluoromethoxy-2-(3-(4-((dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>28</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C by using <b>20e</b> (75 mg, 0.16 mmol) and (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)methanamine (58 mg, 0.20 mmol). Purification by preparative HPLC gave <b>28</b> as an off-white TFA salt (38 mg, 39%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 2H), 7.55–7.48 (m, 5H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 1H), 6.84 (d, <i>J</i> = 8.4 Hz, 1H), 6.14 (t, <i>J</i> = 74.4 Hz, 1H), 5.77 (s, 1H), 4.33 (s, 2H), 3.41 (t, <i>J</i> = 8.4 Hz, 1H), 2.88 (s, 6H), 2.33–2.30 (m, 1H), 2.25–2.21 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>26</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 501.2102; found, 501.2098. HPLC purity: >99.9% at 254 nM.</div></div><div id="sec4_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-5′-Chloro-2-(3-(4-((dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro [cyclopropane-1,3′-indolin]-2′-one (<b>29</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure C from <b>20f</b> (44 mg, 0.1 mmol) and (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)methanamine (43 mg, 0.15 mmol) to give <b>29</b> as a light-yellow TFA salt (29 mg, 50%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 2H), 7.55–7.47 (m, 5H), 7.06–7.01 (m, 2H), 6.90 (d, <i>J</i> = 8.4 Hz, 1H), 5.97 (s, 1H), 4.33 (s, 2H), 3.39 (t, <i>J</i> = 8.4 Hz, 1H), 2.88 (s, 6H), 2.29 (dd, <i>J</i> = 8.0 Hz, 5.2 Hz, 1H), 2.21 (dd, <i>J</i> = 8.8 Hz, 4.8 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>25</sub>ClN<sub>4</sub>O + H]<sup>+</sup>, 469.1795; found, 469.1791. HPLC purity: 99.6% at 214 nM.</div></div><div id="sec4_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methylspiro[cyclopropane-1,3′-indolin]-2′-one (<b>30</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure C using <b>20g</b> (42 mg, 0.1 mmol) and (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)methanamine (43 mg, 0.15 mmol) to give <b>30</b> as a yellow TFA salt (27 mg, 48%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 2H), 7.53 (s, 2H), 7.52 (d, <i>J</i> = 8.8 Hz, 2H), 7.46 (s, 1H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 6.86 (d, <i>J</i> = 8.0 Hz, 1H), 6.82 (d, <i>J</i> = 7.6 Hz, 1H), 5.83 (s, 1H), 4.33 (s, 2H), 3.32 (t, <i>J</i> = 8.4 Hz, 1H), 2.88 (s, 6H), 2.22–2.13 (m, 2H), 1.88 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O + H]<sup>+</sup>, 449.2341; found, 449.2333. HPLC purity: 99.8% at 214 nM.</div></div><div id="sec4_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-fluorospiro [cyclopropane-1,3′-indolin]-2′-one (<b>31</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C by using <b>20c</b> (75 mg, 0.178 mmol) and (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)methanamine (64 mg, 0.22 mmol). Purification by preparative HPLC gave <b>31</b> as a cream-colored TFA salt (42 mg, 41%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.77 (d, <i>J</i> = 8.0 Hz, 2H), 7.57 (s, 2H), 7.56–7.50 (m, 3H), 7.05 (d, <i>J</i> = 8.4 Hz, 1H), 6.91–6.88 (m, 1H), 6.82–6.77 (m, 1H), 5.77 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 4.33 (s, 2H), 3.42–3.38 (m, 1H), 2.88 (s, 6H), 2.32–2.29 (m, 1H), 2.24–2.20 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>25</sub>FN<sub>4</sub>O + H]<sup>+</sup>, 453.2091; found, 453.2089. HPLC purity: 99.9% at 254 nM.</div></div><div id="sec4_12_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-((Dimethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-ethylspiro [cyclopropane-1,3′-indolin]-2′-one (<b>32</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C by using <b>20d</b> (42.9 mg, 0.1 mmol) and (<i>E</i>)-<i>N</i>,<i>N</i>-dimethyl-1-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenyl)methanamine (29 mg, 0.1 mmol). Purification by preparative HPLC gave <b>32</b> as a white TFA salt (19 mg, 34%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.01 (d, <i>J</i> = 8.8 Hz, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 2H), 7.54–7.50 (m, 4H), 7.44 (s, 1H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.86 (d, <i>J</i> = 8.0 Hz, 1H), 6.82 (d, <i>J</i> = 8.0 Hz, 1H), 5.77 (s, 1H), 4.33 (s, 2H), 3.34 (t, <i>J</i> = 8.0 Hz, 1H), 2.88 (s, 6H), 2.25–2.10 (m, 4H), 0.65 (t, <i>J</i> = 7.6 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>30</sub>N<sub>4</sub>O + H]<sup>+</sup>, 463.2498; found, 463.22505. HPLC purity: 99% at 254 nM.</div></div><div id="sec4_12_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-(Morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>33</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C by using <b>20a</b> (50 mg, 0.12 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (65 mg, 0.2 mmol). The residue was purified by reversed phase preparatory HPLC to give <b>33</b> as a pale-yellow TFA salt (30 mg, 41%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.5 Hz, 1H), 7.78 (d, <i>J</i> = 8.6 Hz, 2H), 7.75–7.48 (m, 5H), 7.08–7.05 (m, 2H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 6.59 (t, <i>J</i> = 7.6 Hz, 1H), 5.99 (d, <i>J</i> = 7.5 Hz, 1H), 4.39 (s, 2H), 4.12–4.04 (m, 2H), 3.79–3.68 (m, 2H), 3.44–3.34 (m, 3H), 3.30–3.19 (m, 2H), 2.28–2.16 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 477.2291; found, 477.2286. HPLC purity: 96.4% at 214 nM.</div></div><div id="sec4_12_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-5′-Methoxy-2-(3-(4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro [cyclopropane-1,3′-indolin]-2′-one (<b>34</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C, using <b>20b</b> (30 mg, 0.07 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (30 mg, 0.091 mmol). Purification by column chromatography (5–6% MeOH in CH<sub>2</sub>Cl<sub>2</sub>/MeOH) gave crude material, which was further purified by preparative HPLC to give <b>34</b> as a white TFA salt (18 mg, 51%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (d, <i>J</i> = 8.2 Hz, 2H), 7.57–7.50 (m, 5H), 7.07 (d, <i>J</i> = 8.6 Hz, 1H), 6.83 (d, <i>J</i> = 8.5 Hz, 1H), 6.61 (dd, <i>J</i> = 8.5 Hz, 2.2 Hz, 1H), 5.58 (d, <i>J</i> = 2.2 Hz, 1H), 4.39 (s, 2H), 4.09–4.04 (m, 2H), 3.78–3.72 (m, 2H), 3.43–3.33 (m, 3H), 3.27–3.20 (m, 5H), 2.27–2.23 (m, 1H), 2.21–2.16 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup>, 507.2396; found, 507.2387. HPLC purity: 95.0% at 214 nM.</div></div><div id="sec4_12_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (1<i>R</i>,2<i>S</i>)-5′-Fluoro-2-(3-((<i>E</i>)-4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>35</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C, using <b>20c</b> (60.0 mg, 0.139 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (54 mg, 0.17 mmol). Purification by preparative HPLC gave <b>35</b> as a cream TFA salt (31 mg, 37%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.04 (d, <i>J</i> = 8.8 Hz, 1H), 7.77 (d, <i>J</i> = 7.2 Hz, 2H), 7.59–7.52 (m, 5H), 7.05 (d, <i>J</i> = 8.0 Hz, 1H), 6.91–6.88 (m, 1H), 6.79 (t, <i>J</i> = 8.0 Hz, 1H), 5.74 (d, <i>J</i> = 8.8 Hz, 1H), 4.39 (s, 2H), 4.08–4.05 (bm, 2H), 3.76–3.70 (m, 2H), 3.42–3.35 (m, 3H), 3.26–3.23 (m, 2H), 2.30 (t, <i>J</i> = 5.6 Hz, 1H), 2.24–2.20 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 495.2196; found, 495.2193. HPLC purity: 99.9% at 254 nM.</div></div><div id="sec4_12_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-5′-Methyl-2-(3-(4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>36</b>)</h4><div class="NLM_p last">The title compound was prepared using the general procedure C using <b>20g</b> (83 mg, 0.2 mmol) and (<i>E</i>)-4-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (66 mg, 0.2 mmol) to give <b>36</b> as a yellow TFA salt (27 mg, 22%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (d, <i>J</i> = 8.0 Hz, 2H), 7.44 (d, <i>J</i> = 8.0 Hz, 2H), 7.38 (s, 1H), 7.32 (d, <i>J</i> = 16.8 Hz, 1H), 7.27 (d, <i>J</i> = 16.8 Hz, 1H), 6.82 (d, <i>J</i> = 8.4 Hz, 1H), 6.77 (d, <i>J</i> = 8.0 Hz, 1H), 6.73 (d, <i>J</i> = 8.0 Hz, 1H), 5.78 (s, 1H), 4.29 (s, 2H), 3.99 (d, <i>J</i> = 11.2 Hz, 2H), 3.75 (t, <i>J</i> = 11.6 Hz, 2H), 3.42–3.32 (m, 2H), 3.21 (t, <i>J</i> = 8.4 Hz, 1H), 3.18–3.08 (m, 2H), 2.09–2.01 (m, 2H), 1.72 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 491.2447; found, 491.446. HPLC purity: 99.7% at 214 nM.</div></div><div id="sec4_12_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (1<i>R</i>*,2<i>S</i>*)-2-(3-(3,5-Difluoro-4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro [cyclopropane-1,3′-indolin]-2′-one (<b>37</b>)</h4><div class="NLM_p last">The title compound was synthesized according to the general procedure C using <b>20b</b> (60 mg, 0.14 mmol) and (<i>E</i>)-4-(2,6-difluoro-4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)morpholine (58 mg, 0.16 mmol). Purification by preparative HPLC gave <b>37</b> as a cream TFA salt (29 mg, 27%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.03 (d, <i>J</i> = 8.8 Hz, 1H), 7.63 (d, <i>J</i> = 16.8 Hz, 1H), 7.52–7.49 (m, 4H), 7.06 (s, <i>J</i> = 8.4 Hz, 1H), 6.82 (d, <i>J</i> = 8.4 Hz, 1H), 6.60 (d, <i>J</i> = 8.8 Hz, 1H), 5.57 (s, 1H), 4.51 (s, 2H), 4.10–3.72 (m, 4H), 3.47–3.42 (m, 5H), 3.26 (s, 3H), 2.26–2.23 (m, 1H), 2.21–2.17 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>28</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup>, 543.2208; found, 543.2201. HPLC purity: 99.8% at 254 nM.</div></div><div id="sec4_12_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-((4-Methylpiperazin-1-yl)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro [cyclopropane-1,3′-indolin]-2′-one (<b>38</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure B using <b>21</b> (60 mg, 0.2 mmol) and 1-(4-bromobenzyl)-4-methylpiperazine (54 mg, 0.2 mmol). Purification by preparative HPLC gave <b>38</b> as a white TFA salt (23 mg, 16%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.99 (d, <i>J</i> = 8.4 Hz, 1H), 7.71 (d, <i>J</i> = 8.0 Hz, 2H), 7.53–7.46 (m, 5H), 7.05 (t, <i>J</i> = 7.6 Hz, 1H), 7.04 (d, <i>J</i> = 8.0 Hz, 1H), 6.94 (d, <i>J</i> = 7.6 Hz, 1H), 6.58 (t, <i>J</i> = 7.4 Hz, 1H), 5.99 (d, <i>J</i> = 8.0 Hz, 1H), 4.19 (s, 2H), 3.60–3.30 (m, 9H), 2.95 (s, 3H), 2.24 (dd, <i>J</i> = 7.6, 4.8 Hz, 1H), 2.18 (dd, <i>J</i> = 9.0, 4.6 Hz, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>31</sub>N<sub>5</sub>O + H]<sup>+</sup>, 490.2607; found, 490.2610. HPLC purity: 99% at 254 nM.</div></div><div id="sec4_12_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (1<i>R</i>*,2<i>S</i>*)-2-(3-(4-((Diethylamino)methyl)styryl)-1<i>H</i>-indazol-6-yl)spiro-[cyclopropane-1,3′-indolin]-2′-one (<b>39</b>)</h4><div class="NLM_p last">The title compound was synthesized according to general procedure C, using <b>20a</b> (70 mg, 0.17 mmol) and (<i>E</i>)-<i>N</i>-ethyl-<i>N</i>-(4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzyl)ethanamine (68 mg, 0.22 mmol). Purification by preparative HPLC gave <b>39</b> as a cream TFA salt (29 mg, 29%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.01 (d, <i>J</i> = 8.4 Hz, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 2H), 7.56–7.52 (m, 4H), 7.48 (s, 1H), 7.04 (d, <i>J</i> = 7.2 Hz, 2H), 6.93 (d, <i>J</i> = 7.6 Hz, 1H), 6.58 (t, <i>J</i> = 7.2 Hz, 1H), 5.98 (d, <i>J</i> = 7.6 Hz, 1H), 4.36 (s, 2H), 3.29–3.17 (m, 5H), 2.25 (t, <i>J</i> = 4.8 Hz, 1H), 2.21–2.17 (m, 1H), 1.37 (t, <i>J</i> = 7.2 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>30</sub>N<sub>4</sub>O + H]<sup>+</sup>, 463.2498; found, 463.2491. HPLC purity: >99% at 254 nM.</div></div><div id="sec4_12_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-(Pyrrolidin-1-ylmethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>40</b>)</h4><div class="NLM_p last">To a solution of <b>23</b> (70 mg, 0.17 mmol) and pyrrolidine (71 μL, 0.86 mmol) in THF (3 mL) was added Ti(Oi-Pr)<sub>4</sub> (97 mg, 0.34 mmol), and the mixture was stirred for 30 min. NaBH<sub>4</sub> (13 mg, 0.34 mmol) was added, and the mixture was heated to 50 °C overnight. Water (10 mL) was added, and the solution was extracted with EtOAc (2 × 10 mL), dried over MgSO<sub>4</sub>, and concentrated to a brown solid. Purification by reverse phase preparatory HPLC gave the title compound as a yellow TFA salt (34 mg, 35%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.6 Hz, 1H), 7.76 (d, <i>J</i> = 8.6 Hz, 2H), 7.55–7.48 (m, 5H), 7.08–7.05 (m, 2H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 6.59 (t, <i>J</i> = 7.5 Hz, 1H), 5.99 (d, <i>J</i> = 7.5 Hz, 1H) 4.40 (s, 2H), 3.55–3.46 (m, 2H), 3.38–3.34 (m, 1H), 3.27–3.16 (m, 2H), 2.27–2.17 (m, 4H), 2.06–1.98 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>28</sub>N<sub>4</sub>O + H]<sup>+</sup>, 461.2341; found, 461.3336. HPLC purity: 98.9% at 214 nM.</div></div><div id="sec4_12_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (1<i>R</i>*,2<i>S</i>*)-(<i>E</i>)-2-(3-(4-(Piperidin-1-ylmethyl)styryl)-1<i>H</i>-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (<b>41</b>)</h4><div class="NLM_p last">To a solution of <b>23</b> (20 mg, 0.05 mmol) and piperidine (38 μL, 0.25 mmol) in THF (1 mL) was added Ti(iOPr)<sub>4</sub> (28 mg, 0.1 mmol), and the mixture was stirred for 30 min. NaBH<sub>4</sub> (4 mg, 0.1 mmol) was added, and the mixture was heated to 50 °C overnight. Water (5 mL) was added, and the solution was extracted with EtOAc (2 × 10 mL), dried over MgSO<sub>4</sub> and concentrated to a yellow oil. Purification by reverse phase preparatory HPLC gave the title compound as a yellow TFA salt (8 mg, 28%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.02 (d, <i>J</i> = 8.8 Hz, 1H), 7.77 (d, <i>J</i> = 8.6 Hz, 2H), 7.75–7.48 (m, 5H), 7.08–7.05 (m, 2H), 6.94 (d, <i>J</i> = 7.5 Hz, 1H), 6.59 (t, <i>J</i> = 7.7 Hz, 1H), 5.99 (d, <i>J</i> = 7.3 Hz, 1H), 4.31 (s, 2H), 3.53–3.45 (m, 2H), 3.39–3.34 (m, 1H), 3.04–2.93 (m, 2H) 2.27–2.17 (m, 2H), 2.02–1.95 (m, 2H), 1.88–1.71 (m, 3H), 1.57–1.45 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O + H]<sup>+</sup>, 475.2498; found, 475.2501. HPLC purity: 95.3% at 214 nM.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/jm500537u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis of compound intermediates; crystallographic data and refinement statistics for PLK4/compound <b>18</b> complex. Correlation plot for the predictivity of the PLK4 binding model. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500537u/suppl_file/jm500537u_si_001.pdf">jm500537u_si_001.pdf (1.05 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500537u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter B. Sampson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#09797a6864797a6667497c61677b6c7a6c687b6a61276a68"><span class="__cf_email__" data-cfemail="84f4f7e5e9f4f7ebeac4f1eceaf6e1f7e1e5f6e7ecaae7e5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Liu</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Narendra Kumar Patel</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miklos Feher</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan Forrest</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sze-Wan Li</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Edwards</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Radoslaw Laufer</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunhui Lang</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fuqiang Ban</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald E. Awrey</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guodong Mao</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Plotnikova</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Genie Leung</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Hodgson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline Mason</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Wei</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reza Kiarash</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin Green</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Qiu</span> - <span class="hlFld-Affiliation affiliation">Princess Margaret Cancer Center, University Health Network, Toronto, Ontario M5G 2C4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nickolay Y. Chirgadze</span> - <span class="hlFld-Affiliation affiliation">Princess Margaret Cancer Center, University Health Network, Toronto, Ontario M5G 2C4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tak W. Mak</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guohua Pan</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry W. Pauls</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer
Research, TMDT East Tower,
MaRS Centre, 101 College Street, Toronto, Ontario MG5 1L7, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3974e5574-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Homer Pearce for helpful discussion during the course of the work. The Princess Margaret Cancer Foundation and the Canadian Foundation for Innovation are acknowledged for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i69" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i69"> Abbreviations Used</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">Adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">b</td><td class="NLM_def"><p class="first last">broad</p></td></tr><tr><td class="NLM_term">calcd</td><td class="NLM_def"><p class="first last">calculated</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">fms-related tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal cell growth inhibitory concentration</p></td></tr><tr><td class="NLM_term">G6PDH</td><td class="NLM_def"><p class="first last">glucose-6-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione <i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">KD</td><td class="NLM_def"><p class="first last">kinase domain</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain receptor</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography coupled to mass spectrometry</p></td></tr><tr><td class="NLM_term">MBP</td><td class="NLM_def"><p class="first last">myelin basic protein</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr><tr><td class="NLM_term">MS ESI</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NOE</td><td class="NLM_def"><p class="first last">nuclear Overhauser effect</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PEG400</td><td class="NLM_def"><p class="first last">poly(ethylene glycol) 400</p></td></tr><tr><td class="NLM_term">pin</td><td class="NLM_def"><p class="first last">pinacol</p></td></tr><tr><td class="NLM_term">PMH</td><td class="NLM_def"><p class="first last">Princess Margaret Hospital</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">prep</td><td class="NLM_def"><p class="first last">preparative</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">once a day</p></td></tr><tr><td class="NLM_term">RBF</td><td class="NLM_def"><p class="first last">round-bottomed flask</p></td></tr><tr><td class="NLM_term">RMSE root-mean-square deviation</td><td class="NLM_def"></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">satd</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxy]methyl</p></td></tr><tr><td class="NLM_term">SRB</td><td class="NLM_def"><p class="first last">sulforhodamine B</p></td></tr><tr><td class="NLM_term">SUMO</td><td class="NLM_def"><p class="first last">small ubiquitin modifier</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">temp</td><td class="NLM_def"><p class="first last">temperature</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">tol</td><td class="NLM_def"><p class="first last">toluene</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">UHN IACUC</td><td class="NLM_def"><p class="first last">University Health Network Institutional Animal Care and Use Committee</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0ljv3gyBeotXeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastians, H.</span><span> </span><span class="NLM_article-title">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span> <span class="citation_source-journal">Drug Res. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1016%2Fj.drup.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=17669681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=162-181&author=M.+Schmidtauthor=H.+Bastians&title=Mitotic+drug+targets+and+the+development+of+novel+anti-mitotic+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span></div><div class="casAuthors">Schmidt, Mathias; Bastians, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">162-181</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that interfere with the normal progression of mitosis belong to the most successful chemotherapeutic compds. currently used for anti-cancer treatment.  Classically, these drugs are represented by microtubule binding drugs that inhibit the function of the mitotic spindle in order to halt the cell cycle in mitosis and to induce apoptosis in tumor cells.  However, these compds. act not only on proliferating tumor cells, but exhibit significant side effects on non-proliferating cells including neurons that are highly dependent on intracellular transport processes mediated by microtubules.  Therefore, there is a particular interest in developing novel anti-mitotic drugs that target non-microtubule structures.  In fact, recently several novel drugs that target mitotic kinesins or the Aurora and polo-like kinases have been developed and are currently tested in clin. trials.  In addn., approaches of cell cycle checkpoint abrogation during mitosis and at the G2/M transition inducing mitosis-assocd. tumor cell death are promising new strategies for anti-cancer therapy.  It is expected that this "next generation" of anti-mitotic drugs will be as successful as the classical anti-microtubule drugs, while avoiding some of the adverse side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOJi9lDecBLVg90H21EOLACvtfcHk0lhlRA8ZS4z6FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N&md5=b7262b3578e6daaad41412780d022937</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBastians%26aufirst%3DH.%26atitle%3DMitotic%2520drug%2520targets%2520and%2520the%2520development%2520of%2520novel%2520anti-mitotic%2520anticancer%2520drugs%26jtitle%3DDrug%2520Res.%2520Updates%26date%3D2007%26volume%3D10%26spage%3D162%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Matthews, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visintin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartzoulakis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span> </span><span class="NLM_article-title">Aurora A and B kinases as targets for cancer: Will they be selective for tumors?</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1586%2F14737140.6.1.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=16375648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFygsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=109-120&author=N.+Matthewsauthor=C.+Visintinauthor=B.+Hartzoulakisauthor=A.+Jarvisauthor=D.+L.+Selwood&title=Aurora+A+and+B+kinases+as+targets+for+cancer%3A+Will+they+be+selective+for+tumors%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora A and B kinases as targets for cancer: will they be selective for tumors?</span></div><div class="casAuthors">Matthews, Nick; Visintin, Cristina; Hartzoulakis, Basil; Jarvis, Ashley; Selwood, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-120</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Aurora A and B kinases are closely related kinases involved in regulating sep. points in the cell cycle.  This review highlights the rationale for Aurora kinases as cancer targets and examines the currently known Aurora kinase inhibitors in the patent and scientific literature.  The known crystal structures of the Aurora kinases are described with relevance to bound ligand interactions and the prospect of the generation of drug-resistant mutant forms.  The potential for selectivity vs. primary cells will also be discussed.  The status of the inhibitors in clin. development is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_LCGgBjnCtbVg90H21EOLACvtfcHk0lhlRA8ZS4z6FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFygsLg%253D&md5=6e8cf58ccc390b2bfcad4f5fe1340274</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1586%2F14737140.6.1.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.6.1.109%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DN.%26aulast%3DVisintin%26aufirst%3DC.%26aulast%3DHartzoulakis%26aufirst%3DB.%26aulast%3DJarvis%26aufirst%3DA.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26atitle%3DAurora%2520A%2520and%2520B%2520kinases%2520as%2520targets%2520for%2520cancer%253A%2520Will%2520they%2520be%2520selective%2520for%2520tumors%253F%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2006%26volume%3D6%26spage%3D109%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kollareddy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheleva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzubak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmkshatriya, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepsik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduch, M.</span><span> </span><span class="NLM_article-title">Aurora kinase inhibitors: progress towards the clinic</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2411-2432&author=M.+Kollareddyauthor=D.+Zhelevaauthor=P.+Dzubakauthor=P.+S.+Brahmkshatriyaauthor=M.+Lepsikauthor=M.+Hajduch&title=Aurora+kinase+inhibitors%3A+progress+towards+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKollareddy%26aufirst%3DM.%26aulast%3DZheleva%26aufirst%3DD.%26aulast%3DDzubak%26aufirst%3DP.%26aulast%3DBrahmkshatriya%26aufirst%3DP.%2BS.%26aulast%3DLepsik%26aufirst%3DM.%26aulast%3DHajduch%26aufirst%3DM.%26atitle%3DAurora%2520kinase%2520inhibitors%253A%2520progress%2520towards%2520the%2520clinic%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D31%26spage%3D2411%26epage%3D2432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Friedberg, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebula, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lossos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fingert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danaee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, S. H.</span><span> </span><span class="NLM_article-title">Phase II Study of Alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-Cell non-Hodgkin lymphomes</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1200%2FJCO.2012.46.8793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=24043741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1agtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=44-50&author=J.+W.+Friedbergauthor=D.+Mahadevanauthor=E.+Cebulaauthor=D.+Perskyauthor=I.+Lossosauthor=A.+B.+Agarwalauthor=J.+Jungauthor=R.+Burackauthor=X.+Zhouauthor=E.+J.+Leonardauthor=H.+Fingertauthor=H.+Danaeeauthor=S.+H.+Bernstein&title=Phase+II+Study+of+Alisertib%2C+a+selective+Aurora+A+kinase+inhibitor%2C+in+relapsed+and+refractory+aggressive+B-+and+T-Cell+non-Hodgkin+lymphomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study of alisertib, a selective aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas</span></div><div class="casAuthors">Friedberg, Jonathan W.; Mahadevan, Daruka; Cebula, Erin; Persky, Daniel; Lossos, Izidore; Agarwal, Amit B.; Jung, JungAh; Burack, Richard; Zhou, Xiaofei; Leonard, E. Jane; Fingert, Howard; Danaee, Hadi; Bernstein, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-50</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Aurora A kinase (AAK) is overexpressed in aggressive lymphomas and can correlate with more histol. aggressive forms of disease.  We therefore designed a phase II study of alisertib, a selective AAK inhibitor, in patients with relapsed and refractory aggressive nonHodgkin lymphomas.  Patients and Methods Patients age ≥ 18 years were eligible if they had relapsed or refractory diffuse large B-cell lymphoma (DLBCL), mantle-cell lymphoma (MCL), transformed follicular lymphoma, Burkitt's lymphoma, or noncutaneous T-cell lymphoma.  Alisertib was administered orally at 50 mg twice daily for 7 days in 21-day cycles.  Results We enrolled 48 patients.  Histologies included DLBCL (n = 21), MCL (n = 13), peripheral T-cell lymphoma (n = 8), transformed follicular lymphoma (n = 5), and Burkitt's (n = 1).  Most common grade 3 to 4 adverse events were neutropenia (63%), leukopenia (54%), anemia (35%), thrombocytopenia (33%), stomatitis (15%), febrile neutropenia (13%), and fatigue (6%).  Four deaths during the study were attributed to progressive non-Hodgkin lymphoma (n = 2), treatment-related sepsis (n = 1), and unknown cause (n = 1).  The overall response rate was 27%, including responses in three of 21 patients with DLBCL, three of 13 with MCL, one of one with Burkitt's lymphoma, two of five with transformed follicular lymphoma, and four of eight with noncutaneous T-cell lymphoma.  The alisertib steady-state trough concn. (n = 25) revealed the expected pharmacokinetic variability, with a trend for higher incidence of adverse event-related dose redns. at higher trough concns.  Anal. for AAK gene amplification and total AAK protein revealed no differences between histologies or correlation with clin. response.  Conclusion The novel AAK inhibitor alisertib seems clin. active in both B- and T-cell aggressive lymphomas.  On the basis of these results, confirmatory single-agent and combination studies have been initiated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzeT69vodilrVg90H21EOLACvtfcHk0ljai28XmjCG_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1agtL0%253D&md5=f4aa20df4b3bcce9c673a453fc73e9ee</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.46.8793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.46.8793%26sid%3Dliteratum%253Aachs%26aulast%3DFriedberg%26aufirst%3DJ.%2BW.%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DCebula%26aufirst%3DE.%26aulast%3DPersky%26aufirst%3DD.%26aulast%3DLossos%26aufirst%3DI.%26aulast%3DAgarwal%26aufirst%3DA.%2BB.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DBurack%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLeonard%26aufirst%3DE.%2BJ.%26aulast%3DFingert%26aufirst%3DH.%26aulast%3DDanaee%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DS.%2BH.%26atitle%3DPhase%2520II%2520Study%2520of%2520Alisertib%252C%2520a%2520selective%2520Aurora%2520A%2520kinase%2520inhibitor%252C%2520in%2520relapsed%2520and%2520refractory%2520aggressive%2520B-%2520and%2520T-Cell%2520non-Hodgkin%2520lymphomes%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26spage%3D44%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silljé, H. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell division</span> <span class="citation_source-journal">Nature Rev. Mod. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H.+W.+Sillj%C3%A9author=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0ljai28XmjCG_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillj%25C3%25A9%26aufirst%3DH.%2BH.%2BW.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520division%26jtitle%3DNature%2520Rev.%2520Mod.%2520Cell%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Eckerdt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Polo-like kinases and oncogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=267-276&author=F.+Eckerdtauthor=J.+Yuanauthor=K.+Strebhardt&title=Polo-like+kinases+and+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckerdt%26aufirst%3DF.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DPolo-like%2520kinases%2520and%2520oncogenesis%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D267%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9551</span><span class="NLM_x">–</span> <span class="NLM_lpage">9563</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9551-9563&author=E.+F.+Johnsonauthor=K.+D.+Stewartauthor=K.+W.+Woodsauthor=V.+L.+Girandaauthor=Y.+Luo&title=Pharmacological+and+functional+comparison+of+the+polo-like+kinase+family%3A+insight+into+inhibitor+and+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi7008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7008745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DPharmacological%2520and%2520functional%2520comparison%2520of%2520the%2520polo-like%2520kinase%2520family%253A%2520insight%2520into%2520inhibitor%2520and%2520substrate%2520specificity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D9551%26epage%3D9563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lens, S. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voest, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span> </span><span class="NLM_article-title">Shared and separate functions of polo-like kinases and aurora kinases in cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnrc2964" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=21102634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=825-841&author=S.+M.+A.+Lensauthor=E.+E.+Voestauthor=R.+H.+Medema&title=Shared+and+separate+functions+of+polo-like+kinases+and+aurora+kinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Shared and separate functions of polo-like kinases and aurora kinases in cancer</span></div><div class="casAuthors">Lens, Susanne M. A.; Voest, Emile E.; Medema, Rene H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">825-841</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Large nos. of inhibitors for polo-like kinases and aurora kinases are currently being evaluated as anticancer drugs.  Interest in these drugs is fuelled by the idea that these kinases have unique functions in mitosis.  Within the polo-like kinase family, the emphasis for targeted therapies has been on polo-like kinase 1 (PLK1), and in the aurora kinase family drugs have been developed to specifically target aurora kinase A (AURKA; also known as STK6) and/or aurora kinase B (AURKB; also known as STK12).  Information on the selectivity of these compds. in vivo is limited, but it is likely that off-target effects within the same kinase families will affect efficacy and toxicity profiles.  In addn., it is becoming clear that interplay between polo-like kinases and aurora kinases is much more extensive than initially anticipated, and that both kinase families are important factors in the response to classical chemotherapeutics that damage the genome or the mitotic spindle.  In this Review we discuss the implications of these novel insights on the clin. applicability of polo-like kinase and aurora kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZqNXWXWvq_bVg90H21EOLACvtfcHk0lgPKFs8dVyyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsLbI&md5=f8b721eca926065b3d8ec682ec7a7379</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc2964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2964%26sid%3Dliteratum%253Aachs%26aulast%3DLens%26aufirst%3DS.%2BM.%2BA.%26aulast%3DVoest%26aufirst%3DE.%2BE.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DShared%2520and%2520separate%2520functions%2520of%2520polo-like%2520kinases%2520and%2520aurora%2520kinases%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D825%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Schoffski, P.</span><span> </span><span class="NLM_article-title">Polo-like kinase inhibitors in preclinical and early clinical development</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffski&title=Polo-like+kinase+inhibitors+in+preclinical+and+early+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffski%26aufirst%3DP.%26atitle%3DPolo-like%2520kinase%2520inhibitors%2520in%2520preclinical%2520and%2520early%2520clinical%2520development%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Frost, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kross, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedbom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trommeshauser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span> </span><span class="NLM_article-title">Phase I study of the PLK1 inhibitor BI 2536 administered intravenously on three consecutive days in advance solid tumours</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.3747%2Fco.19.866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=28-35&author=A.+Frostauthor=K.+Krossauthor=S.+Steinbildauthor=S.+Hedbomauthor=C.+Ungerauthor=R.+Kaiserauthor=D.+Trommeshauserauthor=G.+Munzert&title=Phase+I+study+of+the+PLK1+inhibitor+BI+2536+administered+intravenously+on+three+consecutive+days+in+advance+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3747%2Fco.19.866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3747%252Fco.19.866%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DA.%26aulast%3DKross%26aufirst%3DK.%26aulast%3DSteinbild%26aufirst%3DS.%26aulast%3DHedbom%26aufirst%3DS.%26aulast%3DUnger%26aufirst%3DC.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DTrommeshauser%26aufirst%3DD.%26aulast%3DMunzert%26aufirst%3DG.%26atitle%3DPhase%2520I%2520study%2520of%2520the%2520PLK1%2520inhibitor%2520BI%25202536%2520administered%2520intravenously%2520on%2520three%2520consecutive%2520days%2520in%2520advance%2520solid%2520tumours%26jtitle%3DCurr.%2520Oncol.%26date%3D2012%26volume%3D19%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Leung, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization</span> <span class="citation_source-journal">Nature Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnsb848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=12352953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1yksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=719-724&author=G.+C.+Leungauthor=J.+W.+Hudsonauthor=A.+Kozarovaauthor=A.+Davidsonauthor=J.+W.+Dennisauthor=F.+Sicheri&title=The+Sak+polo-box+comprises+a+structural+domain+sufficient+for+mitotic+subcellular+localization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization</span></div><div class="casAuthors">Leung, Genie C.; Hudson, John W.; Kozarova, Anna; Davidson, Alan; Dennis, James W.; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">719-724</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The small family of polo-like kinases (Plks) includes Cdc5 from Saccharomyces cerevisiae, Plo1 from Schizosaccharomyces pombe, Polo from Drosophila melanogaster and the four mammalian genes Plk1, Prk/Fnk, Snk and Sak.  These kinases control cell cycle progression through the regulation of centrosome maturation and sepn., mitotic entry, metaphase to anaphase transition, mitotic exit and cytokinesis.  Plks are characterized by an N-terminal Ser/Thr protein kinase domain and the presence of one or two C-terminal regions of similarity, termed the polo box motifs.  These motifs have been demonstrated for Cdc5 and Plk1 to be required for mitotic progression and for subcellular localization to mitotic structures.  Here we report the 2.0 Å crystal structure of a novel domain composed of the polo box motif of murine Sak.  The structure consists of a dimeric fold with a deep interfacial cleft and pocket, suggestive of a ligand-binding site.  We show that this domain forms homodimers both in vitro and in vivo, and localizes to centrosomes and the cleavage furrow during cytokinesis.  The requirement of the polo domain for Plk family function and the unique phys. properties of the domain identify it as an attractive target for inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNoQ-NIiPD6bVg90H21EOLACvtfcHk0lgPKFs8dVyyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1yksbk%253D&md5=c0cf4bd4f047b5dac622ca2486674f15</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnsb848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb848%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DG.%2BC.%26aulast%3DHudson%26aufirst%3DJ.%2BW.%26aulast%3DKozarova%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DA.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DThe%2520Sak%2520polo-box%2520comprises%2520a%2520structural%2520domain%2520sufficient%2520for%2520mitotic%2520subcellular%2520localization%26jtitle%3DNature%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D719%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sillibourne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornens, M.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4: the odd one out of the family</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1186%2F1747-1028-5-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=20920249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-34&author=J.+E.+Sillibourneauthor=M.+Bornens&title=Polo-like+kinase+4%3A+the+odd+one+out+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 4: the odd one out of the family</span></div><div class="casAuthors">Sillibourne James E; Bornens Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Polo-like kinase 4 (PLK4) is a unique member of the Polo-like family of kinases that shares little homology with its siblings and has an essential role in centriole duplication.  The turn-over of this kinase must be strictly controlled to prevent centriole amplification.  This is achieved, in part, by an autoregulatory mechanism, whereby PLK4 autophosphorylates residues in a PEST sequence located carboxy-terminal to its catalytic domain.  Phosphorylated PLK4 is subsequently recognized by the SCF complex, ubiquitinylated and targeted to the proteasome for degradation.  Recent data have also shown that active PLK4 is restricted to the centrosome, a mechanism that could serve to prevent aberrant centriole assembly elsewhere in the cell.  While significant advances have been made in understanding how PLK4 is regulated it is certain that additional regulatory mechanisms exist to safeguard the fidelity of centriole duplication.  Here, we overview past and present data discussing the regulation and functions of PLK4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQklC7aPJn_9mhHGZei4OW9fW6udTcc2eZev7C8QhBljrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D&md5=bfde20a11fdea2a94976f97ced04e63d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-5-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-5-25%26sid%3Dliteratum%253Aachs%26aulast%3DSillibourne%26aufirst%3DJ.%2BE.%26aulast%3DBornens%26aufirst%3DM.%26atitle%3DPolo-like%2520kinase%25204%253A%2520the%2520odd%2520one%2520out%2520of%2520the%2520family%26jtitle%3DCell%2520Div.%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmenn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatt, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balloux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">SAK/PLK4 is required for centriole duplication and flagella development</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1016%2Fj.cub.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=16326102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2199-2207&author=M.+Bettencourt-Diasauthor=A.+Rodrigues-Martinsauthor=L.+Carpenterauthor=M.+Riparbelliauthor=L.+Lehmennauthor=M.+K.+Gattauthor=N.+Carmoauthor=F.+Ballouxauthor=G.+Callaniauthor=D.+M.+Glover&title=SAK%2FPLK4+is+required+for+centriole+duplication+and+flagella+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SAK/PLK4 Is Required for Centriole Duplication and Flagella Development</span></div><div class="casAuthors">Bettencourt-Dias, M.; Rodrigues-Martins, A.; Carpenter, L.; Riparbelli, M.; Lehmann, L.; Gatt, M. K.; Carmo, N.; Balloux, F.; Callaini, G.; Glover, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2199-2207</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SAK/PLK4 is a distinct member of the polo-like kinase family.  SAK-/- mice die during embryogenesis, whereas SAK+/- mice develop liver and lung tumors and SAK+/- MEFs show mitotic abnormalities.  However, the mechanism underlying these phenotypes is still not known.  Here, the authors show that downregulation of SAK in Drosophila cells, by mutation or RNAi, leads to loss of centrioles, the core structures of centrosomes.  Such cells are able to undergo repeated rounds of cell division, but display broad disorganized mitotic spindle poles.  The authors also show that SAK mutants lose their centrioles during the mitotic divisions preceding male meiosis but still produce cysts of 16 primary spermatocytes as in the wild-type.  Math. modeling of the stereotyped cell divisions of spermatogenesis can account for such loss by defective centriole duplication.  The majority of spermatids in SAK mutants lack centrioles and so are unable to make sperm axonemes.  Finally, the authors show that depletion of SAK in human cells also prevents centriole duplication and gives rise to mitotic abnormalities.  SAK/PLK4 is necessary for centriole duplication both in Drosophila and human cells.  Drosophila cells tolerate the lack of centrioles and undertake mitosis but cannot form basal bodies and hence flagella.  Human cells depleted of SAK show error-prone mitosis, likely to underlie its tumor-suppressor role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFoGUh8x0B_7Vg90H21EOLACvtfcHk0ljIiNOZa2Taeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP&md5=31069d55e1b8e6ecdaaababd791b72a7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DCarpenter%26aufirst%3DL.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DLehmenn%26aufirst%3DL.%26aulast%3DGatt%26aufirst%3DM.%2BK.%26aulast%3DCarmo%26aufirst%3DN.%26aulast%3DBalloux%26aufirst%3DF.%26aulast%3DCallani%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DSAK%252FPLK4%2520is%2520required%2520for%2520centriole%2520duplication%2520and%2520flagella%2520development%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D2199%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">The Polo kinase PLK4 functions in centriole duplication</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fncb1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=16244668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1140-1146&author=R.+Habedanckauthor=Y.-D.+Stierhofauthor=C.+J.+Wilkinsonauthor=E.+A.+Nigg&title=The+Polo+kinase+PLK4+functions+in+centriole+duplication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Polo kinase Plk4 functions in centriole duplication</span></div><div class="casAuthors">Habedanck, Robert; Stierhof, York-Dieter; Wilkinson, Christopher J.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human Polo-like kinase 1 (PLK1) and its functional homologs that are present in other eukaryotes have multiple, crucial roles in meiotic and mitotic cell division.  By contrast, the functions of other mammalian Polo family members remain largely unknown.  Plk4 is the most structurally divergent Polo family member; it is maximally expressed in actively dividing tissues and is essential for mouse embryonic development.  Here, we identify Plk4 as a key regulator of centriole duplication.  Both gain- and loss-of-function expts. demonstrate that Plk4 is required - in cooperation with Cdk2, CP110 and Hs-SAS6 - for the precise reprodn. of centrosomes during the cell cycle.  These findings provide an attractive explanation for the crucial function of Plk4 in cell proliferation and have implications for the role of Polo kinases in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqCnuaYPx-YrVg90H21EOLACvtfcHk0li9-xZrcaLcqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL&md5=dda15e878cf410e2de8796a4345aa405</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncb1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1335%26sid%3Dliteratum%253Aachs%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DWilkinson%26aufirst%3DC.%2BJ.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DThe%2520Polo%2520kinase%2520PLK4%2520functions%2520in%2520centriole%2520duplication%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Mason, J.; Wei, S.; Luo, S.; Nadeem, V.; Kiarash, R.; Huang, P.; Awrey, A.; Leung, G.; Beletskaya, I.; Feher, M.; Forrest, B.; Laufer, R.; Sampson, P.; Li, S.-W.; Liu, Y.; Lang, Y.; Pauls, H. W.; Mak, T. W.; Pan, J. G.</span><span> </span><span class="NLM_article-title">Inhibition of Polo-like kinase 4 as an anti-cancer strategy</span>. <span class="NLM_conf-date">AACR 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2–6, 2011</span> <span class="NLM_fpage">LB-215</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.%3B+Wei%2C+S.%3B+Luo%2C+S.%3B+Nadeem%2C+V.%3B+Kiarash%2C+R.%3B+Huang%2C+P.%3B+Awrey%2C+A.%3B+Leung%2C+G.%3B+Beletskaya%2C+I.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Laufer%2C+R.%3B+Sampson%2C+P.%3B+Li%2C+S.-W.%3B+Liu%2C+Y.%3B+Lang%2C+Y.%3B+Pauls%2C+H.+W.%3B+Mak%2C+T.+W.%3B+Pan%2C+J.+G.+Inhibition+of+Polo-like+kinase+4+as+an+anti-cancer+strategy.+AACR+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2%E2%80%936%2C+2011LB-215."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Polo-like%2520kinase%25204%2520as%2520an%2520anti-cancer%2520strategy%26spage%3DLB-215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the cell cycle in cancer: TTK (MPS1) and PLK4 as novel mitotic targets</span>, <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+cell+cycle+in+cancer%3A+TTK+%28MPS1%29+and+PLK4+as+novel+mitotic+targets%2C+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520cell%2520cycle%2520in%2520cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520novel%2520mitotic%2520targets" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors as novel antiproliferative agents</span>. <span class="NLM_conf-name">Canadian Chemistry Conference & Exhibition</span>, <span class="NLM_conf-loc">Quebec City, QC</span>, <span class="NLM_conf-date">May 26–29, 2013</span>,  <span class="NLM_fpage">BM7-00029</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+The+discovery+of+PLK4+inhibitors+as+novel+antiproliferative+agents.+Canadian+Chemistry+Conference+%26+Exhibition%2C+Quebec+City%2C+QC%2C+May+26%E2%80%9329%2C+2013%2C+BM7-00029."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%2520as%2520novel%2520antiproliferative%2520agents%26spage%3DBM7-00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors: (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones as novel anti-proliferative agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6069</span><span class="NLM_x">–</span> <span class="NLM_lpage">6087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400380m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6069-6087&author=R.+Lauferauthor=B.+Forrestauthor=S.+Liauthor=P.+Sampsonauthor=Y.+Liuauthor=L.+Edwardsauthor=Y.+Langauthor=D.+Awreyauthor=G.+Maoauthor=O.+Plotnikovaauthor=G.+Leungauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=J.+Masonauthor=X.+Luoauthor=V.+Nadeemauthor=M.+Feherauthor=F.+Banauthor=S.+Weiauthor=R.+Kiarashauthor=E.+Greenauthor=T.+Makauthor=J.+Panauthor=H.+W.+Pauls&title=The+discovery+of+PLK4+inhibitors%3A+%28E%29-3-%28%281H-indazol-6-yl%29methylene%29indolin-2-ones+as+novel+anti-proliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm400380m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400380m%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DAwrey%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DMak%26aufirst%3DT.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%253A%2520%2528E%2529-3-%2528%25281H-indazol-6-yl%2529methylene%2529indolin-2-ones%2520as%2520novel%2520anti-proliferative%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6069%26epage%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Harrington, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebbington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajose-Adeogun, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hercend, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diu-Hercend, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. M.</span><span> </span><span class="NLM_article-title">VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=262-267&author=E.+A.+Harringtonauthor=D.+Bebbingtonauthor=J.+Mooreauthor=R.+K.+Rasmussenauthor=A.+O.+Ajose-Adeogunauthor=T.+Nakayamaauthor=J.+A.+Grahamauthor=C.+Demurauthor=T.+Hercendauthor=A.+Diu-Hercendauthor=M.+Suauthor=J.+M.+C.+Golecauthor=K.+M.+Miller&title=VX-680%2C+a+potent+and+selective+small-molecule+inhibitor+of+the+Aurora+kinases%2C+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DE.%2BA.%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DRasmussen%26aufirst%3DR.%2BK.%26aulast%3DAjose-Adeogun%26aufirst%3DA.%2BO.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DJ.%2BA.%26aulast%3DDemur%26aufirst%3DC.%26aulast%3DHercend%26aufirst%3DT.%26aulast%3DDiu-Hercend%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DMiller%26aufirst%3DK.%2BM.%26atitle%3DVX-680%252C%2520a%2520potent%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520the%2520Aurora%2520kinases%252C%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DNature%2520Med.%26date%3D2004%26volume%3D10%26spage%3D262%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hu-Lowe, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazzini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amundson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewolinski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalinsky, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span> </span><span class="NLM_article-title">Nonclinical antiangiogenesis and antitumor activities of Axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7272</span><span class="NLM_x">–</span> <span class="NLM_lpage">7283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1158%2F1078-0432.CCR-08-0652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=19010843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlylur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7272-7283&author=D.+D.+Hu-Loweauthor=H.+Y.+Zouauthor=M.+L.+Grazziniauthor=M.+E.+Hallinauthor=G.+R.+Wickmanauthor=K.+Amundsonauthor=J.+H.+Chenauthor=D.+A.+Rewolinskiauthor=S.+Yamazakiauthor=E.+Y.+Wuauthor=M.+A.+McTigueauthor=B.+W.+Murrayauthor=R.+S.+Kaniaauthor=P.+O%E2%80%99Connorauthor=D.+R.+Shalinskyauthor=S.+L.+Bender&title=Nonclinical+antiangiogenesis+and+antitumor+activities+of+Axitinib+%28AG-013736%29%2C+an+oral%2C+potent%2C+and+selective+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases+1%2C+2%2C+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3</span></div><div class="casAuthors">Hu-Lowe, Dana D.; Zou, Helen Y.; Grazzini, Maren L.; Hallin, Max E.; Wickman, Grant R.; Amundson, Karin; Chen, Jeffrey H.; Rewolinski, David A.; Yamazaki, Shinji; Wu, Ellen Y.; McTigue, Michele A.; Murray, Brion W.; Kania, Robert S.; O'Connor, Patrick; Shalinsky, David R.; Bender, Steve L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7272-7283</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Axitinib (AG-013736) is a potent and selective inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases 1 to 3 that is in clin. development for the treatment of solid tumors.  We provide a comprehensive description of its in vitro characteristics and activities, in vivo antiangiogenesis, and antitumor efficacy and translational pharmacol. data.  Exptl. Design: The potency, kinase selectivity, pharmacol. activity, and antitumor efficacy of axitinib were assessed in various nonclin. models.  RESULTS: Axitinib inhibits cellular autophosphorylation of VEGF receptors (VEGFR) with picomolar IC50 values.  Counterscreening across multiple kinase and protein panels shows it is selective for VEGFRs.  Axitinib blocks VEGF-mediated endothelial cell survival, tube formation, and downstream signaling through endothelial nitric oxide synthase, Akt and extracellular signal-regulated kinase.  Following twice daily oral administration, axitinib produces consistent and dose-dependent antitumor efficacy that is assocd. with blocking VEGFR-2 phosphorylation, vascular permeability, angiogenesis, and concomitant induction of tumor cell apoptosis.  Axitinib in combination with chemotherapeutic or targeted agents enhances antitumor efficacy in many tumor models compared with single agent alone.  Dose scheduling studies in a human pancreatic tumor xenograft model show that simultaneous administration of axitinib and gemcitabine without prolonged dose interruption or truncation of axitinib produces the greatest antitumor efficacy.  The efficacious drug concns. predicted in nonclin. studies are consistent with the range achieved in the clinic.  Although axitinib inhibits platelet-derived growth factor receptors and KIT with nanomolar in vitro potencies, based on pharmacokinetic/pharmacodynamic anal., axitinib acts primarily as a VEGFR tyrosine kinase inhibitor at the current clin. exposure.  CONCLUSIONS: The selectivity, potency for VEGFRs, and robust nonclin. activity may afford broad opportunities for axitinib to improve cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhwUJi2tefWrVg90H21EOLACvtfcHk0lgEsgR2gq1M8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlylur7I&md5=6a616860756379e85551afe6b9eb750e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0652%26sid%3Dliteratum%253Aachs%26aulast%3DHu-Lowe%26aufirst%3DD.%2BD.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DGrazzini%26aufirst%3DM.%2BL.%26aulast%3DHallin%26aufirst%3DM.%2BE.%26aulast%3DWickman%26aufirst%3DG.%2BR.%26aulast%3DAmundson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DRewolinski%26aufirst%3DD.%2BA.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DE.%2BY.%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DShalinsky%26aufirst%3DD.%2BR.%26aulast%3DBender%26aufirst%3DS.%2BL.%26atitle%3DNonclinical%2520antiangiogenesis%2520and%2520antitumor%2520activities%2520of%2520Axitinib%2520%2528AG-013736%2529%252C%2520an%2520oral%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%25201%252C%25202%252C%25203%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7272%26epage%3D7283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Pharmacological and functional comparison of the Polo-like kinase family: insight into inhibitor and substrate specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9551</span><span class="NLM_x">–</span> <span class="NLM_lpage">9563</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9551-9563&author=E.+F.+Johnsonauthor=K.+D.+Stewartauthor=K.+W.+Woodsauthor=V.+L.+Girandaauthor=Y.+Luo&title=Pharmacological+and+functional+comparison+of+the+Polo-like+kinase+family%3A+insight+into+inhibitor+and+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi7008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7008745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DPharmacological%2520and%2520functional%2520comparison%2520of%2520the%2520Polo-like%2520kinase%2520family%253A%2520insight%2520into%2520inhibitor%2520and%2520substrate%2520specificity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D9551%26epage%3D9563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Donaldson, W. A.</span><span> </span><span class="NLM_article-title">Synthesis of cyclopropane containing natural products</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8589</span><span class="NLM_x">–</span> <span class="NLM_lpage">8627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1016%2FS0040-4020%2801%2900777-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2ru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=8589-8627&author=W.+A.+Donaldson&title=Synthesis+of+cyclopropane+containing+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of cyclopropane containing natural products</span></div><div class="casAuthors">Donaldson, W. A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">8589-8627</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review of recent developments in cyclopropane synthesis, and synthesis of selected cyclopropane targets which includes curacin A, cilastatin, marine derived cyclopropane derivs., polycyclopropanes, ambruticin and (carboxycyclopropyl)glycines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAKv8TdOV5VbVg90H21EOLACvtfcHk0lh0M1ZnyM0TMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2ru7w%253D&md5=009dba87a81463fde3b7afeb19a29a0d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2900777-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252900777-3%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520of%2520cyclopropane%2520containing%2520natural%2520products%26jtitle%3DTetrahedron%26date%3D2001%26volume%3D57%26spage%3D8589%26epage%3D8627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lebel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoux, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinaro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charette, A. B.</span><span> </span><span class="NLM_article-title">Stereoselective cyclopropanation reactions</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">1050</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010007e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=977-1050&author=H.+Lebelauthor=J.+F.+Marcouxauthor=C.+Molinaroauthor=A.+B.+Charette&title=Stereoselective+cyclopropanation+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective Cyclopropanation Reactions</span></div><div class="casAuthors">Lebel, Helene; Marcoux, Jean-Francois; Molinaro, Carmela; Charette, Andre B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">977-1050</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUAxS9Vy1tYLVg90H21EOLACvtfcHk0lh0M1ZnyM0TMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislSjt7o%253D&md5=ddd27c744fcd09d7991420025aa613d2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr010007e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010007e%26sid%3Dliteratum%253Aachs%26aulast%3DLebel%26aufirst%3DH.%26aulast%3DMarcoux%26aufirst%3DJ.%2BF.%26aulast%3DMolinaro%26aufirst%3DC.%26aulast%3DCharette%26aufirst%3DA.%2BB.%26atitle%3DStereoselective%2520cyclopropanation%2520reactions%26jtitle%3DChem.%2520Rev.%26date%3D2003%26volume%3D103%26spage%3D977%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. F.</span><span> </span><span class="NLM_article-title">Synthesis and properties of cyclopropane-derived peptidomimetics</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar030255s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkslylu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=433-442&author=A.+Reicheltauthor=S.+F.+Martin&title=Synthesis+and+properties+of+cyclopropane-derived+peptidomimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Properties of Cyclopropane-Derived Peptidomimetics</span></div><div class="casAuthors">Reichelt, Andreas; Martin, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">433-442</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Small peptides exhibit a wide range of biol. activities, but although there are some notable exceptions, they are not generally useful as drugs.  This has spurred widespread interest in designing peptidomimetics and introducing them as replacements of portions of native peptides to enhance their biol. properties.  Special attention has been focused upon rigid replacements because of their potential to preorganize the resulting pseudopeptide in a conformation corresponding to its bound structure.  Toward this goal, we invented trisubstituted cyclopropanes as novel peptidomimetics, anticipating that the cyclopropane ring would locally orient the backbone and the corresponding amino acid side chain in the biol. active conformation.  Selected aspects of the syntheses and applications of these cyclopropane-derived peptidomimetics are presented in this Account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLsUm4nSG2ybVg90H21EOLACvtfcHk0ljRC2vBTJzj4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkslylu7s%253D&md5=b23c01ae876af2f4517c57c9dcba75e4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Far030255s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far030255s%26sid%3Dliteratum%253Aachs%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520and%2520properties%2520of%2520cyclopropane-derived%2520peptidomimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2006%26volume%3D39%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taber, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span> </span><span class="NLM_article-title">Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6023</span><span class="NLM_x">–</span> <span class="NLM_lpage">6034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6023-6034&author=R.+J.+Mattsonauthor=J.+D.+Cattauthor=D.+J.+Denhartauthor=J.+A.+Deskusauthor=J.+L.+Dittaauthor=M.+A.+Higginsauthor=L.+R.+Marconauthor=C.+P.+Sloanauthor=B.+R.+Benoauthor=Q.+Gaoauthor=M.+A.+Cunninghamauthor=G.+K.+Mattsonauthor=T.+F.+Molskiauthor=M.+T.+Taberauthor=N.+J.+Lodge&title=Conformationally+restricted+homotryptamines.+2.+Indole+cyclopropylmethylamines+as+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0503291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503291%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DCatt%26aufirst%3DJ.%2BD.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DHiggins%26aufirst%3DM.%2BA.%26aulast%3DMarcon%26aufirst%3DL.%2BR.%26aulast%3DSloan%26aufirst%3DC.%2BP.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DCunningham%26aufirst%3DM.%2BA.%26aulast%3DMattson%26aufirst%3DG.%2BK.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DTaber%26aufirst%3DM.%2BT.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26atitle%3DConformationally%2520restricted%2520homotryptamines.%25202.%2520Indole%2520cyclopropylmethylamines%2520as%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6023%26epage%3D6034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursulaya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wub, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hea, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluations of novel oxindolesas HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2105</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2105-2108&author=T.+Jiangauthor=K.+L.+Kuhenauthor=K.+Wolffauthor=H.+Yinauthor=K.+Biezaauthor=J.+Caldwellauthor=B.+Bursulayaauthor=T.+Y.+Wubauthor=Y.+Hea&title=Design%2C+synthesis+and+biological+evaluations+of+novel+oxindolesas+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors.+Part+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DWolff%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DBieza%26aufirst%3DK.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DWub%26aufirst%3DT.%2BY.%26aulast%3DHea%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluations%2520of%2520novel%2520oxindolesas%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2105%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wurster, J. A.</span><span> </span><span class="NLM_article-title">3-Spirocyclopropyl-2-oxindole compound tyrosine kinase inhibitors, and their therapeutic use</span>. PCT Int. Appl.  WO2007008664,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+A.+Wurster&title=3-Spirocyclopropyl-2-oxindole+compound+tyrosine+kinase+inhibitors%2C+and+their+therapeutic+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWurster%26aufirst%3DJ.%2BA.%26atitle%3D3-Spirocyclopropyl-2-oxindole%2520compound%2520tyrosine%2520kinase%2520inhibitors%252C%2520and%2520their%2520therapeutic%2520use%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaykovsky, M.</span><span> </span><span class="NLM_article-title">Dimethyloxosulfonium methylide and dimethylsulfonium methylide. Formation and application to organic synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1364</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01084a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1965&pages=1353-1364&author=E.+J.+Coreyauthor=M.+Chaykovsky&title=Dimethyloxosulfonium+methylide+and+dimethylsulfonium+methylide.+Formation+and+application+to+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja01084a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01084a034%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DChaykovsky%26aufirst%3DM.%26atitle%3DDimethyloxosulfonium%2520methylide%2520and%2520dimethylsulfonium%2520methylide.%2520Formation%2520and%2520application%2520to%2520organic%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1965%26volume%3D87%26spage%3D1353%26epage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ciaccio, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, C. E.</span><span> </span><span class="NLM_article-title">“Instant methylide” modification of the Corey–Chaykovsky cyclopropanation reaction</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1080%2F00397910500521837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVGks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=1333-1341&author=J.+A.+Ciaccioauthor=C.+E.+Aman&title=%E2%80%9CInstant+methylide%E2%80%9D+modification+of+the+Corey%E2%80%93Chaykovsky+cyclopropanation+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Instant methylide modification of the Corey-Chaykovsky cyclopropanation reaction</span></div><div class="casAuthors">Ciaccio, James; Aman, Courtney</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1333-1341</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Treatment of various electron-deficient alkenes in DMSO with stable, dry, equimolar mixts. of either Me3S(O)I/tert-BuOK or Me3S(O)I/NaH cleanly afforded the corresponding substituted cyclopropanes in good yields and short reaction times (<20 min for reactions at 50-60°C using 0.4-4.0 mmol alkene).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopFZ4BmTTyDrVg90H21EOLACvtfcHk0liDmTipCg7XSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVGks7o%253D&md5=7c004c8214487e60893a3779ef36a874</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F00397910500521837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910500521837%26sid%3Dliteratum%253Aachs%26aulast%3DCiaccio%26aufirst%3DJ.%2BA.%26aulast%3DAman%26aufirst%3DC.%2BE.%26atitle%3D%25E2%2580%259CInstant%2520methylide%25E2%2580%259D%2520modification%2520of%2520the%2520Corey%25E2%2580%2593Chaykovsky%2520cyclopropanation%2520reaction%26jtitle%3DSynth.%2520Commun.%26date%3D2006%26volume%3D36%26spage%3D1333%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Moldvai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gacs-Baitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szantay, C.</span><span> </span><span class="NLM_article-title">Synthesis of spiro[cyclopropane-1,3′-[3H]indol]-2′(1′<i>H</i>)-ones with antihypoxic effects</span> <span class="citation_source-journal">Arch. Pharm. Pharm. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1002%2Fardp.19963291206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=9038422" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1996&pages=541-549&author=I.+Moldvaiauthor=E.+Gacs-Baitzauthor=M.+Balazsauthor=M.+Inczeauthor=C.+Szantay&title=Synthesis+of+spiro%5Bcyclopropane-1%2C3%E2%80%B2-%5B3H%5Dindol%5D-2%E2%80%B2%281%E2%80%B2H%29-ones+with+antihypoxic+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fardp.19963291206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19963291206%26sid%3Dliteratum%253Aachs%26aulast%3DMoldvai%26aufirst%3DI.%26aulast%3DGacs-Baitz%26aufirst%3DE.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DIncze%26aufirst%3DM.%26aulast%3DSzantay%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520spiro%255Bcyclopropane-1%252C3%25E2%2580%25B2-%255B3H%255Dindol%255D-2%25E2%2580%25B2%25281%25E2%2580%25B2H%2529-ones%2520with%2520antihypoxic%2520effects%26jtitle%3DArch.%2520Pharm.%2520Pharm.%2520Med.%2520Chem.%26date%3D1996%26volume%3D329%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, Y.</span><span> </span><span class="NLM_article-title">Formation of (<i>Z</i>)allylboronates vis ruthenium-catalyzed hydroboration of propargyl ethers with pinacolborane</span> <span class="citation_source-journal">J. Chem. Res. (S)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.3184%2F030823402103171438" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=142-143&author=M.+Murataauthor=S.+Watanabeauthor=Y.+Masuda&title=Formation+of+%28Z%29allylboronates+vis+ruthenium-catalyzed+hydroboration+of+propargyl+ethers+with+pinacolborane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3184%2F030823402103171438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F030823402103171438%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DS.%26aulast%3DMasuda%26aufirst%3DY.%26atitle%3DFormation%2520of%2520%2528Z%2529allylboronates%2520vis%2520ruthenium-catalyzed%2520hydroboration%2520of%2520propargyl%2520ethers%2520with%2520pinacolborane%26jtitle%3DJ.%2520Chem.%2520Res.%2520%2528S%2529%26date%3D2002%26spage%3D142%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hunt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiting, A.</span><span> </span><span class="NLM_article-title">Heck versus Suzuki palladium catalyzed cross-coupling of a vinylboronate ester with aryl halides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3599</span><span class="NLM_x">–</span> <span class="NLM_lpage">3602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=3599-3602&author=A.+R.+Huntauthor=S.+K.+Stewartauthor=A.+Whiting&title=Heck+versus+Suzuki+palladium+catalyzed+cross-coupling+of+a+vinylboronate+ester+with+aryl+halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DA.%2BR.%26aulast%3DStewart%26aufirst%3DS.%2BK.%26aulast%3DWhiting%26aufirst%3DA.%26atitle%3DHeck%2520versus%2520Suzuki%2520palladium%2520catalyzed%2520cross-coupling%2520of%2520a%2520vinylboronate%2520ester%2520with%2520aryl%2520halides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1993%26volume%3D34%26spage%3D3599%26epage%3D3602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span><span> </span><span class="NLM_article-title">PK Functions for Microsoft Excel</span>. In Pharmacokinetic Software; <span class="NLM_publisher-name">David W. A. Bourne</span>,<span class="NLM_x"> </span><span class="NLM_year">2001–2003</span><span class="NLM_x">; </span><a href="http://www.boomer.org/pkin/soft.html" class="extLink">http://www.boomer.org/pkin/soft.html</a>, Accessed November, 2008.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001%E2%80%932003&author=J.+I.+Usansky&author=A.+Desai&author=D.+Tang-Liu&title=PK+Functions+for+Microsoft+Excel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26atitle%3DPK%2520Functions%2520for%2520Microsoft%2520Excel%26jtitle%3DPharmacokinetic%2520Software%26pub%3DDavid%2520W.%2520A.%2520Bourne%26date%3D2001%25E2%2580%25932003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljTjqGpN1IUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Adams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+Adamsauthor=P.+Afonineauthor=G.+Bunkoczi&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljTjqGpN1IUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%26aulast%3DAfonine%26aufirst%3DP.%26aulast%3DBunkoczi%26aufirst%3DG.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljTjqGpN1IUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>Buster 2.10.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=Buster+2.10.0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%25202.10.0%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span>Schrödinger Suite 2009 Protein Preparation Wizard, Epik, <span class="NLM_edition"> version 2.0</span>; <span class="NLM_publisher-name"> Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2009+Protein+Preparation+Wizard%2C+Epik%2C+version+2.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202009%2520Protein%2520Preparation%2520Wizard%252C%2520Epik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref39_2"><span>Impact, <span class="NLM_edition">version 5.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref39_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref39_3"><span>Prime, <span class="NLM_edition">version 2.1</span>; <span class="NLM_publisher-name">Schrödinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+2.1%3B+Schr%C3%B6dinger+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref39_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2009.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec, H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2009.10%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec%2C+H3A+2R7%2C+Canada%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span>Corina, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Molecular Networks GmbH</span>: <span class="NLM_publisher-loc">Erlangen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Corina%2C+version+3.2%3B+Molecular+Networks+GmbH%3A+Erlangen%2C+Germany%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%2520GmbH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Effect of input differences on the results of docking calculations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1704</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9000629" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1704-1714&author=M.+Feherauthor=C.+I.+Williams&title=Effect+of+input+differences+on+the+results+of+docking+calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Input Differences on the Results of Docking Calculations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sensitivity of docking calcns. to the geometry of the input ligand was studied.  It was found that even small changes in the ligand input conformation can lead to large differences in the geometries and scores of the resulting docked poses.  The accuracy of docked poses produced from different ligand input structures, the x-ray structure, the minimized Corina structure, and structures generated from conformational searches and mol. dynamics ensembles, were also assessed.  It was found that using the x-ray ligand conformation as docking input does not always produce the most accurate docked pose when compared with other sources of ligand input conformations.  Furthermore, no one method of conformer generation is guaranteed to always produce the most accurate docking pose.  The docking scores are also highly sensitive to the source of the input conformation, which might introduce some noise in compd. ranking and in binding affinity predictions.  It is concluded that for the purposes of reproducibility and optimal performance, the most prudent procedure is to use multiple input structures for docking.  The implications of these results on docking validation studies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfgWRxj66UbVg90H21EOLACvtfcHk0lhELHd7VzOzyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D&md5=fb35182895e0cc07cf4c4bb4de05e6d1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fci9000629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9000629%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DEffect%2520of%2520input%2520differences%2520on%2520the%2520results%2520of%2520docking%2520calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D1704%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Numerical errors and chaotic behavior in docking simulations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200598m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=724-738&author=M.+Feherauthor=C.+I.+Williams&title=Numerical+errors+and+chaotic+behavior+in+docking+simulations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical Errors and Chaotic Behavior in Docking Simulations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">724-738</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work examines the sensitivity of docking programs to tiny changes in ligand input files.  The results show that nearly identical ligand input structures can produce dramatically different top-scoring docked poses.  Even changing the atom order in a ligand input file can produce significantly different poses and scores.  In well-behaved cases the docking variations are small and follow a normal distribution around a central pose and score, but in many cases the variations are large and reflect wildly different top scores and binding modes.  The docking variations are characterized by statistical methods, and the sensitivity of high-throughput and more precise docking methods are compared.  The results demonstrate that part of docking variation is due to numerical sensitivity and potentially chaotic effects in current docking algorithms and not solely due to incomplete ligand conformation and pose searching.  These results have major implications for the way docking is currently used for pose prediction, ranking, and virtual screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nddk3ttKx7Vg90H21EOLACvtfcHk0lhELHd7VzOzyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D&md5=7aa7ef2005ad88f2b145c1a2975621c9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fci200598m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200598m%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DNumerical%2520errors%2520and%2520chaotic%2520behavior%2520in%2520docking%2520simulations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D724%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span> <span class="citation_source-book">Glide</span>, <span class="NLM_edition">version 2009</span>; <span class="NLM_publisher-name">Schrodinger Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+2009%3B+Schrodinger+Inc.%3A+Portland%2C+OR%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchrodinger%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Sampson, P. B.; Liu, Y.; Forrest, B.; Cumming, G.; Li, S.-W.; Patel, N. K.; Edwards, L.; Laufer, R.; Feher, M.; Ban, F.; Awrey, D. E.; Mao, G.; Plotnikova, O.; Hodgson, R.; Beletskaya, I.</span>; <span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The Discovery of Polo-like Kinase 4 Inhibitors: Identification of (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-(((<i>cis</i>)-2,6- dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a Potent, Orally Active Antitumor Agent</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI <span class="refDoi"> DOI: 10.1021/jm5005336</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm5005336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sampson%2C+P.+B.%3B+Liu%2C+Y.%3B+Forrest%2C+B.%3B+Cumming%2C+G.%3B+Li%2C+S.-W.%3B+Patel%2C+N.+K.%3B+Edwards%2C+L.%3B+Laufer%2C+R.%3B+Feher%2C+M.%3B+Ban%2C+F.%3B+Awrey%2C+D.+E.%3B+Mao%2C+G.%3B+Plotnikova%2C+O.%3B+Hodgson%2C+R.%3B+Beletskaya%2C+I.%3B+Mason%2C+J.+M.%3B+Luo%2C+X.%3B+Nadeem%2C+V.%3B+Wei%2C+X.%3B+Kiarash%2C+R.%3B+Madeira%2C+B.%3B+Huang%2C+P.%3B+Mak%2C+T.+W.%3B+Pan%2C+G.%3B+Pauls%2C+H.+W.+The+Discovery+of+Polo-like+Kinase+4+Inhibitors%3A+Identification+of+%281R%2C2S%29-2-%283-%28%28E%29-4-%28%28%28cis%29-2%2C6-+dimethylmorpholino%29methyl%29styryl%29-1H-indazol-6-yl%29-5%27-methoxyspiro%5Bcyclopropane-1%2C3%27-indolin%5D-2%27-one+%28CFI-400945%29+as+a+Potent%2C+Orally+Active+Antitumor+Agent.+J.+Med.+Chem.+DOI+10.1021%2Fjm5005336."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm5005336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5005336%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520Discovery%2520of%2520Polo-like%2520Kinase%25204%2520Inhibitors%253A%2520Identification%2520of%2520%25281R%252C2S%2529-2-%25283-%2528%2528E%2529-4-%2528%2528%2528cis%2529-2%252C6-%2520dimethylmorpholino%2529methyl%2529styryl%2529-1H-indazol-6-yl%2529-5%2527-methoxyspiro%255Bcyclopropane-1%252C3%2527-indolin%255D-2%2527-one%2520%2528CFI-400945%2529%2520as%2520a%2520Potent%252C%2520Orally%2520Active%2520Antitumor%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm5005336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39','ref39_2','ref39_3'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 62 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wei-Cheng Yuan, Chuan-Wen Lei, Jian-Qiang Zhao, Zhen-Hua Wang, <span class="NLM_string-name hlFld-ContribAuthor">Yong You</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic Asymmetric Cyclopropanation of 3-Acylcoumarins with 3-Halooxindoles: Access to Spirooxindole-cyclopropa[c]coumarin Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (3)
                                     , 2534-2544. <a href="https://doi.org/10.1021/acs.joc.0c02653" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02653%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOrganocatalytic%252BAsymmetric%252BCyclopropanation%252Bof%252B3-Acylcoumarins%252Bwith%252B3-Halooxindoles%25253A%252BAccess%252Bto%252BSpirooxindole-cyclopropa%25255Bc%25255Dcoumarin%252BCompounds%26aulast%3DYuan%26aufirst%3DWei-Cheng%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D06112020%26date%3D11012021%26volume%3D86%26issue%3D3%26spage%3D2534%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kerstin Hiesinger, Dmitry Dar’in, Ewgenij Proschak, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 150-183. <a href="https://doi.org/10.1021/acs.jmedchem.0c01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DHiesinger%26aufirst%3DKerstin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D150%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rui-Ying Zhang, Feng Jin, Xiao-Guang Bao, Hai-Yan Li, Xiao-Ping Xu, <span class="NLM_string-name hlFld-ContribAuthor">Shun-Jun Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Spiro 3,3’-Cyclopropyl Oxindoles Via N-Bromosuccinimide-Mediated Ring-Closing and Contraction Cascade. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (1)
                                     , 1141-1151. <a href="https://doi.org/10.1021/acs.joc.0c02610" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02610%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BSpiro%252B3%25252C3%2525E2%252580%252599-Cyclopropyl%252BOxindoles%252BVia%252BN-Bromosuccinimide-Mediated%252BRing-Closing%252Band%252BContraction%252BCascade%26aulast%3DZhang%26aufirst%3DRui-Ying%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D03112020%26date%3D14122020%26volume%3D86%26issue%3D1%26spage%3D1141%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhongrong Meng, Qiongqiong Wang, Doudou Lu, Tingting Yue, Pu Ai, Hua Liu, Weiran Yang, <span class="NLM_string-name hlFld-ContribAuthor">Jing Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Domino Annulation Reaction of Sulfur Ylides and Morita–Baylis–Hillman Carbonates of Isatins: Synthesis of Oxospiro[bicyclo[3.1.0]hexane-6,3′-indolin] Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (23)
                                     , 15026-15037. <a href="https://doi.org/10.1021/acs.joc.0c01919" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01919%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDomino%252BAnnulation%252BReaction%252Bof%252BSulfur%252BYlides%252Band%252BMorita%2525E2%252580%252593Baylis%2525E2%252580%252593Hillman%252BCarbonates%252Bof%252BIsatins%25253A%252BSynthesis%252Bof%252BOxospiro%25255Bbicyclo%25255B3.1.0%25255Dhexane-6%25252C3%2525E2%252580%2525B2-indolin%25255D%252BScaffolds%26aulast%3DMeng%26aufirst%3DZhongrong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08082020%26date%3D11112020%26volume%3D85%26issue%3D23%26spage%3D15026%26epage%3D15037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin Chen, <span class="NLM_string-name hlFld-ContribAuthor">Jin He</span>. </span><span class="cited-content_cbyCitation_article-title">DABCO-Catalyzed Michael/Alkylation Cascade Reactions Involving α-Substituted Ammonium Ylides for the Construction of Spirocyclopropyl Oxindoles: Access to the Powerful Chemical Leads against HIV-1. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 5203-5219. <a href="https://doi.org/10.1021/acs.joc.9b03164" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03164%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDABCO-Catalyzed%252BMichael%25252FAlkylation%252BCascade%252BReactions%252BInvolving%252B%2525CE%2525B1-Substituted%252BAmmonium%252BYlides%252Bfor%252Bthe%252BConstruction%252Bof%252BSpirocyclopropyl%252BOxindoles%25253A%252BAccess%252Bto%252Bthe%252BPowerful%252BChemical%252BLeads%252Bagainst%252BHIV-1%26aulast%3DChen%26aufirst%3DLin%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D03122019%26date%3D03042020%26date%3D23032020%26volume%3D85%26issue%3D8%26spage%3D5203%26epage%3D5219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jingbo Yu, Xinjie Yang, Chongyang Wu, <span class="NLM_string-name hlFld-ContribAuthor">Weike Su</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed C–H/C–H Cross-Coupling by Mechanochemistry: Direct Alkenylation and Heteroarylation of N1-Protected 1H-Indazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (2)
                                     , 1009-1021. <a href="https://doi.org/10.1021/acs.joc.9b02951" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02951%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-Catalyzed%252BC%2525E2%252580%252593H%25252FC%2525E2%252580%252593H%252BCross-Coupling%252Bby%252BMechanochemistry%25253A%252BDirect%252BAlkenylation%252Band%252BHeteroarylation%252Bof%252BN1-Protected%252B1H-Indazoles%26aulast%3DYu%26aufirst%3DJingbo%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D31102019%26date%3D24122019%26date%3D11122019%26volume%3D85%26issue%3D2%26spage%3D1009%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Saumen Hajra, Sayan Roy, <span class="NLM_string-name hlFld-ContribAuthor">SK Abu Saleh</span>. </span><span class="cited-content_cbyCitation_article-title">Domino Corey–Chaykovsky Reaction for One-Pot Access to Spirocyclopropyl Oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (15)
                                     , 4540-4544. <a href="https://doi.org/10.1021/acs.orglett.8b01840" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDomino%252BCorey%2525E2%252580%252593Chaykovsky%252BReaction%252Bfor%252BOne-Pot%252BAccess%252Bto%252BSpirocyclopropyl%252BOxindoles%26aulast%3DHajra%26aufirst%3DSaumen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13062018%26date%3D23072018%26volume%3D20%26issue%3D15%26spage%3D4540%26epage%3D4544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8712-8756. <a href="https://doi.org/10.1021/acs.jmedchem.6b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B%2525E2%252580%25259CCyclopropyl%252BFragment%2525E2%252580%25259D%252Bis%252Ba%252BVersatile%252BPlayer%252Bthat%252BFrequently%252BAppears%252Bin%252BPreclinical%25252FClinical%252BDrug%252BMolecules%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30032016%26date%3D30062016%26date%3D13102016%26date%3D14062016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Bryan  Forrest</span>, <span class="hlFld-ContribAuthor ">Graham  Cumming</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xunyi  Luo</span>, <span class="hlFld-ContribAuthor ">Vincent  Nadeem</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Brian  Madeira</span>, <span class="hlFld-ContribAuthor ">Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua  Pan</span>, and <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 147-169. <a href="https://doi.org/10.1021/jm5005336" title="DOI URL">https://doi.org/10.1021/jm5005336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5005336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5005336%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BPolo-Like%252BKinase%252B4%252BInhibitors%25253A%252BIdentification%252Bof%252B%2525281R%25252C2S%252529-2-%2525283-%252528%252528E%252529-4-%252528%252528%252528cis%252529-2%25252C6-Dimethylmorpholino%252529methyl%252529styryl%252529-1H-indazol-6-yl%252529-5%2525E2%252580%2525B2-methoxyspiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-one%252B%252528CFI-400945%252529%252Bas%252Ba%252BPotent%25252C%252BOrally%252BActive%252BAntitumor%252BAgent%26aulast%3DSampson%26aufirst%3DPeter%2BB.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D03042014%26date%3D24062014%26date%3D08012015%26date%3D27052014%26volume%3D58%26issue%3D1%26spage%3D147%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maaged  Abdullah</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 3D motifs based on sequences and structures for binding to CFI‐400945, and deep screening‐based design of new lead molecules for PLK‐4. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>21 </em><a href="https://doi.org/10.1111/cbdd.13908" title="DOI URL">https://doi.org/10.1111/cbdd.13908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13908%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIdentification%252Bof%252B3D%252Bmotifs%252Bbased%252Bon%252Bsequences%252Band%252Bstructures%252Bfor%252Bbinding%252Bto%252BCFI%2525E2%252580%252590400945%25252C%252Band%252Bdeep%252Bscreening%2525E2%252580%252590based%252Bdesign%252Bof%252Bnew%252Blead%252Bmolecules%252Bfor%252BPLK%2525E2%252580%2525904%26aulast%3DAbdullah%26aufirst%3DMaaged%26date%3D2021%26date%3D2021%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Wu</span>, <span class="hlFld-ContribAuthor ">Cailing  Gan</span>, <span class="hlFld-ContribAuthor ">Xingping  Su</span>, <span class="hlFld-ContribAuthor ">Hongyao  Liu</span>, <span class="hlFld-ContribAuthor ">Hanyun  Que</span>, <span class="hlFld-ContribAuthor ">Qianyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiang  Xue</span>, <span class="hlFld-ContribAuthor ">Lin  Yue</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of indazole derivatives as anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (26)
                                     , 15675-15687. <a href="https://doi.org/10.1039/D1RA01147B" title="DOI URL">https://doi.org/10.1039/D1RA01147B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA01147B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA01147B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bindazole%252Bderivatives%252Bas%252Banti-cancer%252Bagents%26aulast%3DWei%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D26%26spage%3D15675%26epage%3D15687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prajwal  Dhokne</span>, <span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113334. <a href="https://doi.org/10.1016/j.ejmech.2021.113334" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113334%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Binsights%252Bof%252Boxindole%252Bbased%252Bkinase%252Binhibitors%252Bas%252Banticancer%252Bagents%25253A%252BRecent%252Badvances%26aulast%3DDhokne%26aufirst%3DPrajwal%26date%3D2021%26volume%3D216%26spage%3D113334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander J.  Boddy</span>, <span class="hlFld-ContribAuthor ">James A.  Bull</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective synthesis and applications of spirocyclic oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (5)
                                     , 1026-1084. <a href="https://doi.org/10.1039/D0QO01085E" title="DOI URL">https://doi.org/10.1039/D0QO01085E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01085E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01085E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DStereoselective%252Bsynthesis%252Band%252Bapplications%252Bof%252Bspirocyclic%252Boxindoles%26aulast%3DBoddy%26aufirst%3DAlexander%2BJ.%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D5%26spage%3D1026%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rail R.  Gataullin</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Synthesis of Benzo‐Fused Spiro Nitrogen Heterocycles: New Approaches and Modification of Old Strategies. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2020,</strong> <em>103 </em>
                                    (12)
                                     <a href="https://doi.org/10.1002/hlca.202000137" title="DOI URL">https://doi.org/10.1002/hlca.202000137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.202000137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.202000137%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BBenzo%2525E2%252580%252590Fused%252BSpiro%252BNitrogen%252BHeterocycles%25253A%252BNew%252BApproaches%252Band%252BModification%252Bof%252BOld%252BStrategies%26aulast%3DGataullin%26aufirst%3DRail%2BR.%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arramshetti  Venkanna</span>, <span class="hlFld-ContribAuthor ">Lalita  Subedi</span>, <span class="hlFld-ContribAuthor ">Mahesh K.  Teli</span>, <span class="hlFld-ContribAuthor ">Prema Dhorma  Lama</span>, <span class="hlFld-ContribAuthor ">Bhargav Gupta  Nangunuri</span>, <span class="hlFld-ContribAuthor ">Sang-Yoon  Lee</span>, <span class="hlFld-ContribAuthor ">Sun Yeou  Kim</span>, <span class="hlFld-ContribAuthor ">Mi-hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Positioning of an unprecedented spiro[5.5]undeca ring system into kinase inhibitor space. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-78158-9" title="DOI URL">https://doi.org/10.1038/s41598-020-78158-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-78158-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-78158-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPositioning%252Bof%252Ban%252Bunprecedented%252Bspiro%25255B5.5%25255Dundeca%252Bring%252Bsystem%252Binto%252Bkinase%252Binhibitor%252Bspace%26aulast%3DVenkanna%26aufirst%3DArramshetti%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenzhong  Li</span>, <span class="hlFld-ContribAuthor ">Lorenz  Rösler</span>, <span class="hlFld-ContribAuthor ">Kevin  Herr</span>, <span class="hlFld-ContribAuthor ">Martin  Brodrecht</span>, <span class="hlFld-ContribAuthor ">Hergen  Breitzke</span>, <span class="hlFld-ContribAuthor ">Kathrin  Hofmann</span>, <span class="hlFld-ContribAuthor ">Hans‐Heinrich  Limbach</span>, <span class="hlFld-ContribAuthor ">Torsten  Gutmann</span>, <span class="hlFld-ContribAuthor ">Gerd  Buntkowsky</span>. </span><span class="cited-content_cbyCitation_article-title">Dirhodium Coordination Polymers for Asymmetric Cyclopropanation of Diazooxindoles with Olefins: Synthesis and Spectroscopic Analysis. </span><span class="cited-content_cbyCitation_journal-name">ChemPlusChem</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 1737-1746. <a href="https://doi.org/10.1002/cplu.202000421" title="DOI URL">https://doi.org/10.1002/cplu.202000421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cplu.202000421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcplu.202000421%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPlusChem%26atitle%3DDirhodium%252BCoordination%252BPolymers%252Bfor%252BAsymmetric%252BCyclopropanation%252Bof%252BDiazooxindoles%252Bwith%252BOlefins%25253A%252BSynthesis%252Band%252BSpectroscopic%252BAnalysis%26aulast%3DLi%26aufirst%3DZhenzhong%26date%3D2020%26date%3D2020%26volume%3D85%26issue%3D8%26spage%3D1737%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I. N.  Bardasov</span>, <span class="hlFld-ContribAuthor ">A. Yu.  Alekseeva</span>, <span class="hlFld-ContribAuthor ">A. A.  Mikhailov</span>, <span class="hlFld-ContribAuthor ">O. V.  Ershov</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction of 2-Amino-6-aryl-4-(dicyanomethyl)-3-azabicyclo[3.1.0]hex-2-ene-1,5-dicarbonitriles with Primary and Secondary Amines. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>56 </em>
                                    (8)
                                     , 1432-1437. <a href="https://doi.org/10.1134/S107042802008014X" title="DOI URL">https://doi.org/10.1134/S107042802008014X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S107042802008014X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS107042802008014X%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DReaction%252Bof%252B2-Amino-6-aryl-4-%252528dicyanomethyl%252529-3-azabicyclo%25255B3.1.0%25255Dhex-2-ene-1%25252C5-dicarbonitriles%252Bwith%252BPrimary%252Band%252BSecondary%252BAmines%26aulast%3DBardasov%26aufirst%3DI.%2BN.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D8%26spage%3D1432%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  You</span>, <span class="hlFld-ContribAuthor ">Bao-Xue  Quan</span>, <span class="hlFld-ContribAuthor ">Zhen-Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei-Cheng  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent synthesis of oxindole derivatives
              via
              controllable reactions of isatin-derived
              para
              -quinone methides with sulfur ylides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (24)
                                     , 4560-4565. <a href="https://doi.org/10.1039/D0OB00979B" title="DOI URL">https://doi.org/10.1039/D0OB00979B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00979B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00979B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDivergent%252Bsynthesis%252Bof%252Boxindole%252Bderivatives%252Bvia%252Bcontrollable%252Breactions%252Bof%252Bisatin-derived%252Bpara%252B-quinone%252Bmethides%252Bwith%252Bsulfur%252Bylides%26aulast%3DYou%26aufirst%3DYong%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D24%26spage%3D4560%26epage%3D4565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang-Bo  Wen</span>, <span class="hlFld-ContribAuthor ">Da-Ming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Squaramide-catalysed asymmetric cascade reactions of 2,3-dioxopyrrolidines with 3-chlorooxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (8)
                                     , 1647-1656. <a href="https://doi.org/10.1039/C9OB02663K" title="DOI URL">https://doi.org/10.1039/C9OB02663K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02663K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02663K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSquaramide-catalysed%252Basymmetric%252Bcascade%252Breactions%252Bof%252B2%25252C3-dioxopyrrolidines%252Bwith%252B3-chlorooxindoles%26aulast%3DWen%26aufirst%3DJiang-Bo%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D8%26spage%3D1647%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A.  Milligan</span>, <span class="hlFld-ContribAuthor ">Kevin L.  Burns</span>, <span class="hlFld-ContribAuthor ">Anthony V.  Le</span>, <span class="hlFld-ContribAuthor ">Viktor C.  Polites</span>, <span class="hlFld-ContribAuthor ">Zheng‐Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Gary A.  Molander</span>, <span class="hlFld-ContribAuthor ">Christopher B.  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Radical‐Polar Crossover Annulation: A Platform for Accessing Polycyclic Cyclopropanes. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (1)
                                     , 242-247. <a href="https://doi.org/10.1002/adsc.201901051" title="DOI URL">https://doi.org/10.1002/adsc.201901051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901051%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DRadical%2525E2%252580%252590Polar%252BCrossover%252BAnnulation%25253A%252BA%252BPlatform%252Bfor%252BAccessing%252BPolycyclic%252BCyclopropanes%26aulast%3DMilligan%26aufirst%3DJohn%2BA.%26date%3D2020%26date%3D2019%26volume%3D362%26issue%3D1%26spage%3D242%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Lv</span>, <span class="hlFld-ContribAuthor ">Xiaoxiao  Yang</span>, <span class="hlFld-ContribAuthor ">Mei-Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Peichang  Cao</span>, <span class="hlFld-ContribAuthor ">Shihong  Zheng</span>, <span class="hlFld-ContribAuthor ">Ruijun  Peng</span>, <span class="hlFld-ContribAuthor ">Jihong  Han</span>, <span class="hlFld-ContribAuthor ">Zhouling  Xie</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and SAR development of novel selective polo-like kinase 1 inhibitors having the tetrahydropteridin scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>184 </em>, 111769. <a href="https://doi.org/10.1016/j.ejmech.2019.111769" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111769%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Band%252BSAR%252Bdevelopment%252Bof%252Bnovel%252Bselective%252Bpolo-like%252Bkinase%252B1%252Binhibitors%252Bhaving%252Bthe%252Btetrahydropteridin%252Bscaffold%26aulast%3DLv%26aufirst%3DXiao%26date%3D2019%26volume%3D184%26spage%3D111769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Erin N.  Howe</span>, <span class="hlFld-ContribAuthor ">Emily P.  Bacher</span>, <span class="hlFld-ContribAuthor ">Miranda  Burnette</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Meloche</span>, <span class="hlFld-ContribAuthor ">Jayda  Meisel</span>, <span class="hlFld-ContribAuthor ">Patricia  Schnepp</span>, <span class="hlFld-ContribAuthor ">Xuejuan  Tan</span>, <span class="hlFld-ContribAuthor ">Mayland  Chang</span>, <span class="hlFld-ContribAuthor ">Jeremiah  Zartman</span>, <span class="hlFld-ContribAuthor ">Siyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Brandon L.  Ashfeld</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Scaffold Evaluation and Systems‐Level Transcriptome‐Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (18)
                                     , 1653-1661. <a href="https://doi.org/10.1002/cmdc.201900266" title="DOI URL">https://doi.org/10.1002/cmdc.201900266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900266%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCombined%252BScaffold%252BEvaluation%252Band%252BSystems%2525E2%252580%252590Level%252BTranscriptome%2525E2%252580%252590Based%252BAnalysis%252Bfor%252BAccelerated%252BLead%252BOptimization%252BReveals%252BRibosomal%252BTargeting%252BSpirooxindole%252BCyclopropanes%26aulast%3DRodriguez%26aufirst%3DKevin%2BX.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D18%26spage%3D1653%26epage%3D1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swapnil Pandurang  Bhujbal</span>, <span class="hlFld-ContribAuthor ">Seketoulie  Keretsu</span>, <span class="hlFld-ContribAuthor ">Seung Joo  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">A Combined Molecular Docking and 3D‐QSAR Studies on Tetrahydropteridin Derivatives as PLK2 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2019,</strong> <em>40 </em>
                                    (8)
                                     , 796-802. <a href="https://doi.org/10.1002/bkcs.11824" title="DOI URL">https://doi.org/10.1002/bkcs.11824</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.11824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.11824%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DA%252BCombined%252BMolecular%252BDocking%252Band%252B3D%2525E2%252580%252590QSAR%252BStudies%252Bon%252BTetrahydropteridin%252BDerivatives%252Bas%252BPLK2%252BAntagonists%26aulast%3DBhujbal%26aufirst%3DSwapnil%2BPandurang%26date%3D2019%26date%3D2019%26volume%3D40%26issue%3D8%26spage%3D796%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Suleman</span>, <span class="hlFld-ContribAuthor ">Zhenmin  Li</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Dimerization of Sulfoxonium Ylides with 3-Diazoindolin-2-imines: A Practical and Efficient Approach to Spiro[cyclopropane-1,3′-indolin]-2′-imines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (27)
                                     , 4447-4456. <a href="https://doi.org/10.1002/ejoc.201900675" title="DOI URL">https://doi.org/10.1002/ejoc.201900675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900675%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BDimerization%252Bof%252BSulfoxonium%252BYlides%252Bwith%252B3-Diazoindolin-2-imines%25253A%252BA%252BPractical%252Band%252BEfficient%252BApproach%252Bto%252BSpiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-imines%26aulast%3DSuleman%26aufirst%3DMuhammad%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D27%26spage%3D4447%26epage%3D4456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael F.  Press</span>, <span class="hlFld-ContribAuthor ">Bin  Xie</span>, <span class="hlFld-ContribAuthor ">Simon  Davenport</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Roberta  Guzman</span>, <span class="hlFld-ContribAuthor ">Garry P.  Nolan</span>, <span class="hlFld-ContribAuthor ">Neil  O’Brien</span>, <span class="hlFld-ContribAuthor ">Michael  Palazzolo</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Joan S.  Brugge</span>, <span class="hlFld-ContribAuthor ">Dennis J.  Slamon</span>. </span><span class="cited-content_cbyCitation_article-title">Role for polo-like kinase 4 in mediation of cytokinesis. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (23)
                                     , 11309-11318. <a href="https://doi.org/10.1073/pnas.1818820116" title="DOI URL">https://doi.org/10.1073/pnas.1818820116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1818820116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1818820116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DRole%252Bfor%252Bpolo-like%252Bkinase%252B4%252Bin%252Bmediation%252Bof%252Bcytokinesis%26aulast%3DPress%26aufirst%3DMichael%2BF.%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D23%26spage%3D11309%26epage%3D11318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Pourshab</span>, <span class="hlFld-ContribAuthor ">Sakineh  Asghari</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Tajbakhsh</span>, <span class="hlFld-ContribAuthor ">Asieh  Khalilpour</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Sonochemical Synthesis of Spirocyclopropaneoxindoles and Evaluation of Their Antioxidant and Cytotoxic Activities. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.1002/cbdv.201900087" title="DOI URL">https://doi.org/10.1002/cbdv.201900087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201900087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201900087%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDiastereoselective%252BSonochemical%252BSynthesis%252Bof%252BSpirocyclopropaneoxindoles%252Band%252BEvaluation%252Bof%252BTheir%252BAntioxidant%252Band%252BCytotoxic%252BActivities%26aulast%3DPourshab%26aufirst%3DMaryam%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Xing  Song</span>, <span class="hlFld-ContribAuthor ">Da-Ming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of spirooxindole-fused spirothiazolones
              via
              squaramide-catalysed reaction of 3-chlorooxindoles with 5-alkenyl thiazolones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (21)
                                     , 5375-5380. <a href="https://doi.org/10.1039/C9OB00998A" title="DOI URL">https://doi.org/10.1039/C9OB00998A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00998A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00998A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252Bspirooxindole-fused%252Bspirothiazolones%252Bvia%252Bsquaramide-catalysed%252Breaction%252Bof%252B3-chlorooxindoles%252Bwith%252B5-alkenyl%252Bthiazolones%26aulast%3DSong%26aufirst%3DYong-Xing%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D21%26spage%3D5375%26epage%3D5380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amreena  Suri</span>, <span class="hlFld-ContribAuthor ">Anders W.  Bailey</span>, <span class="hlFld-ContribAuthor ">Maurício T.  Tavares</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Connor P.  Dyer</span>, <span class="hlFld-ContribAuthor ">Alex T.  Grupenmacher</span>, <span class="hlFld-ContribAuthor ">David R.  Piper</span>, <span class="hlFld-ContribAuthor ">Robert A.  Horton</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Saktimayee M.  Roy</span>, <span class="hlFld-ContribAuthor ">Simone T.  Sredni</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (9)
                                     , 2112. <a href="https://doi.org/10.3390/ijms20092112" title="DOI URL">https://doi.org/10.3390/ijms20092112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20092112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20092112%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEvaluation%252Bof%252BProtein%252BKinase%252BInhibitors%252Bwith%252BPLK4%252BCross-Over%252BPotential%252Bin%252Ba%252BPre-Clinical%252BModel%252Bof%252BCancer%26aulast%3DSuri%26aufirst%3DAmreena%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D9%26spage%3D2112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengzheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongjie  Guo</span>, <span class="hlFld-ContribAuthor ">Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Xueying  Liu</span>, <span class="hlFld-ContribAuthor ">Shengyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic asymmetric synthesis of highly functionalized spiro-thiazolone–cyclopropane-oxindoles bearing two vicinal spiro quaternary centers. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (9)
                                     , 1442-1447. <a href="https://doi.org/10.1039/C9QO00145J" title="DOI URL">https://doi.org/10.1039/C9QO00145J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO00145J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO00145J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DOrganocatalytic%252Basymmetric%252Bsynthesis%252Bof%252Bhighly%252Bfunctionalized%252Bspiro-thiazolone%2525E2%252580%252593cyclopropane-oxindoles%252Bbearing%252Btwo%252Bvicinal%252Bspiro%252Bquaternary%252Bcenters%26aulast%3DWang%26aufirst%3DShengzheng%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D9%26spage%3D1442%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babita  Aneja</span>, <span class="hlFld-ContribAuthor ">Nashrah Sharif  Khan</span>, <span class="hlFld-ContribAuthor ">Parvez  Khan</span>, <span class="hlFld-ContribAuthor ">Aarfa  Queen</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Md. Tabish  Rehman</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  Alajmi</span>, <span class="hlFld-ContribAuthor ">Hesham R.  El-Seedi</span>, <span class="hlFld-ContribAuthor ">Sher  Ali</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abid</span>. </span><span class="cited-content_cbyCitation_article-title">Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 840-852. <a href="https://doi.org/10.1016/j.ejmech.2018.12.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdevelopment%252Bof%252BIsatin-triazole%252Bhydrazones%252Bas%252Bpotential%252Binhibitors%252Bof%252Bmicrotubule%252Baffinity-regulating%252Bkinase%252B4%252Bfor%252Bthe%252Btherapeutic%252Bmanagement%252Bof%252Bcell%252Bproliferation%252Band%252Bmetastasis%26aulast%3DAneja%26aufirst%3DBabita%26date%3D2019%26volume%3D163%26spage%3D840%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhu</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Aixin  Geng</span>, <span class="hlFld-ContribAuthor ">Hao  Cui</span>, <span class="hlFld-ContribAuthor ">Liyuan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrafast and Diastereoselective Synthesis of 3-Spirocyclopropyl-2-oxindoles Bearing Three Continuous All-Carbon Quaternary Centers. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2019,</strong> <em>98 </em>
                                    (5)
                                     , 711. <a href="https://doi.org/10.3987/COM-19-14078" title="DOI URL">https://doi.org/10.3987/COM-19-14078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-19-14078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-19-14078%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DUltrafast%252Band%252BDiastereoselective%252BSynthesis%252Bof%252B3-Spirocyclopropyl-2-oxindoles%252BBearing%252BThree%252BContinuous%252BAll-Carbon%252BQuaternary%252BCenters%26aulast%3DZhu%26aufirst%3DYong%26date%3D2019%26volume%3D98%26issue%3D5%26spage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Bailey</span>, <span class="hlFld-ContribAuthor ">Amreena  Suri</span>, <span class="hlFld-ContribAuthor ">Pauline  Chou</span>, <span class="hlFld-ContribAuthor ">Tatiana  Pundy</span>, <span class="hlFld-ContribAuthor ">Samantha  Gadd</span>, <span class="hlFld-ContribAuthor ">Stacey  Raimondi</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>, <span class="hlFld-ContribAuthor ">Simone  Sredni</span>. </span><span class="cited-content_cbyCitation_article-title">Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB). </span><span class="cited-content_cbyCitation_journal-name">Bioengineering</span><span> <strong>2018,</strong> <em>5 </em>
                                    (4)
                                     , 96. <a href="https://doi.org/10.3390/bioengineering5040096" title="DOI URL">https://doi.org/10.3390/bioengineering5040096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/bioengineering5040096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbioengineering5040096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioengineering%26atitle%3DPolo-Like%252BKinase%252B4%252B%252528PLK4%252529%252BIs%252BOverexpressed%252Bin%252BCentral%252BNervous%252BSystem%252BNeuroblastoma%252B%252528CNS-NB%252529%26aulast%3DBailey%26aufirst%3DAnders%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D4%26spage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Weidi  Cao</span>, <span class="hlFld-ContribAuthor ">Hongjiang  Mei</span>, <span class="hlFld-ContribAuthor ">Linfeng  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Synthesis of Chiral Spiro‐cyclopropyl Oxindoles from 3‐Alkenyl‐oxindoles and Sulfoxonium Ylides. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (21)
                                     , 4089-4093. <a href="https://doi.org/10.1002/adsc.201800937" title="DOI URL">https://doi.org/10.1002/adsc.201800937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800937%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCatalytic%252BAsymmetric%252BSynthesis%252Bof%252BChiral%252BSpiro%2525E2%252580%252590cyclopropyl%252BOxindoles%252Bfrom%252B3%2525E2%252580%252590Alkenyl%2525E2%252580%252590oxindoles%252Band%252BSulfoxonium%252BYlides%26aulast%3DWang%26aufirst%3DLifeng%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D21%26spage%3D4089%26epage%3D4093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Qin</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Ke  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient cyclopropanation process of oxindoles via bromoethylsulfonium salt. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (47)
                                     , 6809-6814. <a href="https://doi.org/10.1016/j.tet.2018.09.042" title="DOI URL">https://doi.org/10.1016/j.tet.2018.09.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.09.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.09.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bconvenient%252Bcyclopropanation%252Bprocess%252Bof%252Boxindoles%252Bvia%252Bbromoethylsulfonium%252Bsalt%26aulast%3DQin%26aufirst%3DHui%26date%3D2018%26volume%3D74%26issue%3D47%26spage%3D6809%26epage%3D6814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Lei</span>, <span class="hlFld-ContribAuthor ">Lu  Xiong</span>, <span class="hlFld-ContribAuthor ">Yong  Xia</span>, <span class="hlFld-ContribAuthor ">Zhanzhan  Feng</span>, <span class="hlFld-ContribAuthor ">Tiantao  Gao</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Xuejiao  Song</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>, <span class="hlFld-ContribAuthor ">Ningyu  Wang</span>, <span class="hlFld-ContribAuthor ">Cuiting  Peng</span>, <span class="hlFld-ContribAuthor ">Zhongping  Li</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     <a href="https://doi.org/10.1038/s41419-018-1071-2" title="DOI URL">https://doi.org/10.1038/s41419-018-1071-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-018-1071-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-018-1071-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DYLT-11%25252C%252Ba%252Bnovel%252BPLK4%252Binhibitor%25252C%252Binhibits%252Bhuman%252Bbreast%252Bcancer%252Bgrowth%252Bvia%252Binducing%252Bmaladjusted%252Bcentriole%252Bduplication%252Band%252Bmitotic%252Bdefect%26aulast%3DLei%26aufirst%3DQian%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyun  Dong</span>, <span class="hlFld-ContribAuthor ">Qijing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zengtao  Wang</span>, <span class="hlFld-ContribAuthor ">Guang  Huang</span>, <span class="hlFld-ContribAuthor ">Shaoshun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Indazole-based Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1490-1507. <a href="https://doi.org/10.1002/cmdc.201800253" title="DOI URL">https://doi.org/10.1002/cmdc.201800253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800253%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BIndazole-based%252BAnticancer%252BAgents%26aulast%3DDong%26aufirst%3DJinyun%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1490%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gonzalo  Vera</span>, <span class="hlFld-ContribAuthor ">Benjamín  Diethelm</span>, <span class="hlFld-ContribAuthor ">Claudio  Terraza</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Recabarren-Gajardo</span>. </span><span class="cited-content_cbyCitation_article-title">Suzuki-Type Cross-Coupling Reaction of Unprotected 3-Iodoindazoles with Pinacol Vinyl Boronate: An Expeditive C-3 Vinylation of Indazoles under Microwave Irradiation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 2051. <a href="https://doi.org/10.3390/molecules23082051" title="DOI URL">https://doi.org/10.3390/molecules23082051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23082051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23082051%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSuzuki-Type%252BCross-Coupling%252BReaction%252Bof%252BUnprotected%252B3-Iodoindazoles%252Bwith%252BPinacol%252BVinyl%252BBoronate%25253A%252BAn%252BExpeditive%252BC-3%252BVinylation%252Bof%252BIndazoles%252Bunder%252BMicrowave%252BIrradiation%26aulast%3DVera%26aufirst%3DGonzalo%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kseniya N.  Sedenkova</span>, <span class="hlFld-ContribAuthor ">Kristian S.  Andriasov</span>, <span class="hlFld-ContribAuthor ">Svetlana A.  Stepanova</span>, <span class="hlFld-ContribAuthor ">Igor P.  Gloriozov</span>, <span class="hlFld-ContribAuthor ">Yuri K.  Grishin</span>, <span class="hlFld-ContribAuthor ">Tamara S.  Kuznetsova</span>, <span class="hlFld-ContribAuthor ">Elena B.  Averina</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Oxidation of Cyclopropanated Cyclooctanes as a Synthetic Approach to Polycyclic Cyclopropyl Ketones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (7)
                                     , 879-884. <a href="https://doi.org/10.1002/ejoc.201701671" title="DOI URL">https://doi.org/10.1002/ejoc.201701671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701671%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BOxidation%252Bof%252BCyclopropanated%252BCyclooctanes%252Bas%252Ba%252BSynthetic%252BApproach%252Bto%252BPolycyclic%252BCyclopropyl%252BKetones%26aulast%3DSedenkova%26aufirst%3DKseniya%2BN.%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D7%26spage%3D879%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xing-Xing  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuan  Xiao</span>, <span class="hlFld-ContribAuthor ">Shiyu  Li</span>, <span class="hlFld-ContribAuthor ">Kai  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhouling  Xie</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 724-731. <a href="https://doi.org/10.1016/j.ejmech.2017.11.058" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.058%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bhighly%252Bselective%252Bpolo-like%252Bkinase%252B2%252Binhibitors%252Bbased%252Bon%252Bthe%252Btetrahydropteridin%252Bchemical%252Bscaffold%26aulast%3DZhan%26aufirst%3DMei-Miao%26date%3D2018%26volume%3D143%26spage%3D724%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulong  Kuang</span>, <span class="hlFld-ContribAuthor ">Bin  Shen</span>, <span class="hlFld-ContribAuthor ">Li  Dai</span>, <span class="hlFld-ContribAuthor ">Qian  Yao</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Liu</span>, <span class="hlFld-ContribAuthor ">Lili  Lin</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereodivergent asymmetric Michael-alkylation reactions using chiral
              N
              ,
              N
              ′-dioxide/metal complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 688-692. <a href="https://doi.org/10.1039/C7SC02757E" title="DOI URL">https://doi.org/10.1039/C7SC02757E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7SC02757E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7SC02757E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDiastereodivergent%252Basymmetric%252BMichael-alkylation%252Breactions%252Busing%252Bchiral%252BN%252B%25252C%252BN%252B%2525E2%252580%2525B2-dioxide%25252Fmetal%252Bcomplexes%26aulast%3DKuang%26aufirst%3DYulong%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D688%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnaud  Chevalier</span>, <span class="hlFld-ContribAuthor ">Abdelaaziz  Ouahrouch</span>, <span class="hlFld-ContribAuthor ">Alexandre  Arnaud</span>, <span class="hlFld-ContribAuthor ">Thibault  Gallavardin</span>, <span class="hlFld-ContribAuthor ">Xavier  Franck</span>. </span><span class="cited-content_cbyCitation_article-title">An optimized procedure for direct access to 1
              H
              -indazole-3-carboxaldehyde derivatives by nitrosation of indoles. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (24)
                                     , 13121-13128. <a href="https://doi.org/10.1039/C8RA01546E" title="DOI URL">https://doi.org/10.1039/C8RA01546E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01546E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01546E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAn%252Boptimized%252Bprocedure%252Bfor%252Bdirect%252Baccess%252Bto%252B1%252BH%252B-indazole-3-carboxaldehyde%252Bderivatives%252Bby%252Bnitrosation%252Bof%252Bindoles%26aulast%3DChevalier%26aufirst%3DArnaud%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D24%26spage%3D13121%26epage%3D13128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. R.  Gataullin</span>. </span><span class="cited-content_cbyCitation_article-title">Exocyclic Double Bond in Benzo-Fused Nitrogen Heterocycles: Methods of Introduction and Syntheses with Its Participation. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>54 </em>
                                    (1)
                                     , 1-44. <a href="https://doi.org/10.1134/S1070428018010013" title="DOI URL">https://doi.org/10.1134/S1070428018010013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428018010013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428018010013%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DExocyclic%252BDouble%252BBond%252Bin%252BBenzo-Fused%252BNitrogen%252BHeterocycles%25253A%252BMethods%252Bof%252BIntroduction%252Band%252BSyntheses%252Bwith%252BIts%252BParticipation%26aulast%3DGataullin%26aufirst%3DR.%2BR.%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D1%26spage%3D1%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone Treiger  Sredni</span>, <span class="hlFld-ContribAuthor ">Mario  Suzuki</span>, <span class="hlFld-ContribAuthor ">Jian-Ping  Yang</span>, <span class="hlFld-ContribAuthor ">Jacek  Topczewski</span>, <span class="hlFld-ContribAuthor ">Anders W.  Bailey</span>, <span class="hlFld-ContribAuthor ">Tufan  Gokirmak</span>, <span class="hlFld-ContribAuthor ">Jeffrey N.  Gross</span>, <span class="hlFld-ContribAuthor ">Alexandre  de Andrade</span>, <span class="hlFld-ContribAuthor ">Akihide  Kondo</span>, <span class="hlFld-ContribAuthor ">David R.  Piper</span>, <span class="hlFld-ContribAuthor ">Tadanori  Tomita</span>. </span><span class="cited-content_cbyCitation_article-title">A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain. </span><span class="cited-content_cbyCitation_journal-name">Pediatric Blood & Cancer</span><span> <strong>2017,</strong> <em>64 </em>
                                    (11)
                                     , e26551. <a href="https://doi.org/10.1002/pbc.26551" title="DOI URL">https://doi.org/10.1002/pbc.26551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pbc.26551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpbc.26551%26sid%3Dliteratum%253Aachs%26jtitle%3DPediatric%2520Blood%2520%2526%2520Cancer%26atitle%3DA%252Bfunctional%252Bscreening%252Bof%252Bthe%252Bkinome%252Bidentifies%252Bthe%252BPolo-like%252Bkinase%252B4%252Bas%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Bmalignant%252Brhabdoid%252Btumors%25252C%252Band%252Bpossibly%25252C%252Bother%252Bembryonal%252Btumors%252Bof%252Bthe%252Bbrain%26aulast%3DSredni%26aufirst%3DSimone%2BTreiger%26date%3D2017%26date%3D2017%26volume%3D64%26issue%3D11%26spage%3De26551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nader  Noroozi Pesyan</span>, <span class="hlFld-ContribAuthor ">Hamid  Rashidnejad</span>. </span><span class="cited-content_cbyCitation_article-title">Decades of synthesis and application of spiro cyclopropanes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2017,</strong> <em>14 </em>
                                    (7)
                                     , 1365-1467. <a href="https://doi.org/10.1007/s13738-017-1086-0" title="DOI URL">https://doi.org/10.1007/s13738-017-1086-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-017-1086-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-017-1086-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DDecades%252Bof%252Bsynthesis%252Band%252Bapplication%252Bof%252Bspiro%252Bcyclopropanes%26aulast%3DNoroozi%2BPesyan%26aufirst%3DNader%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D7%26spage%3D1365%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zhu</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Wu</span>, <span class="hlFld-ContribAuthor ">Chenzhou  Hao</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Zizheng  Yan</span>, <span class="hlFld-ContribAuthor ">Wanxu  Huang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (13)
                                     , 3500-3511. <a href="https://doi.org/10.1016/j.bmc.2017.04.047" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bindolin-2-one%252Bderivatives%252Bas%252Bpotent%252BPAK4%252Binhibitors%25253A%252BStructure-activity%252Brelationship%252Banalysis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bstudy%26aulast%3DGuo%26aufirst%3DJing%26date%3D2017%26volume%3D25%26issue%3D13%26spage%3D3500%26epage%3D3511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingwei  Zhou</span>, <span class="hlFld-ContribAuthor ">Ke  En</span>, <span class="hlFld-ContribAuthor ">Yimin  Hu</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Xuhong  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Zinc triflate-mediated cyclopropanation of oxindoles with vinyl diphenyl sulfonium triflate: a mild reaction with broad functional group compatibility. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (7)
                                     , 3741-3745. <a href="https://doi.org/10.1039/C6RA24985J" title="DOI URL">https://doi.org/10.1039/C6RA24985J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA24985J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA24985J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DZinc%252Btriflate-mediated%252Bcyclopropanation%252Bof%252Boxindoles%252Bwith%252Bvinyl%252Bdiphenyl%252Bsulfonium%252Btriflate%25253A%252Ba%252Bmild%252Breaction%252Bwith%252Bbroad%252Bfunctional%252Bgroup%252Bcompatibility%26aulast%3DZhou%26aufirst%3DMingwei%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D7%26spage%3D3741%26epage%3D3745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Qian  Lei</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Lu  Xiong</span>, <span class="hlFld-ContribAuthor ">Yaojie  Shi</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Chao  Gao</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>, <span class="hlFld-ContribAuthor ">Ningyu  Wang</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of (E)-4-(3-arylvinyl-1H-indazol-6-yl)pyrimidin-2-amine derivatives as PLK4 inhibitors for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (44)
                                     , 27737-27746. <a href="https://doi.org/10.1039/C7RA02518A" title="DOI URL">https://doi.org/10.1039/C7RA02518A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA02518A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA02518A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B%252528E%252529-4-%2525283-arylvinyl-1H-indazol-6-yl%252529pyrimidin-2-amine%252Bderivatives%252Bas%252BPLK4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DLiu%26aufirst%3DZhihao%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D44%26spage%3D27737%26epage%3D27746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marjorie  Fournier</span>, <span class="hlFld-ContribAuthor ">Meritxell  Orpinell</span>, <span class="hlFld-ContribAuthor ">Cédric  Grauffel</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Scheer</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Garnier</span>, <span class="hlFld-ContribAuthor ">Tao  Ye</span>, <span class="hlFld-ContribAuthor ">Virginie  Chavant</span>, <span class="hlFld-ContribAuthor ">Mathilde  Joint</span>, <span class="hlFld-ContribAuthor ">Fumiko  Esashi</span>, <span class="hlFld-ContribAuthor ">Annick  Dejaegere</span>, <span class="hlFld-ContribAuthor ">Pierre  Gönczy</span>, <span class="hlFld-ContribAuthor ">László  Tora</span>. </span><span class="cited-content_cbyCitation_article-title">KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms13227" title="DOI URL">https://doi.org/10.1038/ncomms13227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms13227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms13227%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DKAT2A%25252FKAT2B-targeted%252Bacetylome%252Breveals%252Ba%252Brole%252Bfor%252BPLK4%252Bacetylation%252Bin%252Bpreventing%252Bcentrosome%252Bamplification%26aulast%3DFournier%26aufirst%3DMarjorie%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Feng  Chang</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Yih-Shyan  Lin</span>, <span class="hlFld-ContribAuthor ">Wen-Chieh  Wang</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Po-Chu  Kuo</span>, <span class="hlFld-ContribAuthor ">John T.A.  Hsu</span>, <span class="hlFld-ContribAuthor ">Biing-Jiun  Uang</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 186-199. <a href="https://doi.org/10.1016/j.ejmech.2016.08.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Binhibitors%252Bof%252BAurora%252Bkinases%252Bwith%252Bindazole%252Bscaffold%25253A%252BIn%252Bsilico%252Bfragment-based%252Band%252Bknowledge-based%252Bdrug%252Bdesign%26aulast%3DChang%26aufirst%3DChun-Feng%26date%3D2016%26volume%3D124%26spage%3D186%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Bryan T.  Forrest</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Xunyi  Luo</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Erin  Green</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua  Pan</span>, <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>. </span><span class="cited-content_cbyCitation_article-title">Design and optimization of (3-aryl-1 H -indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones as potent PLK4 inhibitors with oral antitumor efficacy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (19)
                                     , 4625-4630. <a href="https://doi.org/10.1016/j.bmcl.2016.08.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.08.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.08.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Boptimization%252Bof%252B%2525283-aryl-1%252BH%252B-indazol-6-yl%252529spiro%25255Bcyclopropane-1%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-ones%252Bas%252Bpotent%252BPLK4%252Binhibitors%252Bwith%252Boral%252Bantitumor%252Befficacy%26aulast%3DLi%26aufirst%3DSze-Wan%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4625%26epage%3D4630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana L. C.  Sousa</span>, <span class="hlFld-ContribAuthor ">Oualid  Talhi</span>, <span class="hlFld-ContribAuthor ">Ricardo F.  Mendes</span>, <span class="hlFld-ContribAuthor ">Filipe A.  Almeida Paz</span>, <span class="hlFld-ContribAuthor ">Khaldoun  Bachari</span>, <span class="hlFld-ContribAuthor ">Artur M. S.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic One-Pot Diastereoselective Michael-Initiated Ring-Closure of Methyl Ketones with 3-Bromochromones: Synthesis of Cyclopropa[
              b
              ]chromanones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (23)
                                     , 3949-3958. <a href="https://doi.org/10.1002/ejoc.201600413" title="DOI URL">https://doi.org/10.1002/ejoc.201600413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600413%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCatalytic%252BOne-Pot%252BDiastereoselective%252BMichael-Initiated%252BRing-Closure%252Bof%252BMethyl%252BKetones%252Bwith%252B3-Bromochromones%25253A%252BSynthesis%252Bof%252BCyclopropa%25255B%252Bb%252B%25255Dchromanones%26aulast%3DSousa%26aufirst%3DJoana%2BL.%2BC.%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D23%26spage%3D3949%26epage%3D3958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei-Hua  Shen</span>, <span class="hlFld-ContribAuthor ">Ke  Xu</span>, <span class="hlFld-ContribAuthor ">Chu-Han  Sun</span>, <span class="hlFld-ContribAuthor ">Hua-Dong  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of aza-spirocyclopropanyl oxindoles by the reaction of 3-(2-bromoethyl)-indole with 2,3-dimethylimidazole-1-sulfonyl azide triflate. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (4)
                                     , 1272-1276. <a href="https://doi.org/10.1039/C5OB02192H" title="DOI URL">https://doi.org/10.1039/C5OB02192H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02192H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02192H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DFacile%252Bsynthesis%252Bof%252Baza-spirocyclopropanyl%252Boxindoles%252Bby%252Bthe%252Breaction%252Bof%252B3-%2525282-bromoethyl%252529-indole%252Bwith%252B2%25252C3-dimethylimidazole-1-sulfonyl%252Bazide%252Btriflate%26aulast%3DShen%26aufirst%3DMei-Hua%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D4%26spage%3D1272%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Palomba</span>, <span class="hlFld-ContribAuthor ">L.  Rossi</span>, <span class="hlFld-ContribAuthor ">L.  Sancineto</span>, <span class="hlFld-ContribAuthor ">E.  Tramontano</span>, <span class="hlFld-ContribAuthor ">A.  Corona</span>, <span class="hlFld-ContribAuthor ">L.  Bagnoli</span>, <span class="hlFld-ContribAuthor ">C.  Santi</span>, <span class="hlFld-ContribAuthor ">C.  Pannecouque</span>, <span class="hlFld-ContribAuthor ">O.  Tabarrini</span>, <span class="hlFld-ContribAuthor ">F.  Marini</span>. </span><span class="cited-content_cbyCitation_article-title">A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (6)
                                     , 2015-2024. <a href="https://doi.org/10.1039/C5OB02451J" title="DOI URL">https://doi.org/10.1039/C5OB02451J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02451J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02451J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bnew%252Bvinyl%252Bselenone-based%252Bdomino%252Bapproach%252Bto%252Bspirocyclopropyl%252Boxindoles%252Bendowed%252Bwith%252Banti-HIV%252BRT%252Bactivity%26aulast%3DPalomba%26aufirst%3DM.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D6%26spage%3D2015%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjian  Chi</span>, <span class="hlFld-ContribAuthor ">Lihua  Qiu</span>, <span class="hlFld-ContribAuthor ">Xinfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Highly enantioselective synthesis of spirocyclopropyloxindoles via a Rh(
              ii
              )-catalyzed asymmetric cyclopropanation reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (44)
                                     , 10357-10361. <a href="https://doi.org/10.1039/C6OB02160C" title="DOI URL">https://doi.org/10.1039/C6OB02160C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB02160C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB02160C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DHighly%252Benantioselective%252Bsynthesis%252Bof%252Bspirocyclopropyloxindoles%252Bvia%252Ba%252BRh%252528%252Bii%252B%252529-catalyzed%252Basymmetric%252Bcyclopropanation%252Breaction%26aulast%3DChi%26aufirst%3DYongjian%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D44%26spage%3D10357%26epage%3D10361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xiao-Nan  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Ping-Ping  Qi</span>, <span class="hlFld-ContribAuthor ">Yi-Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">De-Quan  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of novel antiproliferative steroidal spirooxindoles via the [3+2] cycloaddition reactions of azomethine ylides. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2015,</strong> <em>102 </em>, 92-100. <a href="https://doi.org/10.1016/j.steroids.2015.08.003" title="DOI URL">https://doi.org/10.1016/j.steroids.2015.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2015.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2015.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bnovel%252Bantiproliferative%252Bsteroidal%252Bspirooxindoles%252Bvia%252Bthe%252B%25255B3%25252B2%25255D%252Bcycloaddition%252Breactions%252Bof%252Bazomethine%252Bylides%26aulast%3DYu%26aufirst%3DBin%26date%3D2015%26volume%3D102%26spage%3D92%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin E.  Wilson</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Brandon L.  Ashfeld</span>. </span><span class="cited-content_cbyCitation_article-title">Stereochemical implications in the synthesis of 3,3′-spirocyclopropyl oxindoles from β-aryl/alkyl-substituted alkylidene oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (35)
                                     , 5765-5775. <a href="https://doi.org/10.1016/j.tet.2015.06.004" title="DOI URL">https://doi.org/10.1016/j.tet.2015.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DStereochemical%252Bimplications%252Bin%252Bthe%252Bsynthesis%252Bof%252B3%25252C3%2525E2%252580%2525B2-spirocyclopropyl%252Boxindoles%252Bfrom%252B%2525CE%2525B2-aryl%25252Falkyl-substituted%252Balkylidene%252Boxindoles%26aulast%3DWilson%26aufirst%3DErin%2BE.%26date%3D2015%26volume%3D71%26issue%3D35%26spage%3D5765%26epage%3D5775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karineh  Kazazian</span>, <span class="hlFld-ContribAuthor ">Olga  Brashavitskaya</span>, <span class="hlFld-ContribAuthor ">Francis S. W.  Zih</span>, <span class="hlFld-ContribAuthor ">David  Berger-Richardson</span>, <span class="hlFld-ContribAuthor ">Roland S. Z.  Xu</span>, <span class="hlFld-ContribAuthor ">Karina  Pacholczyk</span>, <span class="hlFld-ContribAuthor ">Jennifer  Macmillan</span>, <span class="hlFld-ContribAuthor ">Carol J.  Swallow</span>. </span><span class="cited-content_cbyCitation_article-title">Polo-Like Kinases in Colorectal Cancer: Potential for Targeted Therapy. </span><span class="cited-content_cbyCitation_journal-name">Current Colorectal Cancer Reports</span><span> <strong>2015,</strong> <em>11 </em>
                                    (4)
                                     , 187-199. <a href="https://doi.org/10.1007/s11888-015-0275-4" title="DOI URL">https://doi.org/10.1007/s11888-015-0275-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11888-015-0275-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11888-015-0275-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Colorectal%2520Cancer%2520Reports%26atitle%3DPolo-Like%252BKinases%252Bin%252BColorectal%252BCancer%25253A%252BPotential%252Bfor%252BTargeted%252BTherapy%26aulast%3DKazazian%26aufirst%3DKarineh%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D4%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Ping-Ping  Qi</span>, <span class="hlFld-ContribAuthor ">De-Quan  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 35-40. <a href="https://doi.org/10.1016/j.ejmech.2015.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Borally%252Bactive%252Banticancer%252Bcandidate%252BCFI-400945%252Bderived%252Bfrom%252Bbiologically%252Bpromising%252Bspirooxindoles%25253A%252BSuccess%252Band%252Bchallenges%26aulast%3DYu%26aufirst%3DBin%26date%3D2015%26volume%3D95%26spage%3D35%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasarao  Arulananda Babu</span>, <span class="hlFld-ContribAuthor ">Rayavarapu  Padmavathi</span>, <span class="hlFld-ContribAuthor ">Nayyar  Ahmad Aslam</span>, <span class="hlFld-ContribAuthor ">Vadla  Rajkumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments on the Synthesis and Applications of Natural Products-Inspired Spirooxindole Frameworks. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 227-339. <a href="https://doi.org/10.1016/B978-0-444-63462-7.00008-7" title="DOI URL">https://doi.org/10.1016/B978-0-444-63462-7.00008-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63462-7.00008-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63462-7.00008-7%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BDevelopments%252Bon%252Bthe%252BSynthesis%252Band%252BApplications%252Bof%252BNatural%252BProducts-Inspired%252BSpirooxindole%252BFrameworks%26aulast%3DArulananda%2BBabu%26aufirst%3DSrinivasarao%26date%3D2015%26spage%3D227%26epage%3D339%26pub%3DElsevier%26date%3D2015%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PLK4 activity of known kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (<i>E</i>)-3-((1<i>H</i>-Indazol-6-yl)methylene)indolin-2-one PLK4 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Racemic 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and Conditions: (i) Me<sub>3</sub>SOI, NaH, DMF, rt.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Racemic Vinylaryl 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones by Cyclopropanation of Methylene-indolin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Me<sub>3</sub>SOI, NaH, DMF, rt; (ii) ArCH═CH<sub>2</sub>, 5 mol % Pd(OAc)<sub>2</sub>, P(o-Tol)<sub>3</sub>, DIPEA, DMF, 130 °C, 2 h; (iii) BF<sub>3</sub>OEt<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 2 h; (iv) 2:1 EtOH/2 M aq HCl, 50 °C, 2 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Racemic Vinylaryl 2-(1<i>H</i>-Indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Me<sub>3</sub>SOI, NaH, DMF, rt; (ii) 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, 2 mol % Pd(PPh<sub>3</sub>)<sub>4</sub>, 2:1 PhCH<sub>3</sub>/EtOH, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, 125 °C, 3 h; (iii) ArBr, 5 mol % Pd(OAc)<sub>2</sub>, P(<i>o</i>-tol)<sub>3</sub>, DIPEA, DMF, 125 °C, 2 h; (iv) 3:1 EtOH/PhCH<sub>3</sub>, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 120 °C, 2 h; (v) diethyl 4-cyanobenzylphosphonate, <i>t</i>-BuOK, DMF, 0 °C; (vi) Raney Nickel, NaH<sub>2</sub>PO<sub>2</sub>, DMF, pyridine, AcOH, H<sub>2</sub>O, 60 °C; (vii) R′<sub>2</sub>NH, Ti(Oi-Pr)<sub>4</sub>, NaBH<sub>4</sub>, THF, 40 °C.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of <i>E</i>-alkene <b>7</b> (green) and the (1<i>R</i>,2<i>S</i>)-cyclopropane <b>8</b> (gray) bioisosteres in the PLK4 binding site. This view was generated by GlideXP docking into the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK">3COK</a>-based model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of in vivo efficacy of PLK4 inhibitors in a mouse MDA-MB-468 breast cancer xenograft model after 21-day treatment (<i>n</i> = 5). <b>2</b>, TGI = 73%, <i>p</i> = 0.036; compound <b>13</b>, TGI = 84%, <i>p</i> = 0.03; compound <b>18</b>, TGI = 76%, <i>p</i> = 0.03. No animals were lost during the course of the study and weight loss was <20% for all treatment arms; TGI, tumor growth inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/medium/jm-2014-00537u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of the active site of the PLK4 enzyme at 2.4 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF">4JXF</a>), co-crystallized with racemic compound <b>18</b>. The co-structure clearly shows binding of the 1<i>R</i>,2<i>S</i> enantiomer of compound <b>18</b>. Hydrogen bonds are depicted by dashed lines. (A) Hydrogen bonding of the indazole to Glu90 and Cys 92 of the hinge region; H-bonds from the indolinone moiety to the side chain of Lys41 and the backbone carbonyl of Gln160. (B) 180° flipped view of PLK4 active site surface: the dimethylamino group extends into solvent; hydrophobic surfaces engage the indazole and vinyl groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500537u/20150106/images/large/jm-2014-00537u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500537u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0liavDizwr47eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastians, H.</span><span> </span><span class="NLM_article-title">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span> <span class="citation_source-journal">Drug Res. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1016%2Fj.drup.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=17669681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=162-181&author=M.+Schmidtauthor=H.+Bastians&title=Mitotic+drug+targets+and+the+development+of+novel+anti-mitotic+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic drug targets and the development of novel anti-mitotic anticancer drugs</span></div><div class="casAuthors">Schmidt, Mathias; Bastians, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">162-181</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that interfere with the normal progression of mitosis belong to the most successful chemotherapeutic compds. currently used for anti-cancer treatment.  Classically, these drugs are represented by microtubule binding drugs that inhibit the function of the mitotic spindle in order to halt the cell cycle in mitosis and to induce apoptosis in tumor cells.  However, these compds. act not only on proliferating tumor cells, but exhibit significant side effects on non-proliferating cells including neurons that are highly dependent on intracellular transport processes mediated by microtubules.  Therefore, there is a particular interest in developing novel anti-mitotic drugs that target non-microtubule structures.  In fact, recently several novel drugs that target mitotic kinesins or the Aurora and polo-like kinases have been developed and are currently tested in clin. trials.  In addn., approaches of cell cycle checkpoint abrogation during mitosis and at the G2/M transition inducing mitosis-assocd. tumor cell death are promising new strategies for anti-cancer therapy.  It is expected that this "next generation" of anti-mitotic drugs will be as successful as the classical anti-microtubule drugs, while avoiding some of the adverse side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiOJi9lDecBLVg90H21EOLACvtfcHk0lgUrDQdXPvcdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWhs73N&md5=b7262b3578e6daaad41412780d022937</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DBastians%26aufirst%3DH.%26atitle%3DMitotic%2520drug%2520targets%2520and%2520the%2520development%2520of%2520novel%2520anti-mitotic%2520anticancer%2520drugs%26jtitle%3DDrug%2520Res.%2520Updates%26date%3D2007%26volume%3D10%26spage%3D162%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Matthews, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visintin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartzoulakis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span> </span><span class="NLM_article-title">Aurora A and B kinases as targets for cancer: Will they be selective for tumors?</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1586%2F14737140.6.1.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=16375648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFygsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=109-120&author=N.+Matthewsauthor=C.+Visintinauthor=B.+Hartzoulakisauthor=A.+Jarvisauthor=D.+L.+Selwood&title=Aurora+A+and+B+kinases+as+targets+for+cancer%3A+Will+they+be+selective+for+tumors%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora A and B kinases as targets for cancer: will they be selective for tumors?</span></div><div class="casAuthors">Matthews, Nick; Visintin, Cristina; Hartzoulakis, Basil; Jarvis, Ashley; Selwood, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-120</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Aurora A and B kinases are closely related kinases involved in regulating sep. points in the cell cycle.  This review highlights the rationale for Aurora kinases as cancer targets and examines the currently known Aurora kinase inhibitors in the patent and scientific literature.  The known crystal structures of the Aurora kinases are described with relevance to bound ligand interactions and the prospect of the generation of drug-resistant mutant forms.  The potential for selectivity vs. primary cells will also be discussed.  The status of the inhibitors in clin. development is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_LCGgBjnCtbVg90H21EOLACvtfcHk0lgUrDQdXPvcdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFygsLg%253D&md5=6e8cf58ccc390b2bfcad4f5fe1340274</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1586%2F14737140.6.1.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.6.1.109%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DN.%26aulast%3DVisintin%26aufirst%3DC.%26aulast%3DHartzoulakis%26aufirst%3DB.%26aulast%3DJarvis%26aufirst%3DA.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26atitle%3DAurora%2520A%2520and%2520B%2520kinases%2520as%2520targets%2520for%2520cancer%253A%2520Will%2520they%2520be%2520selective%2520for%2520tumors%253F%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2006%26volume%3D6%26spage%3D109%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kollareddy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheleva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzubak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmkshatriya, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepsik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduch, M.</span><span> </span><span class="NLM_article-title">Aurora kinase inhibitors: progress towards the clinic</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=2411-2432&author=M.+Kollareddyauthor=D.+Zhelevaauthor=P.+Dzubakauthor=P.+S.+Brahmkshatriyaauthor=M.+Lepsikauthor=M.+Hajduch&title=Aurora+kinase+inhibitors%3A+progress+towards+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKollareddy%26aufirst%3DM.%26aulast%3DZheleva%26aufirst%3DD.%26aulast%3DDzubak%26aufirst%3DP.%26aulast%3DBrahmkshatriya%26aufirst%3DP.%2BS.%26aulast%3DLepsik%26aufirst%3DM.%26aulast%3DHajduch%26aufirst%3DM.%26atitle%3DAurora%2520kinase%2520inhibitors%253A%2520progress%2520towards%2520the%2520clinic%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D31%26spage%3D2411%26epage%3D2432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Friedberg, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebula, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lossos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fingert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danaee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, S. H.</span><span> </span><span class="NLM_article-title">Phase II Study of Alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-Cell non-Hodgkin lymphomes</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1200%2FJCO.2012.46.8793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=24043741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1agtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=44-50&author=J.+W.+Friedbergauthor=D.+Mahadevanauthor=E.+Cebulaauthor=D.+Perskyauthor=I.+Lossosauthor=A.+B.+Agarwalauthor=J.+Jungauthor=R.+Burackauthor=X.+Zhouauthor=E.+J.+Leonardauthor=H.+Fingertauthor=H.+Danaeeauthor=S.+H.+Bernstein&title=Phase+II+Study+of+Alisertib%2C+a+selective+Aurora+A+kinase+inhibitor%2C+in+relapsed+and+refractory+aggressive+B-+and+T-Cell+non-Hodgkin+lymphomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study of alisertib, a selective aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas</span></div><div class="casAuthors">Friedberg, Jonathan W.; Mahadevan, Daruka; Cebula, Erin; Persky, Daniel; Lossos, Izidore; Agarwal, Amit B.; Jung, JungAh; Burack, Richard; Zhou, Xiaofei; Leonard, E. Jane; Fingert, Howard; Danaee, Hadi; Bernstein, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-50</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Aurora A kinase (AAK) is overexpressed in aggressive lymphomas and can correlate with more histol. aggressive forms of disease.  We therefore designed a phase II study of alisertib, a selective AAK inhibitor, in patients with relapsed and refractory aggressive nonHodgkin lymphomas.  Patients and Methods Patients age ≥ 18 years were eligible if they had relapsed or refractory diffuse large B-cell lymphoma (DLBCL), mantle-cell lymphoma (MCL), transformed follicular lymphoma, Burkitt's lymphoma, or noncutaneous T-cell lymphoma.  Alisertib was administered orally at 50 mg twice daily for 7 days in 21-day cycles.  Results We enrolled 48 patients.  Histologies included DLBCL (n = 21), MCL (n = 13), peripheral T-cell lymphoma (n = 8), transformed follicular lymphoma (n = 5), and Burkitt's (n = 1).  Most common grade 3 to 4 adverse events were neutropenia (63%), leukopenia (54%), anemia (35%), thrombocytopenia (33%), stomatitis (15%), febrile neutropenia (13%), and fatigue (6%).  Four deaths during the study were attributed to progressive non-Hodgkin lymphoma (n = 2), treatment-related sepsis (n = 1), and unknown cause (n = 1).  The overall response rate was 27%, including responses in three of 21 patients with DLBCL, three of 13 with MCL, one of one with Burkitt's lymphoma, two of five with transformed follicular lymphoma, and four of eight with noncutaneous T-cell lymphoma.  The alisertib steady-state trough concn. (n = 25) revealed the expected pharmacokinetic variability, with a trend for higher incidence of adverse event-related dose redns. at higher trough concns.  Anal. for AAK gene amplification and total AAK protein revealed no differences between histologies or correlation with clin. response.  Conclusion The novel AAK inhibitor alisertib seems clin. active in both B- and T-cell aggressive lymphomas.  On the basis of these results, confirmatory single-agent and combination studies have been initiated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzeT69vodilrVg90H21EOLACvtfcHk0liPgMdfJgxlUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1agtL0%253D&md5=f4aa20df4b3bcce9c673a453fc73e9ee</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.46.8793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.46.8793%26sid%3Dliteratum%253Aachs%26aulast%3DFriedberg%26aufirst%3DJ.%2BW.%26aulast%3DMahadevan%26aufirst%3DD.%26aulast%3DCebula%26aufirst%3DE.%26aulast%3DPersky%26aufirst%3DD.%26aulast%3DLossos%26aufirst%3DI.%26aulast%3DAgarwal%26aufirst%3DA.%2BB.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DBurack%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLeonard%26aufirst%3DE.%2BJ.%26aulast%3DFingert%26aufirst%3DH.%26aulast%3DDanaee%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DS.%2BH.%26atitle%3DPhase%2520II%2520Study%2520of%2520Alisertib%252C%2520a%2520selective%2520Aurora%2520A%2520kinase%2520inhibitor%252C%2520in%2520relapsed%2520and%2520refractory%2520aggressive%2520B-%2520and%2520T-Cell%2520non-Hodgkin%2520lymphomes%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26spage%3D44%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silljé, H. H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell division</span> <span class="citation_source-journal">Nature Rev. Mod. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H.+W.+Sillj%C3%A9author=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0liPgMdfJgxlUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillj%25C3%25A9%26aufirst%3DH.%2BH.%2BW.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520division%26jtitle%3DNature%2520Rev.%2520Mod.%2520Cell%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Eckerdt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Polo-like kinases and oncogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=267-276&author=F.+Eckerdtauthor=J.+Yuanauthor=K.+Strebhardt&title=Polo-like+kinases+and+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckerdt%26aufirst%3DF.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DPolo-like%2520kinases%2520and%2520oncogenesis%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D267%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9551</span><span class="NLM_x">–</span> <span class="NLM_lpage">9563</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9551-9563&author=E.+F.+Johnsonauthor=K.+D.+Stewartauthor=K.+W.+Woodsauthor=V.+L.+Girandaauthor=Y.+Luo&title=Pharmacological+and+functional+comparison+of+the+polo-like+kinase+family%3A+insight+into+inhibitor+and+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbi7008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7008745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DPharmacological%2520and%2520functional%2520comparison%2520of%2520the%2520polo-like%2520kinase%2520family%253A%2520insight%2520into%2520inhibitor%2520and%2520substrate%2520specificity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D9551%26epage%3D9563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lens, S. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voest, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span> </span><span class="NLM_article-title">Shared and separate functions of polo-like kinases and aurora kinases in cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnrc2964" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=21102634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=825-841&author=S.+M.+A.+Lensauthor=E.+E.+Voestauthor=R.+H.+Medema&title=Shared+and+separate+functions+of+polo-like+kinases+and+aurora+kinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Shared and separate functions of polo-like kinases and aurora kinases in cancer</span></div><div class="casAuthors">Lens, Susanne M. A.; Voest, Emile E.; Medema, Rene H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">825-841</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Large nos. of inhibitors for polo-like kinases and aurora kinases are currently being evaluated as anticancer drugs.  Interest in these drugs is fuelled by the idea that these kinases have unique functions in mitosis.  Within the polo-like kinase family, the emphasis for targeted therapies has been on polo-like kinase 1 (PLK1), and in the aurora kinase family drugs have been developed to specifically target aurora kinase A (AURKA; also known as STK6) and/or aurora kinase B (AURKB; also known as STK12).  Information on the selectivity of these compds. in vivo is limited, but it is likely that off-target effects within the same kinase families will affect efficacy and toxicity profiles.  In addn., it is becoming clear that interplay between polo-like kinases and aurora kinases is much more extensive than initially anticipated, and that both kinase families are important factors in the response to classical chemotherapeutics that damage the genome or the mitotic spindle.  In this Review we discuss the implications of these novel insights on the clin. applicability of polo-like kinase and aurora kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZqNXWXWvq_bVg90H21EOLACvtfcHk0liN_XODhbVy1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsLbI&md5=f8b721eca926065b3d8ec682ec7a7379</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc2964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2964%26sid%3Dliteratum%253Aachs%26aulast%3DLens%26aufirst%3DS.%2BM.%2BA.%26aulast%3DVoest%26aufirst%3DE.%2BE.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DShared%2520and%2520separate%2520functions%2520of%2520polo-like%2520kinases%2520and%2520aurora%2520kinases%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D825%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Schoffski, P.</span><span> </span><span class="NLM_article-title">Polo-like kinase inhibitors in preclinical and early clinical development</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffski&title=Polo-like+kinase+inhibitors+in+preclinical+and+early+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffski%26aufirst%3DP.%26atitle%3DPolo-like%2520kinase%2520inhibitors%2520in%2520preclinical%2520and%2520early%2520clinical%2520development%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Frost, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kross, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedbom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trommeshauser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span> </span><span class="NLM_article-title">Phase I study of the PLK1 inhibitor BI 2536 administered intravenously on three consecutive days in advance solid tumours</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.3747%2Fco.19.866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=28-35&author=A.+Frostauthor=K.+Krossauthor=S.+Steinbildauthor=S.+Hedbomauthor=C.+Ungerauthor=R.+Kaiserauthor=D.+Trommeshauserauthor=G.+Munzert&title=Phase+I+study+of+the+PLK1+inhibitor+BI+2536+administered+intravenously+on+three+consecutive+days+in+advance+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3747%2Fco.19.866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3747%252Fco.19.866%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DA.%26aulast%3DKross%26aufirst%3DK.%26aulast%3DSteinbild%26aufirst%3DS.%26aulast%3DHedbom%26aufirst%3DS.%26aulast%3DUnger%26aufirst%3DC.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DTrommeshauser%26aufirst%3DD.%26aulast%3DMunzert%26aufirst%3DG.%26atitle%3DPhase%2520I%2520study%2520of%2520the%2520PLK1%2520inhibitor%2520BI%25202536%2520administered%2520intravenously%2520on%2520three%2520consecutive%2520days%2520in%2520advance%2520solid%2520tumours%26jtitle%3DCurr.%2520Oncol.%26date%3D2012%26volume%3D19%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Leung, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization</span> <span class="citation_source-journal">Nature Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fnsb848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=12352953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1yksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=719-724&author=G.+C.+Leungauthor=J.+W.+Hudsonauthor=A.+Kozarovaauthor=A.+Davidsonauthor=J.+W.+Dennisauthor=F.+Sicheri&title=The+Sak+polo-box+comprises+a+structural+domain+sufficient+for+mitotic+subcellular+localization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization</span></div><div class="casAuthors">Leung, Genie C.; Hudson, John W.; Kozarova, Anna; Davidson, Alan; Dennis, James W.; Sicheri, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">719-724</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The small family of polo-like kinases (Plks) includes Cdc5 from Saccharomyces cerevisiae, Plo1 from Schizosaccharomyces pombe, Polo from Drosophila melanogaster and the four mammalian genes Plk1, Prk/Fnk, Snk and Sak.  These kinases control cell cycle progression through the regulation of centrosome maturation and sepn., mitotic entry, metaphase to anaphase transition, mitotic exit and cytokinesis.  Plks are characterized by an N-terminal Ser/Thr protein kinase domain and the presence of one or two C-terminal regions of similarity, termed the polo box motifs.  These motifs have been demonstrated for Cdc5 and Plk1 to be required for mitotic progression and for subcellular localization to mitotic structures.  Here we report the 2.0 Å crystal structure of a novel domain composed of the polo box motif of murine Sak.  The structure consists of a dimeric fold with a deep interfacial cleft and pocket, suggestive of a ligand-binding site.  We show that this domain forms homodimers both in vitro and in vivo, and localizes to centrosomes and the cleavage furrow during cytokinesis.  The requirement of the polo domain for Plk family function and the unique phys. properties of the domain identify it as an attractive target for inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNoQ-NIiPD6bVg90H21EOLACvtfcHk0li7U4pEkI5tbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1yksbk%253D&md5=c0cf4bd4f047b5dac622ca2486674f15</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnsb848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb848%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DG.%2BC.%26aulast%3DHudson%26aufirst%3DJ.%2BW.%26aulast%3DKozarova%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DA.%26aulast%3DDennis%26aufirst%3DJ.%2BW.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DThe%2520Sak%2520polo-box%2520comprises%2520a%2520structural%2520domain%2520sufficient%2520for%2520mitotic%2520subcellular%2520localization%26jtitle%3DNature%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D719%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sillibourne, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornens, M.</span><span> </span><span class="NLM_article-title">Polo-like kinase 4: the odd one out of the family</span> <span class="citation_source-journal">Cell Div.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1186%2F1747-1028-5-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=20920249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-34&author=J.+E.+Sillibourneauthor=M.+Bornens&title=Polo-like+kinase+4%3A+the+odd+one+out+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 4: the odd one out of the family</span></div><div class="casAuthors">Sillibourne James E; Bornens Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cell division</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract"> Polo-like kinase 4 (PLK4) is a unique member of the Polo-like family of kinases that shares little homology with its siblings and has an essential role in centriole duplication.  The turn-over of this kinase must be strictly controlled to prevent centriole amplification.  This is achieved, in part, by an autoregulatory mechanism, whereby PLK4 autophosphorylates residues in a PEST sequence located carboxy-terminal to its catalytic domain.  Phosphorylated PLK4 is subsequently recognized by the SCF complex, ubiquitinylated and targeted to the proteasome for degradation.  Recent data have also shown that active PLK4 is restricted to the centrosome, a mechanism that could serve to prevent aberrant centriole assembly elsewhere in the cell.  While significant advances have been made in understanding how PLK4 is regulated it is certain that additional regulatory mechanisms exist to safeguard the fidelity of centriole duplication.  Here, we overview past and present data discussing the regulation and functions of PLK4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQklC7aPJn_9mhHGZei4OW9fW6udTcc2eaqnh0ZZYH0YLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfovVygug%253D%253D&md5=bfde20a11fdea2a94976f97ced04e63d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1747-1028-5-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1747-1028-5-25%26sid%3Dliteratum%253Aachs%26aulast%3DSillibourne%26aufirst%3DJ.%2BE.%26aulast%3DBornens%26aufirst%3DM.%26atitle%3DPolo-like%2520kinase%25204%253A%2520the%2520odd%2520one%2520out%2520of%2520the%2520family%26jtitle%3DCell%2520Div.%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bettencourt-Dias, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Martins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riparbelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmenn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatt, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balloux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">SAK/PLK4 is required for centriole duplication and flagella development</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1016%2Fj.cub.2005.11.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=16326102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2199-2207&author=M.+Bettencourt-Diasauthor=A.+Rodrigues-Martinsauthor=L.+Carpenterauthor=M.+Riparbelliauthor=L.+Lehmennauthor=M.+K.+Gattauthor=N.+Carmoauthor=F.+Ballouxauthor=G.+Callaniauthor=D.+M.+Glover&title=SAK%2FPLK4+is+required+for+centriole+duplication+and+flagella+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SAK/PLK4 Is Required for Centriole Duplication and Flagella Development</span></div><div class="casAuthors">Bettencourt-Dias, M.; Rodrigues-Martins, A.; Carpenter, L.; Riparbelli, M.; Lehmann, L.; Gatt, M. K.; Carmo, N.; Balloux, F.; Callaini, G.; Glover, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2199-2207</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SAK/PLK4 is a distinct member of the polo-like kinase family.  SAK-/- mice die during embryogenesis, whereas SAK+/- mice develop liver and lung tumors and SAK+/- MEFs show mitotic abnormalities.  However, the mechanism underlying these phenotypes is still not known.  Here, the authors show that downregulation of SAK in Drosophila cells, by mutation or RNAi, leads to loss of centrioles, the core structures of centrosomes.  Such cells are able to undergo repeated rounds of cell division, but display broad disorganized mitotic spindle poles.  The authors also show that SAK mutants lose their centrioles during the mitotic divisions preceding male meiosis but still produce cysts of 16 primary spermatocytes as in the wild-type.  Math. modeling of the stereotyped cell divisions of spermatogenesis can account for such loss by defective centriole duplication.  The majority of spermatids in SAK mutants lack centrioles and so are unable to make sperm axonemes.  Finally, the authors show that depletion of SAK in human cells also prevents centriole duplication and gives rise to mitotic abnormalities.  SAK/PLK4 is necessary for centriole duplication both in Drosophila and human cells.  Drosophila cells tolerate the lack of centrioles and undertake mitosis but cannot form basal bodies and hence flagella.  Human cells depleted of SAK show error-prone mitosis, likely to underlie its tumor-suppressor role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFoGUh8x0B_7Vg90H21EOLACvtfcHk0li7U4pEkI5tbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlahu7fP&md5=31069d55e1b8e6ecdaaababd791b72a7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2005.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2005.11.042%26sid%3Dliteratum%253Aachs%26aulast%3DBettencourt-Dias%26aufirst%3DM.%26aulast%3DRodrigues-Martins%26aufirst%3DA.%26aulast%3DCarpenter%26aufirst%3DL.%26aulast%3DRiparbelli%26aufirst%3DM.%26aulast%3DLehmenn%26aufirst%3DL.%26aulast%3DGatt%26aufirst%3DM.%2BK.%26aulast%3DCarmo%26aufirst%3DN.%26aulast%3DBalloux%26aufirst%3DF.%26aulast%3DCallani%26aufirst%3DG.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DSAK%252FPLK4%2520is%2520required%2520for%2520centriole%2520duplication%2520and%2520flagella%2520development%26jtitle%3DCurr.%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D2199%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Habedanck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stierhof, Y.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">The Polo kinase PLK4 functions in centriole duplication</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1038%2Fncb1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=16244668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1140-1146&author=R.+Habedanckauthor=Y.-D.+Stierhofauthor=C.+J.+Wilkinsonauthor=E.+A.+Nigg&title=The+Polo+kinase+PLK4+functions+in+centriole+duplication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Polo kinase Plk4 functions in centriole duplication</span></div><div class="casAuthors">Habedanck, Robert; Stierhof, York-Dieter; Wilkinson, Christopher J.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human Polo-like kinase 1 (PLK1) and its functional homologs that are present in other eukaryotes have multiple, crucial roles in meiotic and mitotic cell division.  By contrast, the functions of other mammalian Polo family members remain largely unknown.  Plk4 is the most structurally divergent Polo family member; it is maximally expressed in actively dividing tissues and is essential for mouse embryonic development.  Here, we identify Plk4 as a key regulator of centriole duplication.  Both gain- and loss-of-function expts. demonstrate that Plk4 is required - in cooperation with Cdk2, CP110 and Hs-SAS6 - for the precise reprodn. of centrosomes during the cell cycle.  These findings provide an attractive explanation for the crucial function of Plk4 in cell proliferation and have implications for the role of Polo kinases in tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqCnuaYPx-YrVg90H21EOLACvtfcHk0lhzsKeAF4iykA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqtrjL&md5=dda15e878cf410e2de8796a4345aa405</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncb1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1335%26sid%3Dliteratum%253Aachs%26aulast%3DHabedanck%26aufirst%3DR.%26aulast%3DStierhof%26aufirst%3DY.-D.%26aulast%3DWilkinson%26aufirst%3DC.%2BJ.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DThe%2520Polo%2520kinase%2520PLK4%2520functions%2520in%2520centriole%2520duplication%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Mason, J.; Wei, S.; Luo, S.; Nadeem, V.; Kiarash, R.; Huang, P.; Awrey, A.; Leung, G.; Beletskaya, I.; Feher, M.; Forrest, B.; Laufer, R.; Sampson, P.; Li, S.-W.; Liu, Y.; Lang, Y.; Pauls, H. W.; Mak, T. W.; Pan, J. G.</span><span> </span><span class="NLM_article-title">Inhibition of Polo-like kinase 4 as an anti-cancer strategy</span>. <span class="NLM_conf-date">AACR 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2–6, 2011</span> <span class="NLM_fpage">LB-215</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mason%2C+J.%3B+Wei%2C+S.%3B+Luo%2C+S.%3B+Nadeem%2C+V.%3B+Kiarash%2C+R.%3B+Huang%2C+P.%3B+Awrey%2C+A.%3B+Leung%2C+G.%3B+Beletskaya%2C+I.%3B+Feher%2C+M.%3B+Forrest%2C+B.%3B+Laufer%2C+R.%3B+Sampson%2C+P.%3B+Li%2C+S.-W.%3B+Liu%2C+Y.%3B+Lang%2C+Y.%3B+Pauls%2C+H.+W.%3B+Mak%2C+T.+W.%3B+Pan%2C+J.+G.+Inhibition+of+Polo-like+kinase+4+as+an+anti-cancer+strategy.+AACR+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2%E2%80%936%2C+2011LB-215."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Polo-like%2520kinase%25204%2520as%2520an%2520anti-cancer%2520strategy%26spage%3DLB-215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the cell cycle in cancer: TTK (MPS1) and PLK4 as novel mitotic targets</span>, <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+cell+cycle+in+cancer%3A+TTK+%28MPS1%29+and+PLK4+as+novel+mitotic+targets%2C+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520cell%2520cycle%2520in%2520cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520novel%2520mitotic%2520targets" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors as novel antiproliferative agents</span>. <span class="NLM_conf-name">Canadian Chemistry Conference & Exhibition</span>, <span class="NLM_conf-loc">Quebec City, QC</span>, <span class="NLM_conf-date">May 26–29, 2013</span>,  <span class="NLM_fpage">BM7-00029</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pauls%2C+H.+W.+The+discovery+of+PLK4+inhibitors+as+novel+antiproliferative+agents.+Canadian+Chemistry+Conference+%26+Exhibition%2C+Quebec+City%2C+QC%2C+May+26%E2%80%9329%2C+2013%2C+BM7-00029."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%2520as%2520novel%2520antiproliferative%2520agents%26spage%3DBM7-00029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The discovery of PLK4 inhibitors: (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones as novel anti-proliferative agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6069</span><span class="NLM_x">–</span> <span class="NLM_lpage">6087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400380m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6069-6087&author=R.+Lauferauthor=B.+Forrestauthor=S.+Liauthor=P.+Sampsonauthor=Y.+Liuauthor=L.+Edwardsauthor=Y.+Langauthor=D.+Awreyauthor=G.+Maoauthor=O.+Plotnikovaauthor=G.+Leungauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=J.+Masonauthor=X.+Luoauthor=V.+Nadeemauthor=M.+Feherauthor=F.+Banauthor=S.+Weiauthor=R.+Kiarashauthor=E.+Greenauthor=T.+Makauthor=J.+Panauthor=H.+W.+Pauls&title=The+discovery+of+PLK4+inhibitors%3A+%28E%29-3-%28%281H-indazol-6-yl%29methylene%29indolin-2-ones+as+novel+anti-proliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm400380m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400380m%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DAwrey%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DMak%26aufirst%3DT.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520discovery%2520of%2520PLK4%2520inhibitors%253A%2520%2528E%2529-3-%2528%25281H-indazol-6-yl%2529methylene%2529indolin-2-ones%2520as%2520novel%2520anti-proliferative%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6069%26epage%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Harrington, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebbington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajose-Adeogun, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hercend, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diu-Hercend, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. M.</span><span> </span><span class="NLM_article-title">VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=262-267&author=E.+A.+Harringtonauthor=D.+Bebbingtonauthor=J.+Mooreauthor=R.+K.+Rasmussenauthor=A.+O.+Ajose-Adeogunauthor=T.+Nakayamaauthor=J.+A.+Grahamauthor=C.+Demurauthor=T.+Hercendauthor=A.+Diu-Hercendauthor=M.+Suauthor=J.+M.+C.+Golecauthor=K.+M.+Miller&title=VX-680%2C+a+potent+and+selective+small-molecule+inhibitor+of+the+Aurora+kinases%2C+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DE.%2BA.%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DRasmussen%26aufirst%3DR.%2BK.%26aulast%3DAjose-Adeogun%26aufirst%3DA.%2BO.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DJ.%2BA.%26aulast%3DDemur%26aufirst%3DC.%26aulast%3DHercend%26aufirst%3DT.%26aulast%3DDiu-Hercend%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DMiller%26aufirst%3DK.%2BM.%26atitle%3DVX-680%252C%2520a%2520potent%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520the%2520Aurora%2520kinases%252C%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DNature%2520Med.%26date%3D2004%26volume%3D10%26spage%3D262%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hu-Lowe, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazzini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amundson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewolinski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalinsky, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span> </span><span class="NLM_article-title">Nonclinical antiangiogenesis and antitumor activities of Axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7272</span><span class="NLM_x">–</span> <span class="NLM_lpage">7283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1158%2F1078-0432.CCR-08-0652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=19010843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlylur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7272-7283&author=D.+D.+Hu-Loweauthor=H.+Y.+Zouauthor=M.+L.+Grazziniauthor=M.+E.+Hallinauthor=G.+R.+Wickmanauthor=K.+Amundsonauthor=J.+H.+Chenauthor=D.+A.+Rewolinskiauthor=S.+Yamazakiauthor=E.+Y.+Wuauthor=M.+A.+McTigueauthor=B.+W.+Murrayauthor=R.+S.+Kaniaauthor=P.+O%E2%80%99Connorauthor=D.+R.+Shalinskyauthor=S.+L.+Bender&title=Nonclinical+antiangiogenesis+and+antitumor+activities+of+Axitinib+%28AG-013736%29%2C+an+oral%2C+potent%2C+and+selective+inhibitor+of+vascular+endothelial+growth+factor+receptor+tyrosine+kinases+1%2C+2%2C+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3</span></div><div class="casAuthors">Hu-Lowe, Dana D.; Zou, Helen Y.; Grazzini, Maren L.; Hallin, Max E.; Wickman, Grant R.; Amundson, Karin; Chen, Jeffrey H.; Rewolinski, David A.; Yamazaki, Shinji; Wu, Ellen Y.; McTigue, Michele A.; Murray, Brion W.; Kania, Robert S.; O'Connor, Patrick; Shalinsky, David R.; Bender, Steve L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7272-7283</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Axitinib (AG-013736) is a potent and selective inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases 1 to 3 that is in clin. development for the treatment of solid tumors.  We provide a comprehensive description of its in vitro characteristics and activities, in vivo antiangiogenesis, and antitumor efficacy and translational pharmacol. data.  Exptl. Design: The potency, kinase selectivity, pharmacol. activity, and antitumor efficacy of axitinib were assessed in various nonclin. models.  RESULTS: Axitinib inhibits cellular autophosphorylation of VEGF receptors (VEGFR) with picomolar IC50 values.  Counterscreening across multiple kinase and protein panels shows it is selective for VEGFRs.  Axitinib blocks VEGF-mediated endothelial cell survival, tube formation, and downstream signaling through endothelial nitric oxide synthase, Akt and extracellular signal-regulated kinase.  Following twice daily oral administration, axitinib produces consistent and dose-dependent antitumor efficacy that is assocd. with blocking VEGFR-2 phosphorylation, vascular permeability, angiogenesis, and concomitant induction of tumor cell apoptosis.  Axitinib in combination with chemotherapeutic or targeted agents enhances antitumor efficacy in many tumor models compared with single agent alone.  Dose scheduling studies in a human pancreatic tumor xenograft model show that simultaneous administration of axitinib and gemcitabine without prolonged dose interruption or truncation of axitinib produces the greatest antitumor efficacy.  The efficacious drug concns. predicted in nonclin. studies are consistent with the range achieved in the clinic.  Although axitinib inhibits platelet-derived growth factor receptors and KIT with nanomolar in vitro potencies, based on pharmacokinetic/pharmacodynamic anal., axitinib acts primarily as a VEGFR tyrosine kinase inhibitor at the current clin. exposure.  CONCLUSIONS: The selectivity, potency for VEGFRs, and robust nonclin. activity may afford broad opportunities for axitinib to improve cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhwUJi2tefWrVg90H21EOLACvtfcHk0ljjJhKe-wGufw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlylur7I&md5=6a616860756379e85551afe6b9eb750e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0652%26sid%3Dliteratum%253Aachs%26aulast%3DHu-Lowe%26aufirst%3DD.%2BD.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DGrazzini%26aufirst%3DM.%2BL.%26aulast%3DHallin%26aufirst%3DM.%2BE.%26aulast%3DWickman%26aufirst%3DG.%2BR.%26aulast%3DAmundson%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%2BH.%26aulast%3DRewolinski%26aufirst%3DD.%2BA.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DE.%2BY.%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DShalinsky%26aufirst%3DD.%2BR.%26aulast%3DBender%26aufirst%3DS.%2BL.%26atitle%3DNonclinical%2520antiangiogenesis%2520and%2520antitumor%2520activities%2520of%2520Axitinib%2520%2528AG-013736%2529%252C%2520an%2520oral%252C%2520potent%252C%2520and%2520selective%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinases%25201%252C%25202%252C%25203%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7272%26epage%3D7283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Pharmacological and functional comparison of the Polo-like kinase family: insight into inhibitor and substrate specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9551</span><span class="NLM_x">–</span> <span class="NLM_lpage">9563</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9551-9563&author=E.+F.+Johnsonauthor=K.+D.+Stewartauthor=K.+W.+Woodsauthor=V.+L.+Girandaauthor=Y.+Luo&title=Pharmacological+and+functional+comparison+of+the+Polo-like+kinase+family%3A+insight+into+inhibitor+and+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi7008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7008745%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DPharmacological%2520and%2520functional%2520comparison%2520of%2520the%2520Polo-like%2520kinase%2520family%253A%2520insight%2520into%2520inhibitor%2520and%2520substrate%2520specificity%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D9551%26epage%3D9563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Donaldson, W. A.</span><span> </span><span class="NLM_article-title">Synthesis of cyclopropane containing natural products</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8589</span><span class="NLM_x">–</span> <span class="NLM_lpage">8627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1016%2FS0040-4020%2801%2900777-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2ru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=8589-8627&author=W.+A.+Donaldson&title=Synthesis+of+cyclopropane+containing+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of cyclopropane containing natural products</span></div><div class="casAuthors">Donaldson, W. A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">8589-8627</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review of recent developments in cyclopropane synthesis, and synthesis of selected cyclopropane targets which includes curacin A, cilastatin, marine derived cyclopropane derivs., polycyclopropanes, ambruticin and (carboxycyclopropyl)glycines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAKv8TdOV5VbVg90H21EOLACvtfcHk0ljjJhKe-wGufw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2ru7w%253D&md5=009dba87a81463fde3b7afeb19a29a0d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2900777-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252900777-3%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520of%2520cyclopropane%2520containing%2520natural%2520products%26jtitle%3DTetrahedron%26date%3D2001%26volume%3D57%26spage%3D8589%26epage%3D8627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lebel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoux, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinaro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charette, A. B.</span><span> </span><span class="NLM_article-title">Stereoselective cyclopropanation reactions</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">1050</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010007e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2003&pages=977-1050&author=H.+Lebelauthor=J.+F.+Marcouxauthor=C.+Molinaroauthor=A.+B.+Charette&title=Stereoselective+cyclopropanation+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective Cyclopropanation Reactions</span></div><div class="casAuthors">Lebel, Helene; Marcoux, Jean-Francois; Molinaro, Carmela; Charette, Andre B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">977-1050</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUAxS9Vy1tYLVg90H21EOLACvtfcHk0ljjJhKe-wGufw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislSjt7o%253D&md5=ddd27c744fcd09d7991420025aa613d2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr010007e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010007e%26sid%3Dliteratum%253Aachs%26aulast%3DLebel%26aufirst%3DH.%26aulast%3DMarcoux%26aufirst%3DJ.%2BF.%26aulast%3DMolinaro%26aufirst%3DC.%26aulast%3DCharette%26aufirst%3DA.%2BB.%26atitle%3DStereoselective%2520cyclopropanation%2520reactions%26jtitle%3DChem.%2520Rev.%26date%3D2003%26volume%3D103%26spage%3D977%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. F.</span><span> </span><span class="NLM_article-title">Synthesis and properties of cyclopropane-derived peptidomimetics</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar030255s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkslylu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=433-442&author=A.+Reicheltauthor=S.+F.+Martin&title=Synthesis+and+properties+of+cyclopropane-derived+peptidomimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Properties of Cyclopropane-Derived Peptidomimetics</span></div><div class="casAuthors">Reichelt, Andreas; Martin, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">433-442</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Small peptides exhibit a wide range of biol. activities, but although there are some notable exceptions, they are not generally useful as drugs.  This has spurred widespread interest in designing peptidomimetics and introducing them as replacements of portions of native peptides to enhance their biol. properties.  Special attention has been focused upon rigid replacements because of their potential to preorganize the resulting pseudopeptide in a conformation corresponding to its bound structure.  Toward this goal, we invented trisubstituted cyclopropanes as novel peptidomimetics, anticipating that the cyclopropane ring would locally orient the backbone and the corresponding amino acid side chain in the biol. active conformation.  Selected aspects of the syntheses and applications of these cyclopropane-derived peptidomimetics are presented in this Account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLsUm4nSG2ybVg90H21EOLACvtfcHk0lg6tHUZtqnCGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkslylu7s%253D&md5=b23c01ae876af2f4517c57c9dcba75e4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Far030255s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far030255s%26sid%3Dliteratum%253Aachs%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520and%2520properties%2520of%2520cyclopropane-derived%2520peptidomimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2006%26volume%3D39%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taber, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span> </span><span class="NLM_article-title">Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6023</span><span class="NLM_x">–</span> <span class="NLM_lpage">6034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6023-6034&author=R.+J.+Mattsonauthor=J.+D.+Cattauthor=D.+J.+Denhartauthor=J.+A.+Deskusauthor=J.+L.+Dittaauthor=M.+A.+Higginsauthor=L.+R.+Marconauthor=C.+P.+Sloanauthor=B.+R.+Benoauthor=Q.+Gaoauthor=M.+A.+Cunninghamauthor=G.+K.+Mattsonauthor=T.+F.+Molskiauthor=M.+T.+Taberauthor=N.+J.+Lodge&title=Conformationally+restricted+homotryptamines.+2.+Indole+cyclopropylmethylamines+as+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0503291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503291%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DCatt%26aufirst%3DJ.%2BD.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DHiggins%26aufirst%3DM.%2BA.%26aulast%3DMarcon%26aufirst%3DL.%2BR.%26aulast%3DSloan%26aufirst%3DC.%2BP.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DCunningham%26aufirst%3DM.%2BA.%26aulast%3DMattson%26aufirst%3DG.%2BK.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DTaber%26aufirst%3DM.%2BT.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26atitle%3DConformationally%2520restricted%2520homotryptamines.%25202.%2520Indole%2520cyclopropylmethylamines%2520as%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6023%26epage%3D6034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursulaya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wub, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hea, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluations of novel oxindolesas HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2105</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2105-2108&author=T.+Jiangauthor=K.+L.+Kuhenauthor=K.+Wolffauthor=H.+Yinauthor=K.+Biezaauthor=J.+Caldwellauthor=B.+Bursulayaauthor=T.+Y.+Wubauthor=Y.+Hea&title=Design%2C+synthesis+and+biological+evaluations+of+novel+oxindolesas+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors.+Part+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DWolff%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DBieza%26aufirst%3DK.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DWub%26aufirst%3DT.%2BY.%26aulast%3DHea%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluations%2520of%2520novel%2520oxindolesas%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors.%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2105%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wurster, J. A.</span><span> </span><span class="NLM_article-title">3-Spirocyclopropyl-2-oxindole compound tyrosine kinase inhibitors, and their therapeutic use</span>. PCT Int. Appl.  WO2007008664,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+A.+Wurster&title=3-Spirocyclopropyl-2-oxindole+compound+tyrosine+kinase+inhibitors%2C+and+their+therapeutic+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWurster%26aufirst%3DJ.%2BA.%26atitle%3D3-Spirocyclopropyl-2-oxindole%2520compound%2520tyrosine%2520kinase%2520inhibitors%252C%2520and%2520their%2520therapeutic%2520use%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Corey, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaykovsky, M.</span><span> </span><span class="NLM_article-title">Dimethyloxosulfonium methylide and dimethylsulfonium methylide. Formation and application to organic synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1364</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01084a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1965&pages=1353-1364&author=E.+J.+Coreyauthor=M.+Chaykovsky&title=Dimethyloxosulfonium+methylide+and+dimethylsulfonium+methylide.+Formation+and+application+to+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja01084a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01084a034%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DChaykovsky%26aufirst%3DM.%26atitle%3DDimethyloxosulfonium%2520methylide%2520and%2520dimethylsulfonium%2520methylide.%2520Formation%2520and%2520application%2520to%2520organic%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1965%26volume%3D87%26spage%3D1353%26epage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ciaccio, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, C. E.</span><span> </span><span class="NLM_article-title">“Instant methylide” modification of the Corey–Chaykovsky cyclopropanation reaction</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1080%2F00397910500521837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVGks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=1333-1341&author=J.+A.+Ciaccioauthor=C.+E.+Aman&title=%E2%80%9CInstant+methylide%E2%80%9D+modification+of+the+Corey%E2%80%93Chaykovsky+cyclopropanation+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Instant methylide modification of the Corey-Chaykovsky cyclopropanation reaction</span></div><div class="casAuthors">Ciaccio, James; Aman, Courtney</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1333-1341</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Treatment of various electron-deficient alkenes in DMSO with stable, dry, equimolar mixts. of either Me3S(O)I/tert-BuOK or Me3S(O)I/NaH cleanly afforded the corresponding substituted cyclopropanes in good yields and short reaction times (<20 min for reactions at 50-60°C using 0.4-4.0 mmol alkene).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopFZ4BmTTyDrVg90H21EOLACvtfcHk0lg6tHUZtqnCGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVGks7o%253D&md5=7c004c8214487e60893a3779ef36a874</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F00397910500521837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910500521837%26sid%3Dliteratum%253Aachs%26aulast%3DCiaccio%26aufirst%3DJ.%2BA.%26aulast%3DAman%26aufirst%3DC.%2BE.%26atitle%3D%25E2%2580%259CInstant%2520methylide%25E2%2580%259D%2520modification%2520of%2520the%2520Corey%25E2%2580%2593Chaykovsky%2520cyclopropanation%2520reaction%26jtitle%3DSynth.%2520Commun.%26date%3D2006%26volume%3D36%26spage%3D1333%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Moldvai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gacs-Baitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szantay, C.</span><span> </span><span class="NLM_article-title">Synthesis of spiro[cyclopropane-1,3′-[3H]indol]-2′(1′<i>H</i>)-ones with antihypoxic effects</span> <span class="citation_source-journal">Arch. Pharm. Pharm. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1002%2Fardp.19963291206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=9038422" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1996&pages=541-549&author=I.+Moldvaiauthor=E.+Gacs-Baitzauthor=M.+Balazsauthor=M.+Inczeauthor=C.+Szantay&title=Synthesis+of+spiro%5Bcyclopropane-1%2C3%E2%80%B2-%5B3H%5Dindol%5D-2%E2%80%B2%281%E2%80%B2H%29-ones+with+antihypoxic+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fardp.19963291206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19963291206%26sid%3Dliteratum%253Aachs%26aulast%3DMoldvai%26aufirst%3DI.%26aulast%3DGacs-Baitz%26aufirst%3DE.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DIncze%26aufirst%3DM.%26aulast%3DSzantay%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520spiro%255Bcyclopropane-1%252C3%25E2%2580%25B2-%255B3H%255Dindol%255D-2%25E2%2580%25B2%25281%25E2%2580%25B2H%2529-ones%2520with%2520antihypoxic%2520effects%26jtitle%3DArch.%2520Pharm.%2520Pharm.%2520Med.%2520Chem.%26date%3D1996%26volume%3D329%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, Y.</span><span> </span><span class="NLM_article-title">Formation of (<i>Z</i>)allylboronates vis ruthenium-catalyzed hydroboration of propargyl ethers with pinacolborane</span> <span class="citation_source-journal">J. Chem. Res. (S)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.3184%2F030823402103171438" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=142-143&author=M.+Murataauthor=S.+Watanabeauthor=Y.+Masuda&title=Formation+of+%28Z%29allylboronates+vis+ruthenium-catalyzed+hydroboration+of+propargyl+ethers+with+pinacolborane"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3184%2F030823402103171438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F030823402103171438%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DS.%26aulast%3DMasuda%26aufirst%3DY.%26atitle%3DFormation%2520of%2520%2528Z%2529allylboronates%2520vis%2520ruthenium-catalyzed%2520hydroboration%2520of%2520propargyl%2520ethers%2520with%2520pinacolborane%26jtitle%3DJ.%2520Chem.%2520Res.%2520%2528S%2529%26date%3D2002%26spage%3D142%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hunt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiting, A.</span><span> </span><span class="NLM_article-title">Heck versus Suzuki palladium catalyzed cross-coupling of a vinylboronate ester with aryl halides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3599</span><span class="NLM_x">–</span> <span class="NLM_lpage">3602</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=3599-3602&author=A.+R.+Huntauthor=S.+K.+Stewartauthor=A.+Whiting&title=Heck+versus+Suzuki+palladium+catalyzed+cross-coupling+of+a+vinylboronate+ester+with+aryl+halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DA.%2BR.%26aulast%3DStewart%26aufirst%3DS.%2BK.%26aulast%3DWhiting%26aufirst%3DA.%26atitle%3DHeck%2520versus%2520Suzuki%2520palladium%2520catalyzed%2520cross-coupling%2520of%2520a%2520vinylboronate%2520ester%2520with%2520aryl%2520halides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1993%26volume%3D34%26spage%3D3599%26epage%3D3602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span><span> </span><span class="NLM_article-title">PK Functions for Microsoft Excel</span>. In Pharmacokinetic Software; <span class="NLM_publisher-name">David W. A. Bourne</span>,<span class="NLM_x"> </span><span class="NLM_year">2001–2003</span><span class="NLM_x">; </span><a href="http://www.boomer.org/pkin/soft.html" class="extLink">http://www.boomer.org/pkin/soft.html</a>, Accessed November, 2008.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001%E2%80%932003&author=J.+I.+Usansky&author=A.+Desai&author=D.+Tang-Liu&title=PK+Functions+for+Microsoft+Excel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26atitle%3DPK%2520Functions%2520for%2520Microsoft%2520Excel%26jtitle%3DPharmacokinetic%2520Software%26pub%3DDavid%2520W.%2520A.%2520Bourne%26date%3D2001%25E2%2580%25932003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgar7J6eLQb3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Adams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+Adamsauthor=P.+Afonineauthor=G.+Bunkoczi&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgar7J6eLQb3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%26aulast%3DAfonine%26aufirst%3DP.%26aulast%3DBunkoczi%26aufirst%3DG.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500537u&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm500537u&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgs6Z0h23_IbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>Buster 2.10.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=Buster+2.10.0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%25202.10.0%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span>Schrödinger Suite 2009 Protein Preparation Wizard, Epik, <span class="NLM_edition"> version 2.0</span>; <span class="NLM_publisher-name"> Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2009+Protein+Preparation+Wizard%2C+Epik%2C+version+2.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202009%2520Protein%2520Preparation%2520Wizard%252C%2520Epik%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref39_2"><span>Impact, <span class="NLM_edition">version 5.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2009%3B+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref39_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref39_3"><span>Prime, <span class="NLM_edition">version 2.1</span>; <span class="NLM_publisher-name">Schrödinger LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+2.1%3B+Schr%C3%B6dinger+LLC%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref39_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2009.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec, H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2009.10%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec%2C+H3A+2R7%2C+Canada%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span>Corina, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Molecular Networks GmbH</span>: <span class="NLM_publisher-loc">Erlangen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Corina%2C+version+3.2%3B+Molecular+Networks+GmbH%3A+Erlangen%2C+Germany%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%2520GmbH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Effect of input differences on the results of docking calculations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1704</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9000629" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1704-1714&author=M.+Feherauthor=C.+I.+Williams&title=Effect+of+input+differences+on+the+results+of+docking+calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Input Differences on the Results of Docking Calculations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sensitivity of docking calcns. to the geometry of the input ligand was studied.  It was found that even small changes in the ligand input conformation can lead to large differences in the geometries and scores of the resulting docked poses.  The accuracy of docked poses produced from different ligand input structures, the x-ray structure, the minimized Corina structure, and structures generated from conformational searches and mol. dynamics ensembles, were also assessed.  It was found that using the x-ray ligand conformation as docking input does not always produce the most accurate docked pose when compared with other sources of ligand input conformations.  Furthermore, no one method of conformer generation is guaranteed to always produce the most accurate docking pose.  The docking scores are also highly sensitive to the source of the input conformation, which might introduce some noise in compd. ranking and in binding affinity predictions.  It is concluded that for the purposes of reproducibility and optimal performance, the most prudent procedure is to use multiple input structures for docking.  The implications of these results on docking validation studies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfgWRxj66UbVg90H21EOLACvtfcHk0lgs6Z0h23_IbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D&md5=fb35182895e0cc07cf4c4bb4de05e6d1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fci9000629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9000629%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DEffect%2520of%2520input%2520differences%2520on%2520the%2520results%2520of%2520docking%2520calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D1704%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Numerical errors and chaotic behavior in docking simulations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200598m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm500537u&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=724-738&author=M.+Feherauthor=C.+I.+Williams&title=Numerical+errors+and+chaotic+behavior+in+docking+simulations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical Errors and Chaotic Behavior in Docking Simulations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">724-738</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work examines the sensitivity of docking programs to tiny changes in ligand input files.  The results show that nearly identical ligand input structures can produce dramatically different top-scoring docked poses.  Even changing the atom order in a ligand input file can produce significantly different poses and scores.  In well-behaved cases the docking variations are small and follow a normal distribution around a central pose and score, but in many cases the variations are large and reflect wildly different top scores and binding modes.  The docking variations are characterized by statistical methods, and the sensitivity of high-throughput and more precise docking methods are compared.  The results demonstrate that part of docking variation is due to numerical sensitivity and potentially chaotic effects in current docking algorithms and not solely due to incomplete ligand conformation and pose searching.  These results have major implications for the way docking is currently used for pose prediction, ranking, and virtual screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nddk3ttKx7Vg90H21EOLACvtfcHk0lhsNjerNra9qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D&md5=7aa7ef2005ad88f2b145c1a2975621c9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fci200598m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200598m%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DNumerical%2520errors%2520and%2520chaotic%2520behavior%2520in%2520docking%2520simulations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D724%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span> <span class="citation_source-book">Glide</span>, <span class="NLM_edition">version 2009</span>; <span class="NLM_publisher-name">Schrodinger Inc.</span>: <span class="NLM_publisher-loc">Portland, OR</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+2009%3B+Schrodinger+Inc.%3A+Portland%2C+OR%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGlide%26pub%3DSchrodinger%2520Inc%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Sampson, P. B.; Liu, Y.; Forrest, B.; Cumming, G.; Li, S.-W.; Patel, N. K.; Edwards, L.; Laufer, R.; Feher, M.; Ban, F.; Awrey, D. E.; Mao, G.; Plotnikova, O.; Hodgson, R.; Beletskaya, I.</span>; <span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeira, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The Discovery of Polo-like Kinase 4 Inhibitors: Identification of (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-(((<i>cis</i>)-2,6- dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a Potent, Orally Active Antitumor Agent</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI <span class="refDoi"> DOI: 10.1021/jm5005336</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm5005336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sampson%2C+P.+B.%3B+Liu%2C+Y.%3B+Forrest%2C+B.%3B+Cumming%2C+G.%3B+Li%2C+S.-W.%3B+Patel%2C+N.+K.%3B+Edwards%2C+L.%3B+Laufer%2C+R.%3B+Feher%2C+M.%3B+Ban%2C+F.%3B+Awrey%2C+D.+E.%3B+Mao%2C+G.%3B+Plotnikova%2C+O.%3B+Hodgson%2C+R.%3B+Beletskaya%2C+I.%3B+Mason%2C+J.+M.%3B+Luo%2C+X.%3B+Nadeem%2C+V.%3B+Wei%2C+X.%3B+Kiarash%2C+R.%3B+Madeira%2C+B.%3B+Huang%2C+P.%3B+Mak%2C+T.+W.%3B+Pan%2C+G.%3B+Pauls%2C+H.+W.+The+Discovery+of+Polo-like+Kinase+4+Inhibitors%3A+Identification+of+%281R%2C2S%29-2-%283-%28%28E%29-4-%28%28%28cis%29-2%2C6-+dimethylmorpholino%29methyl%29styryl%29-1H-indazol-6-yl%29-5%27-methoxyspiro%5Bcyclopropane-1%2C3%27-indolin%5D-2%27-one+%28CFI-400945%29+as+a+Potent%2C+Orally+Active+Antitumor+Agent.+J.+Med.+Chem.+DOI+10.1021%2Fjm5005336."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm5005336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5005336%26sid%3Dliteratum%253Aachs%26aulast%3DSampson%26aufirst%3DP.%2BB.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DMadeira%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520Discovery%2520of%2520Polo-like%2520Kinase%25204%2520Inhibitors%253A%2520Identification%2520of%2520%25281R%252C2S%2529-2-%25283-%2528%2528E%2529-4-%2528%2528%2528cis%2529-2%252C6-%2520dimethylmorpholino%2529methyl%2529styryl%2529-1H-indazol-6-yl%2529-5%2527-methoxyspiro%255Bcyclopropane-1%252C3%2527-indolin%255D-2%2527-one%2520%2528CFI-400945%2529%2520as%2520a%2520Potent%252C%2520Orally%2520Active%2520Antitumor%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm5005336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3COK','PDB','3COK'); return false;">PDB: 3COK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JXF','PDB','4JXF'); return false;">PDB: 4JXF</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a href="/doi/suppl/10.1021/jm500537u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77163"></div></div></div></div></div><hr /></hr><p class="last">Synthesis of compound intermediates; crystallographic data and refinement statistics for PLK4/compound <b>18</b> complex. Correlation plot for the predictivity of the PLK4 binding model. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500537u/suppl_file/jm500537u_si_001.pdf">jm500537u_si_001.pdf (1.05 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500537u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm500537u%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-1%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500537u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679996be9b7e24d3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
